Compound
coenzyme Q10
A lipid-soluble benzoquinone which is involved in electron transport in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.
Studied for
34 endpoints · 67 findings · 34 papers · 39 null
- C-reactive protein concentrationno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Fasting blood glucoseno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Total antioxidant capacityno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Tumour necrosis factor alpha concentrationlowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- All-cause mortalityno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
Structure
A ubiquinone having a side chain of 10 isoprenoid units. In the naturally occurring isomer, all isoprenyl double bonds are in the E- configuration.
No three-dimensional record for this entry.
- Class
- Organic compound
- Formula
- C59H90O4
- Mass
- 863.365 g/mol
- Charge
- 0
- InChIKey
- ACTIUHUUMQJHFO-UPTCCGCDSA-N
- SMILES
- COC1=C(OC)C(=O)C(C/C=C(C)CC/C=C(C)CC/C=C(C)CC/C=C(C)CC/C=C(C)CC/C=C(C)CC/C=C(C)CC/C=C(C)CC/C=C(C)CCC=C(C)C)=C(C)C1=O
- Look it up
- ChEBIBy InChIKey
Identity from ChEBI. Not evidence.
What the evidence says
How to read these marks67 findings · 34 endpoints · 34 papers · 39 null · by evidence strength
- Evidence strength
- Strong
- Moderate
- Limited
- Very limited
- Insufficient
What moved
28 findings
Increases clinical pregnancy rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Compared with the control group, CoQ10 (OR 2.22, 95%CI: 1.05 to 4.71) and DHEA (OR 1.92, 95%CI: 1.16 to 3.16) showed obvious advantages in improving the clinical pregnancy rate.”
Quoted verbatim from TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis.. - Study
- meta-analysis
- Population
- women with poor ovarian response (POR) undergoing IVF-ET, defined by Bologna criteria; network meta-analysis of 16 RCTs (2323 participants)
Effect 2.22 odds ratio, 95% CI 1.05 to 4.71
TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis.2023PMID:37464357Permalink
Decreases serum leptin
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Remarkably, a meta-analysis of included studies revealed significant reduction of leptin levels in individuals on CoQ10 supplementation when compared to those on placebo (SMD: −0.59 [95% CI: −0.98, −0.21]; I2 = 0%, p = 0.37).”
Quoted verbatim from Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- adults with metabolic syndrome; meta-analysis of 6 RCTs (318 participants)
Effect -0.59 standardised mean difference, 95% CI -0.98 to -0.21
Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.2020PMID:32375340Permalink
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“All-cause mortality was lower in the CoQ10 group, 10 (9%) patients vs. 24 (20%) patients in the placebo group, corresponding to a relative reduction of 53% (p = 0.040).”
Quoted verbatim from Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.. - Study
- RCT
- Dose
- CoQ10 (Ubiquinone) 300 mg/day added to standard heart failure therapy
- Population
- European sub-population (n=231) of the Q-SYMBIO trial, moderate-to-severe chronic heart failure, on standard HF therapy in both arms, long-term (2-year) follow-up
Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.2019PMID:30835327Permalink
Decreases tumour necrosis factor alpha concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“The subjects in the Q10-300 group had a significantly lower level of TNF-α than those in the placebo group at week 12 (P = 0.039).”
Quoted verbatim from Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 300 mg/day (150 mg twice daily) for 12 weeks
- Population
- Patients with coronary artery disease on statin therapy for at least one month; single-blind placebo-controlled trial, 42 completers (placebo n = 19, coenzyme Q10 n = 23); week 12 between-group comparison
Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial.2013PMID:24192015Permalink
Decreases fasting blood glucose
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×1“The administration of CoQ10 resulted in a significant decrease in FBG levels (ESWMD = −5.04, 95% CI: −7.67, −2.40; p < 0.001, I 2 = 58.7%, p = 0.04) (Figure.”
Quoted verbatim from Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta-Analyses of Randomised Controlled Trials.. - Study
- meta-analysis
- Dose
- 110 to 376.6 mg/day CoQ10 across the included meta-analyses
- Population
- Adults with type 2 diabetes, obesity, polycystic ovary syndrome, chronic kidney disease, metabolic syndrome and other cardiometabolic conditions, from the randomised controlled trials pooled by eight meta-analyses.
Effect -5.04 mean difference, 95% CI -7.67 to -2.4
Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta-Analyses of Randomised Controlled Trials.2026PMID:41859772Permalink
Increases flow-mediated dilation
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×1“CoQ10 increased brachial artery FMD by mean ± SEM 1.0 ± 0.5% (P = 0.04) compared with placebo but did not alter nitrate-mediated dilatation (P = 0.66).”
Quoted verbatim from Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.. - Study
- crossover
- Duration
- 3 months
- Dose
- 200 mg/day
- Population
- Statin-treated type 2 diabetic patients aged 40-79 years with endothelial dysfunction (brachial FMD <5.5%) and LDL cholesterol <2.5 mmol/l; double-blind crossover versus placebo
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.2009PMID:19228872Permalink
Show the remaining 22
Decreases interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“CoQ10 supplementation significantly reduced the levels of circulating CRP (WMD: -0.35mg/L, 95% CI: -0.64 to -0.05, P=0.022), IL-6 (WMD: -1.61pg/mL, 95% CI: -2.64 to -0.58, P=0.002) and TNF-α (WMD: -0.49pg/mL, 95% CI: -0.93 to -0.06, P=0.027).”
Quoted verbatim from Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- patients from randomized controlled trials of CoQ10 supplementation (disease population not specified in abstract)
Effect -1.61 mean difference, 95% CI -2.64 to -0.58
Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.2017PMID:28179205Permalink
Decreases tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“CoQ10 supplementation significantly reduced the levels of circulating CRP (WMD: -0.35mg/L, 95% CI: -0.64 to -0.05, P=0.022), IL-6 (WMD: -1.61pg/mL, 95% CI: -2.64 to -0.58, P=0.002) and TNF-α (WMD: -0.49pg/mL, 95% CI: -0.93 to -0.06, P=0.027).”
Quoted verbatim from Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- patients from randomized controlled trials of CoQ10 supplementation (disease population not specified in abstract)
Effect -0.49 mean difference, 95% CI -0.93 to -0.06
Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.2017PMID:28179205Permalink
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“CoQ10 supplementation significantly reduced the levels of circulating CRP (WMD: -0.35mg/L, 95% CI: -0.64 to -0.05, P=0.022), IL-6 (WMD: -1.61pg/mL, 95% CI: -2.64 to -0.58, P=0.002) and TNF-α (WMD: -0.49pg/mL, 95% CI: -0.93 to -0.06, P=0.027).”
Quoted verbatim from Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- patients from randomized controlled trials of CoQ10 supplementation (disease population not specified in abstract)
Effect -0.35 mean difference, 95% CI -0.64 to -0.05
Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.2017PMID:28179205Permalink
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“The supplementation of CoQ10 decreased significantly the scores of Beck Depression Inventory (BDI) (p = .03) and Beck Anxiety Inventory (BAI) (p = .01) and high-sensitivity C-reactive protein (hs-CRP) level (p = .005) when comparing with the placebo group.”
Quoted verbatim from The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.. - Study
- RCT
- Duration
- 3 months
- Dose
- 100 mg/day CoQ10, 12 weeks
- Population
- Women with polycystic ovary syndrome (PCOS), aged 18-40 years
The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.2022PMID:34664527Permalink
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“At the end of study, compared with pldacebo, CoQ10 supplementation resulted in significant decreases in serum levels of TNF-α (p = 0.009), hs-CRP and IL-6 (p = 0.001, p = 0.007, respectively).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg CoQ10 capsules per day, 8 weeks
- Population
- Overweight and obese women with polycystic ovary syndrome (PCOS)
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.2021PMID:32544011Permalink
Increases circulating coenzyme Q10 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Pooled data did indicate that supplementation increased blood levels of coenzyme Q10 (MD 1.46; 95% CI 1.19 to 1.72, n = 112).”
Quoted verbatim from Coenzyme Q10 for heart failure.. - Study
- meta-analysis
- Participants
- 112
- Population
- patients with heart failure; Cochrane meta-analysis of 7 RCTs, 914 participants total, coenzyme Q10 versus placebo
Effect 1.46 mean difference, 95% CI 1.19 to 1.72
Coenzyme Q10 for heart failure.2014PMID:24049047Permalink
Increases circulating coenzyme Q10 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“At 3 months, CoQ10 concentration was significantly higher in the CoQ10 group (3.85 μg/mL) compared with placebo (1.13 μg/mL); this difference was not present at 6 months.”
Quoted verbatim from No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.. - Study
- RCT
- Dose
- 300 mg/day
- Population
- adults with schizophrenia or schizoaffective disorder, CoQ10 300 mg/day vs placebo; measured at 3 months (difference not present at 6 months)
No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.2020PMID:33347024Permalink
Decreases systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Treatment with coenzyme Q10 in subjects with systolic BP (SBP) > 140 mmHg or diastolic BP (DBP) > 90 mmHg resulted in mean decreases in SBP of 11 mmHg (95% CI 8, 14) and DBP of 7 mmHg (95% CI 5, 8).”
Quoted verbatim from Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.. - Study
- meta-analysis
- Population
- adults with primary hypertension (SBP >140 mmHg or DBP >90 mmHg); Cochrane meta-analysis of 3 RCTs, 96 participants, coenzyme Q10 versus placebo for at least 3 weeks
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.2009PMID:19821418Permalink
Decreases diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Treatment with coenzyme Q10 in subjects with systolic BP (SBP) > 140 mmHg or diastolic BP (DBP) > 90 mmHg resulted in mean decreases in SBP of 11 mmHg (95% CI 8, 14) and DBP of 7 mmHg (95% CI 5, 8).”
Quoted verbatim from Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.. - Study
- meta-analysis
- Population
- adults with primary hypertension (SBP >140 mmHg or DBP >90 mmHg); Cochrane meta-analysis of 3 RCTs, 96 participants, coenzyme Q10 versus placebo for at least 3 weeks
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.2009PMID:19821418Permalink
Decreases tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“At the end of study, compared with pldacebo, CoQ10 supplementation resulted in significant decreases in serum levels of TNF-α (p = 0.009), hs-CRP and IL-6 (p = 0.001, p = 0.007, respectively).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg CoQ10 capsules per day, 8 weeks
- Population
- Overweight and obese women with polycystic ovary syndrome (PCOS)
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.2021PMID:32544011Permalink
Increases flow-mediated dilation
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Meta-analysis using random-effects model showed treatment with coenzyme Q10 significantly improvement in endothelial function assessed peripherally by flow-mediated dilatation (SMD 1.70, 95% CI: 1.00-2.4, p<0.0001).”
Quoted verbatim from Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- patients with and without established cardiovascular disease
Effect 1.7 standardised mean difference, 95% CI 1 to 2.4
Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials.2012PMID:22088605Permalink
Decreases interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“At the end of study, compared with pldacebo, CoQ10 supplementation resulted in significant decreases in serum levels of TNF-α (p = 0.009), hs-CRP and IL-6 (p = 0.001, p = 0.007, respectively).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg CoQ10 capsules per day, 8 weeks
- Population
- Overweight and obese women with polycystic ovary syndrome (PCOS)
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.2021PMID:32544011Permalink
Decreases total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Overall, the current meta-analysis demonstrated that CoQ10 supplementation significantly improved metabolic profile in patients with CKD by reducing total cholesterol, LDL-cholesterol, MDA and creatinine levels, yet it did not affect fasting glucose, insulin, HOMA-IR, and CRP concentrations.”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with chronic kidney disease
The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:30417782Permalink
Decreases HOMA-IR
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“CoQ10 alone or combined with vitamin E, and inositols were successful in decreasing HOMA-IR.”
Quoted verbatim from The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network Meta-analysis.. - Study
- meta-analysis
- Population
- women with polycystic ovary syndrome
The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network Meta-analysis.2021PMID:33988478Permalink
Decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“CoQ10 supplementation was associated with modest but statistically significant reductions in FBG (-7.33 mg/dL; 95% CI: -10.67 to -3.99), HbA1c (-0.12%; 95% CI: -0.28 to 0.03), and fasting insulin (-0.84 μIU/mL; 95% CI: -1.18 to -0.49) compared to placebo.”
Quoted verbatim from The effects of coenzyme Q10 supplementation on glycemic control in diabetic and non-diabetic individuals: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- adults with and without type 2 diabetes mellitus
The effects of coenzyme Q10 supplementation on glycemic control in diabetic and non-diabetic individuals: a systematic review and meta-analysis.2026PMID:41630501Permalink
Decreases serum creatinine concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Overall, the current meta-analysis demonstrated that CoQ10 supplementation significantly improved metabolic profile in patients with CKD by reducing total cholesterol, LDL-cholesterol, MDA and creatinine levels, yet it did not affect fasting glucose, insulin, HOMA-IR, and CRP concentrations.”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with chronic kidney disease
The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:30417782Permalink
Increases total antioxidant capacity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“CoQ10 supplementation, in the tested range of doses, was shown to reduce MDA concentrations, and increase TAC and antioxidant defense system enzymes.”
Quoted verbatim from Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.. - Study
- meta-analysis
- Population
- participants in randomized clinical trials of CoQ10 supplementation
Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.2020PMID:32583356Permalink
Increases clinical attachment level (CAL) gain
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Daily oral supplementation (120 mg/day) with CoQ10 resulted in a greater mean reduction of PD by 0.41 mm (95% CI: 0.02-0.80) and a greater mean CAL gain by 0.52 mm (95% CI: 0.26-0.78) than seen in controls.”
Quoted verbatim from Clinical efficacy of adjunctive use of coenzyme Q10 in non-surgical periodontal treatment: A systematic review.. - Study
- meta-analysis
- Dose
- 120 mg/day
- Population
- adults with periodontitis receiving scaling and root planing; oral CoQ10 supplementation
Clinical efficacy of adjunctive use of coenzyme Q10 in non-surgical periodontal treatment: A systematic review.2025PMID:39920883Permalink
Decreases malondialdehyde (circulating)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“CoQ10 supplementation, in the tested range of doses, was shown to reduce MDA concentrations, and increase TAC and antioxidant defense system enzymes.”
Quoted verbatim from Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.. - Study
- meta-analysis
- Population
- participants in randomized clinical trials of CoQ10 supplementation
Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.2020PMID:32583356Permalink
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Regarding oxidative stress and inflammation, pooled analysis showed that CoQ10 supplementation significantly reduced malonaldehyde (WMD: - 1.15 95% CI - 1.48 to - 0.81) and high-sensitivity C reactive protein levels (WMD: - 1.18 95% CI - 2.21 to - 0.15).”
Quoted verbatim from A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.. - Study
- meta-analysis
- Population
- adults with chronic kidney disease (CKD); meta-analysis of 12 studies (17 publications)
Effect -1.18 mean difference, 95% CI -2.21 to -0.15
A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.2022PMID:33782820Permalink
Decreases systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Results showed that CoQ10 supplementation significantly decreased systolic blood pressure (SBP) (SMD - 0.30; 95% CI - 0.52, - 0.08).”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with metabolic diseases, pooled from 17 randomized controlled trials (684 participants)
Effect -0.3 standardised mean difference, 95% CI -0.52 to -0.08
The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:29330704Permalink
Inhibits MTOR
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“As demonstrated in Figure 4A-C, the findings revealed that the relative phosphorylation levels of PI3K, AKT, and mTOR were significantly lower in the RANKL + CoQ10 group than in the RANKL group (all P<0.05).”
Quoted verbatim from Coenzyme Q10 prevents RANKL-induced osteoclastogenesis by promoting autophagy via inactivation of the PI3K/AKT/mTOR and MAPK pathways.. - Study
- in vitro · not in humans
- Dose
- 10-3 M
- Population
- RAW264.7 mouse macrophage cells treated with 50 ng/mL RANKL, with or without 10-3 M CoQ10
Coenzyme Q10 prevents RANKL-induced osteoclastogenesis by promoting autophagy via inactivation of the PI3K/AKT/mTOR and MAPK pathways.2024PMID:38716985Permalink
What did not
39 findings
No detected effect on fasting blood glucose
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“Additionally, the groups did not differ significantly in terms of the fasting blood glucose, insulin, and HbA1c concentrations.”
Quoted verbatim from Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- coenzyme Q10 200 mg/day for 8 weeks
- Population
- adults with impaired glucose tolerance (prediabetes)
Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.2018PMID:30151373Permalink
No detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Moreover, no significant difference was observed in the 28-day mortality rate between the two groups (2 in the CoQ10 group vs. 3 in the placebo group) (P = 0.99).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; secondary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“The differences in the CRP and ESR levels were not significant between CoQ10 and placebo groups (P = 0.550 and P = 0.306, respectively) (Table 2).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; primary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on maximal oxygen uptake
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Cardiorespiratory fitness (CRF) and VO2 peak were not significantly different with NR and CoQ10 supplementation, with means of 21.38 ± 4.93 mL/min/kg (P = 0.36) and 21.41 ± 4.74 (P = 0.33), respectively and Table 2).”
Quoted verbatim from Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease.. - Study
- RCT
- Duration
- 6 weeks
- Dose
- 1200 mg/day
- Population
- adults with chronic kidney disease, eGFR under 60 mL/min/1.73m2
Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease.2023PMID:37159264Permalink
No detected effect on glycated haemoglobin (HbA1c)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“Additionally, the groups did not differ significantly in terms of the fasting blood glucose, insulin, and HbA1c concentrations.”
Quoted verbatim from Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- coenzyme Q10 200 mg/day for 8 weeks
- Population
- adults with impaired glucose tolerance (prediabetes)
Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.2018PMID:30151373Permalink
No detected effect on haematocrit
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“As shown in Table 2, there were no significant differences in hematological parameters (RBC, hemoglobin, hematocrit, MCV, MCH, MCHC, WBC, lymphocyte, neutrophil, and platelet) between CoQ10 and placebo groups at the end of the study (P > 0.05).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; secondary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
Show the remaining 33
No detected effect on blood haemoglobin concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“As shown in Table 2, there were no significant differences in hematological parameters (RBC, hemoglobin, hematocrit, MCV, MCH, MCHC, WBC, lymphocyte, neutrophil, and platelet) between CoQ10 and placebo groups at the end of the study (P > 0.05).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; secondary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on malondialdehyde (circulating)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“As shown in Table 2, the between-group comparison revealed no significant difference between CoQ10 and placebo groups at the end of the study for MDA (P = 0.692), SOD activity (P = 0.633), and TAC (P = 0.865).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; primary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on clinical pregnancy rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“No noticeable variations were demonstrated in clinical pregnancy rates (P = 0.888), lower miscarriage rates (p = 0.676), or twin pregnancies (p = 0.792); however, CoQ10 appeared to demonstrate promising outcomes (Table 3).”
Quoted verbatim from Coenzyme Q10 Impact on Ovarian Reserve Measures and the Intra-Cytoplasmic Sperm Injection (ICSI) Outcomes in Women with Poor Ovarian Response: A Randomized Controlled Study.. - Study
- RCT
- Dose
- Coenzyme Q10 200 mg twice daily (Synapse CoQ10 200 mg, Synapse Pharm), started one month before the ICSI cycle and continued through it
- Population
- Women aged 25 to 45 with poor ovarian response by the Bologna criteria undergoing intracytoplasmic sperm injection; secondary endpoint.
Coenzyme Q10 Impact on Ovarian Reserve Measures and the Intra-Cytoplasmic Sperm Injection (ICSI) Outcomes in Women with Poor Ovarian Response: A Randomized Controlled Study.2026PMID:41800295Permalink
No detected effect on total leukocyte count
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“As shown in Table 2, there were no significant differences in hematological parameters (RBC, hemoglobin, hematocrit, MCV, MCH, MCHC, WBC, lymphocyte, neutrophil, and platelet) between CoQ10 and placebo groups at the end of the study (P > 0.05).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; primary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on erythrocyte sedimentation rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The differences in the CRP and ESR levels were not significant between CoQ10 and placebo groups (P = 0.550 and P = 0.306, respectively) (Table 2).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; primary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on superoxide dismutase activity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“As shown in Table 2, the between-group comparison revealed no significant difference between CoQ10 and placebo groups at the end of the study for MDA (P = 0.692), SOD activity (P = 0.633), and TAC (P = 0.865).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; primary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on total antioxidant capacity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×2“As shown in Table 2, the between-group comparison revealed no significant difference between CoQ10 and placebo groups at the end of the study for MDA (P = 0.692), SOD activity (P = 0.633), and TAC (P = 0.865).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; primary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on intensive care unit length of stay
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“ICU length of stay in the CoQ10 group (18.83 ± 10.72) was shorter than the placebo group (23.60 ± 10.03); however, the difference was not statistically significant (P = 0.122).”
Quoted verbatim from Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 52
- Duration
- 10 days
- Dose
- 100 mg three times a day after meals, total 300 mg/day
- Population
- Adults aged 18-65 with 20-60% total body surface area burns admitted to a burn ICU in Isfahan, Iran, all receiving routine burn care and the unit's standard vitamin, selenium, zinc and B-complex supplementation in both arms; secondary outcome.
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.2024PMID:38431600Permalink
No detected effect on total antioxidant capacity
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull resultreplicated ×2“There was no statistically significant change in TAC between the patients treated with doxorubicin + CoQ10 and doxorubicin + placebo.”
Quoted verbatim from Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment.. - Study
- crossover
- Participants
- 6
- Dose
- 300 mg/day, two 150 mg softgel capsules once daily with food
- Population
- Women aged 21 or older with stage I-III breast cancer receiving dose-dense doxorubicin plus cyclophosphamide, each acting as her own control across one cycle with coenzyme Q10 and one with placebo; secondary endpoint.
Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment.2025PMID:41261512Permalink
No detected effect on HDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×3“In addition, CoQ10, alone or in combination with fenofibrate, did not alter LDL-C, HDL-C and blood pressure.”
Quoted verbatim from Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- patients with diabetes; pooled across CoQ10 monotherapy and CoQ10 plus fenofibrate trials
Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.2015PMID:25913756Permalink
No detected effect on LDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“The pooled results indicated that CoQ10 supplementation had no effects on total cholesterol, or LDL-cholesterol, or on HDL-cholesterol, and triglycerides.”
Quoted verbatim from A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.. - Study
- meta-analysis
- Population
- adults with chronic kidney disease (CKD); meta-analysis of 12 studies (17 publications)
A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.2022PMID:33782820Permalink
No detected effect on HOMA-IR
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Triglycerides, HDL-cholesterol, fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and C-reactive protein (CRP) concentrations did not affect following CoQ10 supplementation.”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with chronic kidney disease (CKD)
The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:30417782Permalink
No detected effect on triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“The pooled results indicated that CoQ10 supplementation had no effects on total cholesterol, or LDL-cholesterol, or on HDL-cholesterol, and triglycerides.”
Quoted verbatim from A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.. - Study
- meta-analysis
- Population
- adults with chronic kidney disease (CKD); meta-analysis of 12 studies (17 publications)
A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.2022PMID:33782820Permalink
No detected effect on diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“For diastolic blood pressure we performed a random-effects meta-analysis, which showed no evidence of effect of CoQ10 supplementation when these two small trials were pooled (MD -1.62 mmHg, 95% CI -5.2 to 1.96).”
Quoted verbatim from Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.. - Study
- meta-analysis
- Population
- adults at high risk of cardiovascular disease without a diagnosis of CVD; pooled analysis of two small RCTs
Effect -1.62 mean difference, 95% CI -5.2 to 1.96
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.2014PMID:25474484Permalink
Source retracted Do not rely on it.
No detected effect on withdrawal due to adverse events
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“In safety outcomes, only the risk ratios (RR) of pharyngitis (RR 1.04, 95% CI 0.18 to 5.89) and diarrhea (RR 1.39, 95% CI 0.62 to 3.16) are mild elevated between coenzyme Q10 therapy and placebo and there were no differences in the number of withdrawals due to adverse effects (RR 0.61, 95% CI 0.23 to 1.62).”
Quoted verbatim from Coenzyme Q10 for Parkinson's disease.. - Study
- meta-analysis
- Dose
- 1200 mg/d for 16 months
- Population
- patients with early and midstage Parkinson's disease; Cochrane meta-analysis of 4 RCTs, 452 patients, coenzyme Q10 versus placebo
Effect 0.61 risk ratio, 95% CI 0.23 to 1.62
Coenzyme Q10 for Parkinson's disease.2011PMID:22161420Permalink
No detected effect on total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“The trial showed no evidence of effect of CoQ10 supplementation on total cholesterol (MD 0.30 mmol/L, 95% CI -0.10 to 0.70), high-density lipoprotein (HDL)-cholesterol (MD 0.02 mmol/L, 95% CI -0.13 to 0.17) or triglycerides (MD 0.05 mmol/L, 95% CI -0.42 to 0.52).”
Quoted verbatim from Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.. - Study
- RCT
- Population
- adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)
Effect 0.3 mean difference, 95% CI -0.1 to 0.7
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.2014PMID:25474484Permalink
No detected effect on total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“Neither total cholesterol and cholesterol subfractions, nor triglyceride levels were affected by CoQ10 supplementation.”
Quoted verbatim from Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- patients from placebo-controlled trials of CoQ10 supplementation (409 subjects total, 206 CoQ10, 203 control)
Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis.2016PMID:26836888Permalink
No detected effect on total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“The pooled results indicated that CoQ10 supplementation had no effects on total cholesterol, or LDL-cholesterol, or on HDL-cholesterol, and triglycerides.”
Quoted verbatim from A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.. - Study
- meta-analysis
- Population
- adults with chronic kidney disease (CKD); meta-analysis of 12 studies (17 publications)
A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.2022PMID:33782820Permalink
No detected effect on HDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×3“The trial showed no evidence of effect of CoQ10 supplementation on total cholesterol (MD 0.30 mmol/L, 95% CI -0.10 to 0.70), high-density lipoprotein (HDL)-cholesterol (MD 0.02 mmol/L, 95% CI -0.13 to 0.17) or triglycerides (MD 0.05 mmol/L, 95% CI -0.42 to 0.52).”
Quoted verbatim from Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.. - Study
- RCT
- Population
- adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)
Effect 0.02 mean difference, 95% CI -0.13 to 0.17
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.2014PMID:25474484Permalink
No detected effect on HDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×3“Triglycerides, HDL-cholesterol, fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and C-reactive protein (CRP) concentrations did not affect following CoQ10 supplementation.”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with chronic kidney disease (CKD)
The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:30417782Permalink
No detected effect on HDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×3“The pooled results indicated that CoQ10 supplementation had no effects on total cholesterol, or LDL-cholesterol, or on HDL-cholesterol, and triglycerides.”
Quoted verbatim from A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.. - Study
- meta-analysis
- Population
- adults with chronic kidney disease (CKD); meta-analysis of 12 studies (17 publications)
A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.2022PMID:33782820Permalink
No detected effect on triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“The trial showed no evidence of effect of CoQ10 supplementation on total cholesterol (MD 0.30 mmol/L, 95% CI -0.10 to 0.70), high-density lipoprotein (HDL)-cholesterol (MD 0.02 mmol/L, 95% CI -0.13 to 0.17) or triglycerides (MD 0.05 mmol/L, 95% CI -0.42 to 0.52).”
Quoted verbatim from Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.. - Study
- RCT
- Population
- adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)
Effect 0.05 mean difference, 95% CI -0.42 to 0.52
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.2014PMID:25474484Permalink
No detected effect on triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“Triglycerides, HDL-cholesterol, fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and C-reactive protein (CRP) concentrations did not affect following CoQ10 supplementation.”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with chronic kidney disease (CKD)
The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:30417782Permalink
No detected effect on catalase activity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“However, there were no significant effects of CoQ10 on NO, GSH concentrations, or CAT activity.”
Quoted verbatim from Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.. - Study
- meta-analysis
- Population
- participants in randomized clinical trials of CoQ10 supplementation
Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.2020PMID:32583356Permalink
No detected effect on C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Triglycerides, HDL-cholesterol, fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and C-reactive protein (CRP) concentrations did not affect following CoQ10 supplementation.”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with chronic kidney disease (CKD)
The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:30417782Permalink
No detected effect on subjective fatigue
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“No significant benefit was observed for fatigue (SMD: -0.33; 95% CI: -1.38 to 0.72; P =0.54; I2 =89%), based on only 2 trials.”
Quoted verbatim from Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with depression, primary or comorbid with medical illness; pooled across 2 trials
Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2025PMID:41294251Permalink
No detected effect on reduced glutathione concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“However, there were no significant effects of CoQ10 on NO, GSH concentrations, or CAT activity.”
Quoted verbatim from Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.. - Study
- meta-analysis
- Population
- participants in randomized clinical trials of CoQ10 supplementation
Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.2020PMID:32583356Permalink
No detected effect on fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Triglycerides, HDL-cholesterol, fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and C-reactive protein (CRP) concentrations did not affect following CoQ10 supplementation.”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with chronic kidney disease (CKD)
The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:30417782Permalink
No detected effect on glycated haemoglobin (HbA1c)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“The effect of Co-Q10 on HbA1c and fasting insulin was not significant.”
Quoted verbatim from Effect of Coenzyme Q10 Supplementation on Diabetes Biomarkers: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials.. - Study
- meta-analysis
- Population
- patients with diabetes, pooled from randomized controlled trials of CoQ10 supplementation
Effect of Coenzyme Q10 Supplementation on Diabetes Biomarkers: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials.2016PMID:27544369Permalink
No detected effect on anxiety symptom severity (pooled across unnamed instruments)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Regarding anxiety severity, only two small studies were analyzed, and no statistically significant reduction was observed with CoQ10 (101 patients, -0.28 [-0.70, 0.13]).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on depressive symptoms and anxiety: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Participants
- 101
- Population
- patients across clinical populations with anxiety symptoms
The effect of coenzyme Q10 supplementation on depressive symptoms and anxiety: a systematic review and meta-analysis of randomized controlled trials.2025PMID:40833470Permalink
No detected effect on clinical attachment level (CAL) gain
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There was no significant effect of local use of CoQ10 on reduction of PD and gain in CAL.”
Quoted verbatim from Clinical efficacy of adjunctive use of coenzyme Q10 in non-surgical periodontal treatment: A systematic review.. - Study
- meta-analysis
- Population
- adults with periodontitis receiving scaling and root planing; locally delivered (topical or intra-pocket) CoQ10
Clinical efficacy of adjunctive use of coenzyme Q10 in non-surgical periodontal treatment: A systematic review.2025PMID:39920883Permalink
No detected effect on total antioxidant capacity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“No significant alteration in total antioxidant capacity was observed post-CoQ10 treatment.”
Quoted verbatim from The effects of coenzyme Q10 supplementation on biomarkers of exercise-induced muscle damage, physical performance, and oxidative stress: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- adults in randomized controlled trials of exercise-induced muscle damage and oxidative stress
The effects of coenzyme Q10 supplementation on biomarkers of exercise-induced muscle damage, physical performance, and oxidative stress: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.2024PMID:38479900Permalink
No detected effect on LDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“In addition, CoQ10, alone or in combination with fenofibrate, did not alter LDL-C, HDL-C and blood pressure.”
Quoted verbatim from Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- patients with diabetes; pooled across CoQ10 monotherapy and CoQ10 plus fenofibrate trials
Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.2015PMID:25913756Permalink
What it touches on the way
Mechanistic reach
5 entities
5 entities reached.
0 reported hops5 assembled from the scaffold
- STARD7ProteinUNIPROT:Q9NQZ5transported byInferred only212 paths193 endpoints
- NQO1ProteinUNIPROT:P15559metabolized byInferred only41 paths40 endpoints
- MTORProteinUNIPROT:P42345inhibitsInferred only33 paths33 endpoints
- AIFM2ProteinUNIPROT:Q9BRQ8substrate ofInferred only20 paths10 endpoints
- SQORProteinUNIPROT:Q9Y6N5substrate ofInferred only14 paths7 endpoints
What the reference databases state
Regulatory determinations
LiverTox likelihood score ELiverTox
LiverTox Likelihood Score E — despite extensive use, no evidence that the agent has caused liver injury. Chapter: "Coenzyme Q10". Source: LiverTox Master List (NBK571102).
The document·Public Domain (NLM/NIH)·Transcribed, not assessed
Statements
8 statements
8 statements · 1 reference database · Subject: coenzyme Q10 · Sources: Rhea
- coenzyme Q10 is converted to ubiquinol-10CompoundRhea RHEA:61984Inferred only
- coenzyme Q10 is converted to ubiquinol-10CompoundRhea RHEA:61980Inferred only
- coenzyme Q10 is metabolised by NQO1ProteinRhea RHEA:61984Inferred only
- coenzyme Q10 is a substrate of AIFM2ProteinRhea RHEA:61984Inferred only
- coenzyme Q10 is a substrate of AIFM2ProteinRhea RHEA:61980Inferred only
- coenzyme Q10 is a substrate of SQORProteinRhea RHEA:38359Inferred only
- coenzyme Q10 is a substrate of SQORProteinRhea RHEA:62608Inferred only
- coenzyme Q10 is transported by STARD7ProteinRhea RHEA:86447Inferred only
Reactions
6 reactions
coenzyme Q10+hydrogen sulfide+sulfite+2hydronubiquinol-10+thiosulfate
Catalysed by SQOR
Reaction pageLeft to rightBalanced
Rhea RHEA:38359CC BY 4.0Reference data
coenzyme Q10+trans-4-hydroxy-L-proline(3R,5S)-1-pyrroline-3-hydroxy-5-carboxylate+ubiquinol-10+hydron
Reaction pageDirection not assertedBalanced
Rhea RHEA:52516CC BY 4.0Reference data
coenzyme Q10+NADPH(4-)+hydronubiquinol-10+NADP(3-)
Catalysed by AIFM2
Reaction pageLeft to rightBalanced
Rhea RHEA:61980CC BY 4.0Reference data
coenzyme Q10+NADH(2-)+hydronubiquinol-10+NAD(1-)
Reaction pageLeft to rightBalanced
Rhea RHEA:61984CC BY 4.0Reference data
coenzyme Q10+hydrogen sulfide+glutathione+hydronS-sulfanylglutathione+ubiquinol-10
Catalysed by SQOR
Reaction pageLeft to rightBalanced
Rhea RHEA:62608CC BY 4.0Reference data
Transported by STARD7
Reaction pageDirection not assertedBalanced
Rhea RHEA:86447CC BY 4.0Reference data
On the label
Labelled products
2,958 products
Source: NIH DSLD · Ingredient: coenzyme Q10 · 2,958 products · Declared amount per serving: 1–1,050 mg (976 products) · Showing 1,000 of 2,958
997 labels state an amount3 do not
- 'Merica LabzGuts 'N Glory Gut PunchUbiquinone · CoQ10 (Form: as Ubiquinone)100 mgper 5.1 Gram(s)DSLD:213374
- 21st CenturyCo Q-10 100 mg100 mgper 1 Capsule(s)DSLD:207491
- 21st CenturyCo Q-10 200 mg200 mgper 1 Capsule(s)DSLD:233405
- 21st CenturyCo Q-10 30 mg30 mgper 1 Capsule(s)DSLD:205616
- 21st CenturyCo Q-10 30 mg30 mgper 1 Capsule(s)DSLD:207483
- 21st CenturyCo Q-10 400 mg400 mgper 1 Vegetarian Capsule(s)DSLD:206557
- 21st CenturyCo Q-10 60 mg60 mgper 1 Capsule(s)DSLD:205827
- 21st CenturyCo Q10 100 mg100 mgper 1 Capsule(s)DSLD:11151
- 21st CenturyMaximum Strength Co Q10 200 mg200 mgper 1 Capsule(s)DSLD:11152
- 21st CenturyUltra Formula Co Q10 400 mg400 mgper 1 Vegetarian Capsule(s)DSLD:11147
- AB American BiologicsUltra Coenzyme Q1060 mgper 1 Capsule(s)DSLD:20310
- Activator EssentialsRestore ADEK2Ubiquinol · CoQ10 (Form: as Ubiquinol)400 mgper 1 mLDSLD:240217
Show the remaining 2,946
- Adaptogen ResearchMax CoQ10 100 mgCoQ10 · Ubiquinol (Form: reduced form of CoQ10) (Alt. Name: Kaneka QH Ubiquinol)100 mgper 1 Softgel(s)DSLD:247105
- Adaptogen ResearchRed Yeast Rice Plus50 mgper 1 Vegetable Capsule(s)DSLD:247252
- AddrenaBlemless7.5 mgper 1 Tablet(s)DSLD:206827
- AdvoCareCore Nutrition SystemUbidecarenone · Coenzyme Q–10 (Form: as Ubidecarenone)102 mgper 1 4-Packet Strip(s)DSLD:177397
- AdvoCareCore Nutrition System100 mgper 1 Blister Card(s)DSLD:206857
- AdvoCareMNS 3100 mgper 2 Packet(s)DSLD:177961
- AdvoCareMNS C150 mcgper 2 Packet(s)DSLD:207148
- AdvoCareMNS E150 mcgper 1 Packet(s)DSLD:177964
- AdvoCare FITPre Strawberry Lemonade30 mgper 7 Gram(s)DSLD:208993
- Aesthetic LabsOsta 2.0105 mgper 3 Capsule(s)DSLD:181988
- AFI America's FinestCoQ10 + Hawthorn BerryUbiquinone325 mgper 1 Capsule(s)DSLD:246819
- Allergy Research GroupCoenzyme Q10 50 mg with Vitamin C100 mgper 1 Capsule(s)DSLD:207691
- Allergy Research GroupCoQ-Gamma E with Tocotrienols & Carotenoids75 mgper 1 Softgel(s)DSLD:233412
- Allergy Research GroupCoQH-CF UbiquinolCoQ10 · Ubiquinol (Form: reduced CoQ10)100 mgper 1 Softgel(s)DSLD:207710
- Allergy Research GroupNTFactor CoQ10 Chocolate Chewables100 mgper 1 Tablet(s)DSLD:233334
- Allergy Research GroupOxyNutrients Electron Transport Formula12.5 mgper 1 Capsule(s)DSLD:20398
- Allergy Research GroupThe New AntiOx Cysteine Free15 mgper 1 Capsule(s)DSLD:20138
- Allergy Research Group Essential-BioticHeart with LRC and CoQ10100 mgper 2 Capsule(s)DSLD:207842
- AltrumCoenzyme Q-10 30 mg30 mgper 1 Softgel(s)DSLD:17082
- AltrumCoenzyme Q-10 60 mg60 mgper 1 Softgel(s)DSLD:204065
- AltrumCoQ10 60 mg60 mgper 1 Vegetarian Capsule(s)DSLD:231507
- AltrumEnergy Support10 mgper 2 Veg Capsule(s)DSLD:255012
- AltrumMen's MultiUbiquinone · CoQ10 (Form: as Ubiquinone)10 mgper 2 Softgel(s)DSLD:255017
- AltrumUltra Multi with Iron500 mcgper 6 Tablet(s)DSLD:204059
- AltrumWomen's Multi with IronUbiquinone · CoQ10 (Form: as Ubiquinone)10 mgper 3 Softgel(s)DSLD:255027
- AmbrosiaNektar Apple Symphony50 mgper 5.56 Gram(s)DSLD:229370
- AmbrosiaNektar Fruit Symphony50 mgper 6.45 Gram(s)DSLD:229372
- AmbrosiaNektar Strawberry Basil50 mgper 5.5 Gram(s)DSLD:229367
- American HealthMore Than A Multiple With Energy Essentials60 mgper 3 Tablet(s)DSLD:241568
- American HealthNutri-Mega100 mcgper 2 Softgel(s)DSLD:16693
- American HealthNutri-Mega100 mcgper 2 Softgel(s)DSLD:16695
- AN Amazing Nutrition Amazing FormulasCardio Support33.33 mgper 2 Capsule(s)DSLD:251698
- AN Amazing Nutrition Amazing FormulasCoQ10 200 mg with BioPerine200 mgper 1 Softgel(s)DSLD:251806
- AN Amazing Nutrition Amazing FormulasRed Yeast Rice Complex 1,570 mgUbiquinone60 mgper 2 Veggie Capsule(s)DSLD:251504
- AN Amazing Nutrition Amazing FormulasUbiquinol 200 mg200 mgper 1 Softgel(s)DSLD:251416
- ANTIAGING Institute of CaliforniaCoQ10 100 mgUbidecarenone100 mgper 1 Softgel Capsule(s)DSLD:210274
- AOR Advanced Orthomolecular Research AdvancedCardioNOxUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)300 mgper 1 Capsule(s)DSLD:214551
- AOR Advanced Orthomolecular Research AdvancedCogni-Q300 mgper 1 Capsule(s)DSLD:214559
- AOR Advanced Orthomolecular Research AdvancedTotal EUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) Note: from natural-biofermentation30 mgper 1 Softgel(s)DSLD:214867
- AOR Advanced Orthomolecular Research UltraAntioxidant Synergy7.5 mgper 1 Capsule(s)DSLD:214426
- AOR Advanced Orthomolecular Research UltraMito-ChargerUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)17 mgper 1 Capsule(s)DSLD:214778
- Arazo NutritionCoQ-10Ubiquinone200 mgper 1 Capsule(s)DSLD:237112
- Ayush HerbsArjuna-Heart30 mgper 1 Capsule(s)DSLD:20536
- Ayush HerbsCoCurcumin Drink Mix100 mgper 1 tspDSLD:20587
- Basic VitaminsHigh Potency Coenzyme Q-10 100 mg100 mgper 1 Capsule(s)DSLD:249960
- Basic VitaminsHigh Potency Coenzyme Q-10 200 mg200 mgper 1 Softgel(s)DSLD:249961
- Basic VitaminsHigh Potency Coenzyme Q-10 50 mg50 mgper 1 Softgel(s)DSLD:249962
- BELDT LabsPrizmUbidicarenone · Coenzyme Q10 (Form: natural Ubidicarenone)50 mcgper 2 Capsule(s)DSLD:236970
- Bio NutritionBlood Pressure WellnessUbiquinone50 mgper 2 Tablet(s)DSLD:200557
- Bio NutritionBrain Wellness10 mgper 2 Vegetable Capsule(s)DSLD:200631
- Bio NutritionCholesterol Wellness25 mgper 2 Vegetable Capsule(s)DSLD:200642
- Bioclinic NaturalsBioFoundation-GCoenzyme Q10 Note: microorganism50 mgper 1 Tablet(s)DSLD:20935
- Bioclinic NaturalsCogniCare* PQQ-10200 mgper 1 Capsule(s)DSLD:20853
- Bioclinic NaturalsCoQ10Ubiquinone200 mgper 1 Softgel(s)DSLD:20790
- Bioclinic NaturalsCoQ10Ubiquinone200 mgper 1 Softgel(s)DSLD:20792
- Bioclinic NaturalsCoQ10Ubiquinone400 mgper 1 Softgel(s)DSLD:20793
- Bioclinic NaturalsUbiquinol CoQ10CoQ10 · Ubiquinol (Form: as Kaneka QH(R) Ubiquinol, Bioactive and Reduced Form CoQ10) Note: Microorganism100 mgper 1 Softgel(s)DSLD:20794
- Biotics Research CorporationBio-Anabolic1,000 mcgper 1 Packet(s)DSLD:21691
- Biotics Research CorporationBio-Cardio 36930 mgper 1 Packet(s)DSLD:21723
- Biotics Research CorporationBio-Cardio Packs30 mgper 1 Packet(s)DSLD:21749
- Biotics Research CorporationBio-Cardiozyme Forte1 mgper 4 Tablet(s)DSLD:21754
- Biotics Research CorporationBio-Cardiozyme Forte1 mgper 4 Tablet(s)DSLD:21764
- Biotics Research CorporationBio-Detox Packs1 mgper 1 Packet(s)DSLD:21771
- Biotics Research CorporationBio-Immunozyme ForteCoenzyme Q10 Note: emulsified1 mgper 2 Capsule(s)DSLD:22021
- Biotics Research CorporationBio-Immunozyme ForteCoenzyme Q10 Note: emulsified1 mgper 2 Capsule(s)DSLD:22019
- Biotics Research CorporationBio-Multi Plus1 mgper 3 Tablet(s)DSLD:22137
- Biotics Research CorporationBio-Multi Plus1 mgper 3 Tablet(s)DSLD:22138
- Biotics Research CorporationBio-Multi Plus Iron & Copper Free1 mgper 3 Tablet(s)DSLD:22139
- Biotics Research CorporationBio-Multi Plus Iron & Copper Free1 mgper 3 Tablet(s)DSLD:22140
- Biotics Research CorporationBio-Multi Plus Iron Free1 mgper 3 Tablet(s)DSLD:22141
- Biotics Research CorporationBio-Multi Plus Iron Free1 mgper 3 Tablet(s)DSLD:22142
- Biotics Research CorporationBioProtect3 mgper 3 Capsule(s)DSLD:21879
- Biotics Research CorporationBioProtect3 mgper 1 Capsule(s)DSLD:21884
- Biotics Research CorporationCoQ-Zyme 100 PlusCoenzyme Q10 Note: emulsified100 mgper 1 Capsule(s)DSLD:21596
- Biotics Research CorporationCoQ-Zyme 3030 mgper 1 Tablet(s)DSLD:21575
- Biotics Research CorporationCoQ-Zyme 3030 mgper 1 Tablet(s)DSLD:21577
- Biotics Research CorporationEqui-Fem1 mgper 2 Tablet(s)DSLD:21806
- Biotics Research CorporationEqui-Fem1 mgper 2 Tablet(s)DSLD:21810
- Biotics Research CorporationEqui-Fem Iron & Copper Free1 mgper 2 Tablet(s)DSLD:22149
- Biotics Research CorporationPCOH-Plus2.5 mgper 1 Capsule(s)DSLD:22119
- Biotics Research CorporationPMTCoenzyme Q10 Note: emulsified1 mgper 2 Tablet(s)DSLD:22200
- Biotics Research CorporationStamina Caps1 mgper 2 Capsule(s)DSLD:22218
- BIOVEACoQ10 100 mgUbidecarenone100 mgper 1 Vegetarian Capsule(s)DSLD:249024
- BIOVEACoQ10 30 mg30 mgper 1 Vegetarian Capsule(s)DSLD:207400
- BIOVEACoQ10 60 mg60 mgper 1 Vegetarian Capsule(s)DSLD:207399
- BIOVEACoQ10 with Red Yeast Rice60 mgper 1 Softgel(s)DSLD:207286
- BIOVEAUbiquinol CoQH 50 mgCoQ-10 · Kaneka Ubiquinol (Form: enhanced bioactivity CoQ-10)100 mgper 2 Softgel(s)DSLD:207813
- BluebonnetCellularActive CoQ10 Ubiquinol 100 mg100 mgper 1 Vegetarian Capsule(s)DSLD:204247
- BluebonnetCellularActive CoQ10 Ubiquinol 100 mg100 mgper 1 Vegetarian Softgel(s)DSLD:204263
- BluebonnetCellularActive CoQ10 Ubiquinol 200 mg200 mgper 1 Vegetarian Softgel(s)DSLD:204265
- BluebonnetCellularActive CoQ10 Ubiquinol 200 mg200 mgper 1 Vegetarian Softgel(s)DSLD:204268
- BluebonnetCellularActive CoQ10 Ubiquinol 25 mg25 mgper 1 Vegetarian Softgel(s)DSLD:178479
- BluebonnetCellularActive CoQ10 Ubiquinol 25 mg25 mgper 1 Vegetarian Softgel(s)DSLD:178480
- BluebonnetCellularActive CoQ10 Ubiquinol 50 mg50 mgper 1 Vegetarian Softgel(s)DSLD:204159
- BluebonnetCellularActive CoQ10 Ubiquinol 50 mg50 mgper 1 Vegetarian Softgel(s)DSLD:204166
- BluebonnetCholesteRiceUbiquinone · CoQ10 (Form: as Ubiquinone)30 mgper 2 Capsule(s)DSLD:204229
- BluebonnetCholesteRiceUbiquinone · CoQ10 (Form: as Ubiquinone)30 mgper 2 Capsule(s)DSLD:204847
- BluebonnetCoQ10 100 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Vegetarian Softgel(s)DSLD:178580
- BluebonnetCoQ10 100 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Vegetarian Softgel(s)DSLD:178583
- BluebonnetCoQ10 100 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Vegetarian Softgel(s)DSLD:178585
- BluebonnetCoQ10 200 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)200 mgper 1 Vegetarian Softgel(s)DSLD:178633
- BluebonnetCoQ10 30 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 1 Vegetarian Softgel(s)DSLD:178507
- BluebonnetCoQ10 30 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 1 Vegetarian Softgel(s)DSLD:178509
- BluebonnetCoQ10 30 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 1 Vegetarian Softgel(s)DSLD:178510
- BluebonnetCoQ10 30 mg CapsulesUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 1 Capsule(s)DSLD:178586
- BluebonnetCoQ10 60 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)60 mgper 1 Vegetarian Softgel(s)DSLD:178512
- BluebonnetCoQ10 60 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)60 mgper 1 Vegetarian Softgel(s)DSLD:178513
- BluebonnetCoQ10 60 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)60 mgper 1 Vegetarian Softgel(s)DSLD:178514
- BluebonnetCoQ10 60 mg CapsulesUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)60 mgper 1 Capsule(s)DSLD:178622
- BluebonnetCoQ10 60 mg CapsulesUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)60 mgper 1 Capsule(s)DSLD:178624
- BluebonnetHeart AntioxidantUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 4 Capsule(s)DSLD:177819
- BluebonnetHeart AntioxidantUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 4 Capsule(s)DSLD:177820
- BluebonnetSuper Vita-CoQ10 FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 3 Caplet(s)DSLD:177532
- BluebonnetSuper Vita-CoQ10 FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 3 Caplet(s)DSLD:177533
- BluebonnetSuper Vita-CoQ10 FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 3 Caplet(s)DSLD:177535
- BluebonnetSuper Vita-CoQ10 FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 3 Caplet(s)DSLD:177536
- Bluebonnet Super EarthAntiOxidantUbiquinone30 mgper 2 Caplet(s)DSLD:177813
- Bluebonnet Super EarthAntiOxidantUbiquinone30 mgper 2 Caplet(s)DSLD:177815
- Botanic ChoiceCoEnzyme Q-10 120 mgUbidicarenone120 mgper 1 Capsule(s)DSLD:199579
- Botanic ChoiceCoEnzyme Q-10 200 mgUbidicarenone · Coenzyme Q10 (Form: as Ubidicarenone)200 mgper 1 Capsule(s)DSLD:199577
- Botanic ChoiceCoEnzyme Q-10 75 mgUbidicarenone75 mgper 1 Capsule(s)DSLD:199580
- Botanic ChoiceCoQ-10 60 mg with Fish Oil 600 mg60 mgper 2 Softgel(s)DSLD:199596
- Botanic ChoiceCoQ-10 Plus L-CarnitineUbidicarenone · Coenzyme Q10 (Form: as Ubidicarenone)30 mgper 1 Capsule(s)DSLD:199569
- Botanic ChoiceCoQ-10 Power PlexUbidicarenone · Coenzyme Q10 (Form: as Ubidicarenone)60 mgper 1 Capsule(s)DSLD:199659
- Botanic ChoiceHerbal 9 EssentialsUbidicarenone · Coenzyme Q10 (Form: as Ubidicarenone)30 mgper 4 Capsule(s)DSLD:200032
- Botanic ChoiceSTART! Multi-Vitamin + HeartUbidicarenone · Coenzyme Q10 (Form: as Ubidicarenone)30 mgper 1 Vege Capsule(s)DSLD:200048
- BRI NutritionEnhanced CoQsol-10100 mgper 1 Softgel(s)DSLD:218988
- BronsonAcetyl L-Carnitine with CoQ-10Ubiquinone-1030 mgper 2 Capsule(s)DSLD:257321
- BronsonCoQ10 100 mg100 mgper 1 Softgel(s)DSLD:232981
- BronsonCoQ10 100 mg100 mgper 1 Softgel(s)DSLD:232982
- BronsonCoQ10 100 mg100 mgper 1 Softgel(s)DSLD:232983
- Bronson LaboratoriesBP ControlUbiquinone15 mgper 1 Capsule(s)DSLD:25470
- Bronson LaboratoriesCoQ-10 With L-Carnitine60 mgper 2 Softgel(s)DSLD:25258
- Bronson LaboratoriesCoQ10 Complex60 mgper 2 Softgel(s)DSLD:25262
- Burbank Glendale ChiropracticUltimate Health Cardio20 mgper 3 Capsule(s)DSLD:22091
- California Academy of HealthLiquid Coenzyme Q10 Advanced Formula100 mgper 1 Teaspoon(s)DSLD:251195
- Cardiovascular ResearchCo-Enzyme Q10 200 mg200 mgper 1 Softgel(s)DSLD:22373
- Cardiovascular ResearchCo-Enzyme Q10 30 mg30 mgper 1 Capsule(s)DSLD:22365
- CarlsonCo-Q10 200 mg200 mgper 1 Softgel(s)DSLD:209159
- CarlsonCo-Q10 200 mg200 mgper 1 Softgel(s)DSLD:216459
- CarlsonCo-Q10 30 mg30 mgper 1 Softgel(s)DSLD:209178
- CarlsonCo-Q10 30 mg30 mgper 1 Soft Gel(s)DSLD:209183
- CarlsonCo-Q10 30 mg30 mgper 1 Softgel(s)DSLD:209185
- CarlsonCo-Q10 30 mg30 mgper 1 Softgel(s)DSLD:209187
- CarlsonCo-Q10 300 mg300 mgper 1 Softgel(s)DSLD:216462
- CarlsonCo-Q10 300 mg300 mgper 1 Softgel(s)DSLD:216477
- CarlsonCo-Q10 50 mg50 mgper 1 Softgel(s)DSLD:241657
- CarlsonFish Oil Q50 mgper 2 Softgel(s)DSLD:19503
- CarlsonFish Oil Q50 mgper 2 Softgel(s)DSLD:19506
- CarlsonHeart Fit25 mgper 2 Soft Gel(s)DSLD:209320
- CarlsonHeart Fit25 mgper 2 Softgel(s)DSLD:209321
- CarlsonRhythm Rite20 mgper 2 Softgel(s)DSLD:209334
- CarlsonRhythm Rite20 mgper 2 Softgel(s)DSLD:242123
- CarlsonRhythm Rite20 mgper 2 Softgel(s)DSLD:242128
- CentrumCentrum Energy50 mgper 2 Capsule(s)DSLD:256981
- CentrumCentrum Energy & Vitality50 mgper 2 Capsule(s)DSLD:251343
- Centurion LabzEngage75 mgper 1 Capsule(s)DSLD:236842
- CHK NutritionCoEnzyme Q10 Softgel 200 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)200 mgper 1 Softgel(s)DSLD:228642
- Coast ScienceCoast Q10Ubiquinone200 mgper 1 Veggie Capsule(s)DSLD:241262
- Coast ScienceFertile One Prenatal Plus100 mgper 3 Veggie Capsule(s)DSLD:241281
- Coast Science She-ologyMenopause Plus50 mgper 6 Veggie Capsule(s)DSLD:241330
- Confidence USACoQ10 200 mg200 mgper 1 Softgel(s)DSLD:246683
- Confidence USASuper CrossUbiquinone50 mgper 2 Capsule(s)DSLD:246675
- Cooper CompleteElite AthleteUbiquinone100 mgper 8 Tablet(s)DSLD:209868
- CoromegaHeart Omega3 Squeeze Juicy OrangeUbiquinone50 mgper 1 Packet(s)DSLD:19079
- Country LifeCircu-PressureUbiquinone15 mgper 2 Tablet(s)DSLD:14003
- Country LifeCoQ10 30 mgUbiquinone30 mgper 1 Softgel(s)DSLD:13152
- Country LifeCoQ10 60 mgUbiquinone60 mgper 1 Capsule(s)DSLD:13145
- Country LifeMaxi-Sorb Mega CoQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:221094
- Country LifeUltra CoQ10 60 mgUbiquinone60 mgper 1 Softgel(s)DSLD:13173
- CVS HealthCoQ-10 200 mg200 mgper 1 Softgel(s)DSLD:207540
- CVS HealthCoQ-10 50 mg50 mgper 1 Softgel(s)DSLD:207534
- CVS PharmacyCoQ10 200 mgUbiquinone200 mgper 2 Gummy(ies)DSLD:18184
- CymbiotikaD3 + K2 + CoQ10 Organic LemonUbiquinol20 mgper 2 mLDSLD:253141
- DaVinci Laboratories of VermontCoenzyme Q10 - 100 mgUbiquinone100 mgper 1 Chewable Tablet(s)DSLD:245070
- DaVinci Laboratories of VermontCoenzyme Q10 - 50 mgUbiquinone50 mgper 1 Chewable Tablet(s)DSLD:245071
- DaVinci Laboratories Of VermontCell Support5 mgper 2 Capsule(s)DSLD:22005
- DaVinci Laboratories Of VermontCoenzyme Q10 - 10 mgUbiquinone10 mgper 1 Capsule(s)DSLD:22055
- DaVinci Laboratories Of VermontCoenzyme Q10 - 30 mgUbiquinone30 mgper 1 Capsule(s)DSLD:22094
- DaVinci Laboratories Of VermontCoenzyme Q10 - 50 mgUbiquinone50 mgper 1 Tablet(s)DSLD:22064
- DaVinci Laboratories Of VermontGenessentials HCH-233.34 mgper 1 Tablet(s)DSLD:22704
- DaVinci Laboratories Of VermontGenessentials OS-15 mgper 2 Capsule(s)DSLD:22710
- DaVinci Laboratories Of VermontGenessentials OS-15 mgper 2 Capsule(s)DSLD:22712
- DCCo-Q10 100 mg100 mgper 1 Softgel(s)DSLD:245349
- DCCoQ10 400 mg400 mgper 1 Softgel(s)DSLD:244712
- DCCoQ10 with BioPerine200 mgper 1 Capsule(s)DSLD:244983
- DCCoQsol 30 mgCoQsol · Coenzyme Q10 (Form: as CoQsol)30 mgper 1 Softgel(s)DSLD:244769
- DCDiabetes Advanced Support Packs10 mgper 1 Pack(s)DSLD:245605
- DCQ10 Mega100 mgper 1 Capsule(s)DSLD:245398
- DCQ10 Super30 mgper 1 Capsule(s)DSLD:245546
- DCQ10 Ultra10 mgper 1 Capsule(s)DSLD:245545
- Designs for HealthCoQnol 100 mgKaneka QH(TM) · Ubiquinol (Form: as Kaneka QH(TM) (Form: reduced form of CoQ10))100 mgper 1 Softgel(s)DSLD:22383
- Designs for HealthCoQnol 50 mgKaneka QH(TM) · Ubiquinol (Form: as Kaneka QH(TM) (Form: reduced form of CoQ10))50 mgper 1 Softgel(s)DSLD:22381
- Designs for HealthMitochondrial NRGUbiquinone100 mgper 2 Capsule(s)DSLD:22943
- Designs for HealthQ-Avail VS 100 Micro-emulsified CoQ10Ubiquinone100 mgper 1 Softgel(s)DSLD:22526
- Designs for HealthQ-Avail VS 200 Micro-emulsified CoQ10Ubiquinone200 mgper 1 Softgel(s)DSLD:23191
- Designs for HealthRYR SynergyUbiquinone40 mgper 2 Capsule(s)DSLD:23527
- DEVAVegan Coenzyme Q10 100 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Tablet(s)DSLD:248379
- Diatrix DietCoQ10 (Ubiquinone) 200 mgUbiquinone200 mgper 1 Capsule(s)DSLD:22170
- Doctor GilmoreMeta-Seven50 mgper 1 Capsule(s)DSLD:182030
- Doctor's BestBest CoQ10100 mgper 1 Capsule(s)DSLD:25169
- Doctor's BestBest Red Yeast Rice 1200 With CoQ1030 mgper 1 Tablet(s)DSLD:24681
- Doctor's BestBest Red Yeast Rice 1200 With CoQ1030 mgper 1 Tablet(s)DSLD:25217
- Doctor's BestBest Red Yeast Rice 600 With CoQ1030 mgper 1 Capsule(s)DSLD:25216
- Doctor's BestBest Red Yeast Rice With CoQ10 And CholesstrinolUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Capsule(s)DSLD:25219
- Doctor's BestCoQ10 L-Carnitine MagnesiumUbiquinone200 mgper 3 Veggie Capsule(s)DSLD:203385
- Doctor's BestCoQ10 plus Selenium YeastUbiquinone200 mgper 1 Veggie Capsule(s)DSLD:203414
- Doctor's BestHigh Absorption CoQ10 100 mg100 mgper 1 Softgel(s)DSLD:24968
- Doctor's BestHigh Absorption CoQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:253169
- Doctor's BestHigh Absorption CoQ10 100 mg with BioPerineUbiquinone100 mgper 1 Softgel(s)DSLD:202992
- Doctor's BestHigh Absorption CoQ10 100 mg with BioPerineUbiquinone100 mgper 1 Veggie Capsule(s)DSLD:203219
- Doctor's BestHigh Absorption CoQ10 200 mg with BioPerineUbiquinone200 mgper 1 Veggie Capsule(s)DSLD:202908
- Doctor's BestHigh Absorption CoQ10 400 mg with BioPerineUbiquinone400 mgper 1 Veggie Capsule(s)DSLD:203196
- Doctor's BestHigh Absorption CoQ10 plus PQQ with PureQQ and BioPerineUbiquinone100 mgper 1 Veggie Capsule(s)DSLD:203235
- Doctor's BestHigh Concentrate EPA plus CoQ10 with KD-Pur EPA and BioPerineUbiquinone100 mgper 2 Softgel(s)DSLD:203362
- Doctor's BestQ+ KinaseUbiquinone100 mgper 1 Capsule(s)DSLD:25001
- dotFITSuperior Antioxidant100 mgper 1 Softgel(s)DSLD:12982
- Douglas Cooper Co.Energy Support16 mgper 2 Veg Capsule(s)DSLD:247317
- Douglas Cooper Co.Ultra Optical CareUbiquinone · CoQ10 (Form: as Ubiquinone)10 mgper 3 Veg Capsule(s)DSLD:239512
- Douglas LaboratoriesAM Pack60 mgper 1 Packet(s)DSLD:230286
- Douglas LaboratoriesBasic Antiox50 mgper 1 Packet(s)DSLD:10794
- Douglas LaboratoriesBasics Plus With CopperUbiquinone25 mgper 1 Packet(s)DSLD:10769
- Douglas LaboratoriesCaplique Coenzyme Q-10 Suspended In Natural Vitamin E30 mgper 1 Capsule(s)DSLD:10232
- Douglas LaboratoriesChewable Co-Enzyme Q10Ubiquinone200 mgper 1 Tablet(s)DSLD:10811
- Douglas LaboratoriesCitrus-Q10 100100 mgper 1 Tablet(s)DSLD:232569
- Douglas LaboratoriesCitrus-Q10 30 Delicious Citrus-Flavored Natural Coenzyme Q1030 mgper 1 Tablet(s)DSLD:10521
- Douglas LaboratoriesCitrus-Q10 300300 mgper 1 Tablet(s)DSLD:237155
- Douglas LaboratoriesCitrus-Q10 6060 mgper 1 Tablet(s)DSLD:231877
- Douglas LaboratoriesCo-Enzyme Q-10Ubiquinone25 mgper 1 Tablet(s)DSLD:10810
- Douglas LaboratoriesCoenzyme Q-10 with Lipoic Acid60 mgper 1 Capsule(s)DSLD:232563
- Douglas LaboratoriesCoenzyme Q10 With Lipoic Acid60 mgper 1 Capsule(s)DSLD:245253
- Douglas LaboratoriesCoenzyme Q10 with Vitamin C50 mgper 1 Capsule(s)DSLD:245251
- Douglas LaboratoriesCoQ-loz 100 Natural Orange Flavored Coenzyme Q10 100 mg100 mgper 1 Tablet(s)DSLD:10487
- Douglas LaboratoriesCoQ-loz 300 Natural Orange Flavored Coenzyme Q10 300 mg300 mgper 1 Tablet(s)DSLD:10351
- Douglas LaboratoriesCoQmelt Natural Orange Flavored Coenzyme Q10 100 mg100 mgper 1 Tablet(s)DSLD:10331
- Douglas LaboratoriesCoQmelt Natural Orange Flavored Coenzyme Q10 100 mg100 mgper 1 Tablet(s)DSLD:10333
- Douglas LaboratoriesCoQmelt Natural Orange Flavored Coenzyme Q10 60 mg60 mgper 1 Tablet(s)DSLD:10336
- Douglas LaboratoriesEnergy RechargeUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)50 mgper 1 Vegetarian Capsule(s)DSLD:232881
- Douglas LaboratoriesEssential-4 Nutrition Pack100 mgper 1 Packet(s)DSLD:10038
- Douglas LaboratoriesEssential-4 Nutrition PackCoQ10 · Ubiquinol (Form: reduced form of CoQ10) (Alt. Name: Kaneka QH)100 mgper 1 Packet(s)DSLD:233000
- Douglas LaboratoriesHi-Vidomin Nutritional Immune-Support (hVnl-S)120 mgper 2 Vegetarian Capsule(s)DSLD:10381
- Douglas LaboratoriesLongevity Support Pack100 mgper 1 Pack(s)DSLD:10041
- Douglas LaboratoriesMitoTone PlusUbiquinone50 mgper 3 Vegetarian Capsule(s)DSLD:232823
- Douglas LaboratoriesNeuro Comfort100 mgper 2 Vegetarian Capsule(s)DSLD:232604
- Douglas LaboratoriesOpti-Omega Q (With Phytosterols)50 mgper 5 mLDSLD:10410
- Douglas LaboratoriesUbiquinol-QHUbiquinol (Alt. Name: Kaneka QH) Note: reduced form of CoQ10100 mgper 1 Softgel(s)DSLD:232201
- Douglas LaboratoriesUbiquinol-QHUbiquinol (Alt. Name: Kaneka QH) Note: reduced form of CoQ10100 mgper 1 Softgel Capsule(s)DSLD:244684
- Douglas LaboratoriesUbiquinol-QH With Vesisorb TechnologyUbiquinol (Alt. Name: Kaneka QH) Note: reduced form of CoQ10100 mgper 1 Capsule(s)DSLD:10573
- Douglas LaboratoriesUbiquinol-QH With Vesisorb TechnologyUbiquinol (Alt. Name: Kaneka QH) Note: reduced form of CoQ10100 mgper 1 Capsule(s)DSLD:10574
- Douglas LaboratoriesUltra Cardio Support Pack100 mgper 1 Packet(s)DSLD:10045
- Douglas LaboratoriesUltra Coenzyme Q-10200 mgper 1 Tablet(s)DSLD:232577
- Douglas LaboratoriesUltra Coenzyme Q10200 mgper 1 Chewable Tablet(s)DSLD:245364
- Douglas LaboratoriesUltra Coenzyme Q10200 mgper 1 Chewable Tablet(s)DSLD:245389
- Douglas LaboratoriesUltra Preventive 50+Ubiquinone · Co-Enzyme Q10 (Form: as Ubiquinone)50 mgper 2 Tablet(s)DSLD:233096
- Douglas LaboratoriesUltra Preventive 50+Ubiquinone · Co-Enzyme Q10 (Form: as Ubiquinone)50 mgper 2 Tablet(s)DSLD:245416
- Douglas LaboratoriesUltra Preventive Forte-Chel30 mgper 9 Tablet(s)DSLD:10212
- Douglas LaboratoriesUltra Preventive Forte-Chel (Capsules)30 mgper 15 Capsule(s)DSLD:10186
- Dr. Clark Research Association Dr. Clark ZentrumCo-Enzyme Q10 30 mg30 mgper 1 Capsule(s)DSLD:223483
- Dr. Clark Research Association Dr. Clark ZentrumCo-Enzyme Q10 400 mg400 mgper 1 Capsule(s)DSLD:223486
- Dr. Clark StoreCo Q10 400 mgUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)400 mgper 1 Capsule(s)DSLD:219826
- Dr. David WilliamsCoQ10 AdvantageUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)200 mgper 2 Capsule(s)DSLD:231073
- Dr. MercolaLiposomal CoQ10 100 mgUbiquinone100 mgper 1 Capsule(s)DSLD:231483
- Dr. MercolaUbiquinol100 mgper 2 mLDSLD:232940
- Dr. SinatraChew Q10 PlusUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: Hydro Q-Sorb)100 mgper 1 Tablet(s)DSLD:233104
- Dr. SinatraCoQ10 100 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Softgel(s)DSLD:200864
- Dr. SinatraOmega Q PlusUbiquinone · Hydro Q-Sorb Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Softgel(s)DSLD:201859
- Dr. SinatraOmega Q PlusUbiquinone · Hydro Q-Sorb Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Softgel(s)DSLD:201867
- Dr. SinatraOmega Q PlusUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Softgel(s)DSLD:207789
- Dr. SinatraOmega Q PlusUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: Hydro Q-Sorb)50 mgper 2 Softgel(s)DSLD:230535
- Dr. SinatraOmega Q Plus 100Ubiquinone · Hydro Q-Sorb Coenzyme Q10 (Form: as Ubiquinone)100 mgper 2 Softgel(s)DSLD:179511
- Dr. SinatraOmega Q Plus 100Ubiquinone · Hydro Q-Sorb Coenzyme Q10 (Form: as Ubiquinone)100 mgper 2 Softgel(s)DSLD:239716
- Dr. SinatraOmega Q Plus 100Ubiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: Hydro Q-Sorb)100 mgper 2 Softgel(s)DSLD:242827
- Dr. SinatraOmega Q Plus 100 ResveratrolUbiquinone · Hydro Q-Sorb Coenzyme Q10 (Form: as Ubiquinone)100 mgper 2 Softgel(s)DSLD:201865
- Dr. SinatraOmega Q Plus 100 ResveratrolUbiquinone · Hydro Q-Sorb Coenzyme Q10 (Form: as Ubiquinone)100 mgper 2 Softgel(s)DSLD:201866
- Dr. SinatraOmega Q Plus 100 ResveratrolUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: Hydro Q-Sorb)100 mgper 2 Softgel(s)DSLD:230544
- Dr. SinatraOmega Q Plus 100 ResveratrolUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: Hydro Q-Sorb)100 mgper 2 Softgel(s)DSLD:230550
- Dr. SinatraOmega Q Plus 100 ResveratrolUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: Hydro Q-Sorb)100 mgper 2 Softgel(s)DSLD:256782
- Dr. SinatraOmega Q Plus 100 ResveratrolUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: Hydro Q-Sorb)100 mgper 2 Softgel(s)DSLD:256783
- Dr. SinatraOmega Q Plus LuteinUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Softgel(s)DSLD:207811
- Dr. SinatraOmega Q Plus MaxUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: Hydro Q-Sorb)100 mgper 2 Softgel(s)DSLD:230521
- Dr. SinatraOmega Q Plus ResveratrolUbiquinone · Hydro Q-Sorb Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Softgel(s)DSLD:230524
- Dr. SinatraOmega Q Plus Resveratrol And TurmericUbiquinone · Hydro Q-Sorb Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Softgel(s)DSLD:179536
- Drucker LabsintraMAX 2.0 Peach Mango Flavoramount not statedper 1 fl. Oz.DSLD:236722
- EmeraldCholesterol HealthUbiquinone25 mgper 1 Capsule(s)DSLD:221162
- EmeraldCoEnzymated Complete Clinical+Multi 4 DailyCoQ10 Note: fermented, tobacco-free25 mgper 2 Capsule(s)DSLD:220809
- Emerald LaboratoriesCoEnzymated Complete Premium+Multi 2 DailyCoQ10 Note: fermented15 mgper 2 Capsule(s)DSLD:221512
- Endurance Products CompanyCo-Enzyme Q10 100 mg100 mgper 1 Softgel(s)DSLD:177929
- EnergetixCoQ1032 mgper 0.25 tspDSLD:22636
- Enriching GiftsComplete Vitamins Plus4 mgper 5 Capsule(s)DSLD:228254
- Enriching GiftsMetabolic Complete30 mgper 1 Capsule(s)DSLD:228216
- EquateHigh Absorption CoQ-10 100 mg100 mgper 1 Softgel(s)DSLD:178852
- Esmond NaturalMen's Vitality Complex1 mgper 1 Tablet(s)DSLD:230788
- Esmond NaturalNatto 3,000 Fu/g30 mgper 1 Tablet(s)DSLD:230792
- Esmond NaturalQ-Sorb Co Q-10 100 mg100 mgper 1 Softgel(s)DSLD:178638
- Exchange SelectCo Q-10 100 mg100 mgper 1 Softgel(s)DSLD:200326
- Exchange Select XCo Q-10 200 mg200 mgper 1 Softgel(s)DSLD:24944
- Farmacias de Similares S.A. de C.VForte VF Q10amount not statedper 0 Not PresentDSLD:210272
- FemMedHeart Health Omega-3 + CoQ10Ubidecarenone100 mgper 2 Softgel(s)DSLD:19206
- Foods PlusCoQ10 100 mg100 mgper 1 Capsule(s)DSLD:211921
- ForeverForever Multi-Maca10 mgper 2 Tablet(s)DSLD:13177
- FreedaPure Co Q-10 100 mg100 mgper 1 Vegetarian Capsule(s)DSLD:221597
- FreedaPure Co Q-10 100 mg100 mgper 1 Vegetarian Capsule(s)DSLD:221599
- Fresh NutritionCoQ10 250 mg250 mgper 2 Softgel Capsule(s)DSLD:241918
- Full LifeCoQ10 30 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)80 mgper 1 Softgel(s)DSLD:242508
- Full LifeMultivita-Fem10 mgper 1 Softgel(s)DSLD:242605
- Full LifeMultivita-Men 1,000 mg10 mgper 1 Softgel(s)DSLD:242607
- Genceutic Naturals24hr CoQ10 100 mgBeta-Cyclodextrin · MicroActive CoQ10 Complex (Form: as Beta-Cyclodextrin, and CoQ10) Note: standardized to supply400 mgper 1 Capsule(s)DSLD:191074
- Genestra BrandsCoQ10 + TaurineCoenzyme Q10 Note: from yeast fermentation30 mgper 3 Capsule(s)DSLD:203253
- Genestra BrandsCoQ10 100Coenzyme Q10 Note: from yeast fermentation100 mgper 1 Capsule(s)DSLD:233573
- Genestra BrandsCoQ10 Chewable Blackcurrant FlavorCoenzyme Q10 Note: from bacterial fermentation60 mgper 1 Tablet(s)DSLD:242896
- Genestra BrandsCoQ10 Lipo 100Coenzyme Q10 Note: from yeast fermentation100 mgper 1 Capsule(s)DSLD:239108
- Genestra BrandsSuper EFA Liquid Plus CoQ10 Natural Orange FlavorCoenzyme Q10 Note: from yeast fermentation50 mgper 5 mLDSLD:242898
- Geri-CareCoQ10 100 mg100 mgper 1 Softgel(s)DSLD:255411
- Get Healthy AgainGlutathione Force IICoenzyme Q10 Note: liposoluble50 mgper 1 tspDSLD:175341
- Global Healing CenterCoQ10 & BioPQQ with ShilajitKaneka Q10 Ubiquinol · Coenzyme Q10 (Form: as Kaneka Q10 Ubiquinol)150 mgper 1 Capsule(s)DSLD:231134
- GNCCoQ-10 100 mgCoenzyme Q-10 Note: natural100 mgper 1 Softgel(s)DSLD:223595
- GNCCoQ-10 100 mgCoenzyme Q-10 Note: natural100 mgper 1 Softgel(s)DSLD:224609
- GNCCoQ-10 200 mgCoenzyme Q-10 Note: natural200 mgper 1 Softgel(s)DSLD:224628
- GNCCoQ-10 200 mgCoenzyme Q-10 Note: natural200 mgper 1 Softgel(s)DSLD:224629
- GNCCoQ-10 400 mgCoenzyme Q-10 Note: natural400 mgper 1 Softgel(s)DSLD:224630
- GNCCoQ-10 50 mgCoenzyme Q-10 Note: natural50 mgper 1 Softgel Capsule(s)DSLD:243057
- GNC Mega MenFish Oil with CoQ-10Coenzyme Q-10 Note: natural100 mgper 1 Softgel(s)DSLD:15716
- GNC Mega MenMemoralCoenzyme Q-10 Note: natural5 mgper 1 Softgel(s)DSLD:15717
- GNC Preventive NutritionCoQ-10 100 mgCoenzyme Q-10 Note: natural100 mgper 1 Softgel(s)DSLD:18439
- GNC Preventive NutritionCoQ-10 400 mgCoenzyme Q-10 Note: natural400 mgper 1 Soft Gel Capsule(s)DSLD:1843
- GNC Preventive NutritionCoQ-10 50 mgCoenzyme Q-10 Note: natural50 mgper 1 Soft Gel Capsule(s)DSLD:1844
- GNC Preventive NutritionMemorall10 mgper 2 Softgel(s)DSLD:1837
- GNC Preventive NutritionSuper CoQ-10 100 mgCoenzyme Q-10 Note: natural100 mgper 1 Softgel(s)DSLD:1839
- Greens TodayJoint Formula French Vanilla FlavorCoQ10 Note: co-enzyme1 mgper 15 Gram(s)DSLD:11568
- Harmonic InnerprizesHeartLight60 mgper 1 Vegetarian Capsule(s)DSLD:19666
- Harmonic InnerprizesHeartLight120 mgper 2 Vegetable Capsule(s)DSLD:213160
- HBC Health SolutionsEffinex with C300 mgper 1 Capsule(s)DSLD:247898
- HD MuscleVitaHD Essential Health MultiKaneka Ubiquinol · Ubiquinol (Form: as Kaneka Ubiquinol)50 mgper 5 Capsule(s)DSLD:245711
- Health Thru Nutrition NaturallyCoQ10 100 mgUbidecarenone100 mgper 1 Softgel(s)DSLD:229744
- Health Thru Nutrition NaturallyH2Q 100 mgHydroQsorb · Coenzyme Q10 (Form: Ubidecarenone Note: USP, as HydroQsorb (Form: 100% water soluble CoQ10))100 mgper 1 Capsule(s)DSLD:177441
- Health Thru Nutrition NaturallyH2Q 100 mgHydroQsorb · Coenzyme Q10 (Form: Ubidecarenone Note: USP, as HydroQsorb (Form: 100% water soluble CoQ10))100 mgper 1 Capsule(s)DSLD:177448
- Health Thru Nutrition NaturallyPhysician's MultiVitamin FormulaCoenzyme Q-10 Note: powder1 mgper 1 Caplet(s)DSLD:177596
- Healthy Choice NaturalsCoEnzyme Q10 30 mg30 mgper 1 Softgel(s)DSLD:11353
- Healthy Choice NaturalsFull Spectrum Daily Multiple10 mgper 3 Tablet(s)DSLD:209037
- Healthy ItemsCardio-Care30 mgper 4 Capsule(s)DSLD:183338
- Healthy ItemsLiposomal Can-Help Complex89 mgper 1 TbspDSLD:231116
- Healthy ItemsLiposomal CoQ10166 mgper 1 tspDSLD:231055
- Healthy Items Liposomal NutritionalsLiposomal Age-Less25 mgper 0.5 Ounce(s)DSLD:11445
- Healthy OriginsCoQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:108255
- HerbadietCoQ 10 (with Piperine)95 mgper 100 mgDSLD:244214
- HerbadietCoQ10 with Piperine200 mgper 1 Capsule(s)DSLD:244236
- Hi-Tech PharmaceuticalsCoQ10 100 mg With Extend-Rx Technology100 mgper 1 Tablet(s)DSLD:10237
- Higher NatureAll Man2.7 mgper 3 Capsule(s)DSLD:223104
- Higher NatureAll Man2.7 mgper 3 Capsule(s)DSLD:245892
- Higher NatureCardio Heart Nutrients30 mgper 2 Capsule(s)DSLD:223389
- Higher NatureCo-Enzyme Q1030 mgper 1 Tablet(s)DSLD:223396
- Higher NatureCo-Enzyme Q1030 mgper 1 Tablet(s)DSLD:245451
- Higher NatureCo-Enzyme Q1030 mgper 1 Tablet(s)DSLD:246087
- Higher NatureKeep Sharp50 mgper 1 Jelly(s)DSLD:178205
- Higher NatureMaxi Co-Q1030 mgper 1 Capsule(s)DSLD:228566
- Higher NatureSuper Antioxidant Protection5 mgper 1 Tablet(s)DSLD:228425
- Higher NatureSuper Antioxidant Protection5 mgper 1 Tablet(s)DSLD:240564
- Higher NatureSuper Antioxidant Protection5 mgper 1 Tablet(s)DSLD:245830
- Higher NatureTrue Food All ManTrue Food nutrients2.7 mgper 3 Capsule(s)DSLD:217313
- Higher NatureWise Woman2 mgper 3 Capsule(s)DSLD:245901
- Higher NatureWise Woman2 mgper 3 Capsule(s)DSLD:245905
- HUMMighty Night25 mgper 2 Softgel(s)DSLD:241699
- ImmunotecOmega Gen VUbiquinone-1076 mgper 4 Softgel(s)DSLD:240031
- Indiana Botanic GardensCoEnzyme Q-10Ubiquinone · Coenzyme Q-10 (Form: as Ubiquinone)20 mgper 2 Softgel(s)DSLD:18463
- Infiniti CreationsCoQ10 Ubiquinone 200 mg dailyUbiquinone200 mgper 1 Capsule(s)DSLD:238948
- InfoWars LifeExtend WiseUbiquinone100 mgper 1 Softgel(s)DSLD:218912
- InfoWars LifeVitamin Mineral Fusion Fruit Punch Flavor25 mgper 8.02 Gram(s)DSLD:218950
- Innate Response FormulasComplete Multi PowderUbiquinone50 mgper 6.5 Gram(s)DSLD:177941
- Innate Response FormulasCoQ10 100 mg100 mgper 1 Vegetarian Capsule(s)DSLD:178040
- Innate Response FormulasOne Daily CapUbiquinone50 mgper 1 Capsule(s)DSLD:177868
- Integrative TherapeuticsCoQ10 100 mgUbiquinone 10100 mgper 1 Softgel(s)DSLD:251172
- Integrative TherapeuticsDetoxication FactorsUbiquinone8.4 mgper 1 Capsule(s)DSLD:242307
- Integrative TherapeuticsDetoxication FactorsUbiquinone8.4 mgper 1 Capsule(s)DSLD:242311
- Integrative TherapeuticsHDL RXUbiquinone 1024 mgper 2 Tablet(s)DSLD:184909
- Integrative TherapeuticsLearner's EdgeUbiquinone30 mgper 3 Capsule(s)DSLD:230053
- Integrative TherapeuticsUBQH 50 mgKaneka Ubiquinol · reduced form Coenzyme Q10 (Form: as Kaneka Ubiquinol)50 mgper 1 Softgel(s)DSLD:222917
- Integrative TherapeuticsVitaline CoQ10 1,200 mg Cherry Vanilla FlavoredUbiquinone1.2 Gram(s)per 3 Wafer(s)DSLD:223198
- Integrative TherapeuticsVitaline CoQ10 100 mg CoQ10 Chocolate FlavoredUbiquinone 10100 mgper 1 Wafer(s)DSLD:223100
- Integrative TherapeuticsVitaline CoQ10 60 mg Natural Orange Flavortrans CoQ10 · Natural Coenzyme Q10 (Form: trans CoQ10) (Alt. Name: Ubiquinone 10) Note: derived from yeast fermentation60 mgper 1 Wafer(s)DSLD:24435
- IsagenixCytoActivesUbidecarenone100 mgper 2 Softgel(s)DSLD:238840
- IsotonixIsochrome60 mgper 3.3 Gram(s)DSLD:217910
- IVL Institute For Vibrant LivingOmega Max SoftgelsUbiquinone100 mgper 2 Softgel(s)DSLD:15547
- IVL Institute For Vibrant LivingOral Guard With XylitolCoenzyme Q-10 Note: spray160 mcgper 0.2 Gram(s)DSLD:24876
- Jigsaw HealthCoQ10 w/SRT100 mgper 1 Capsule(s)DSLD:240645
- John Gilmore, MDMeta-Seven50 mgper 1 Capsule(s)DSLD:231127
- Kaneka Q+Ubiquinol 100 mg100 mgper 1 Softgel(s)DSLD:243447
- KarunaCoQ-10 100 mg100 mgper 1 Softgel(s)DSLD:25253
- KarunaCoQ-10 30 mg30 mgper 1 Softgel(s)DSLD:25252
- KidzPlayFun Play1 mgper 1 mLDSLD:22517
- Kirkland SignatureCoQ10 300 mg300 mgper 1 Softgel(s)DSLD:207421
- Kirkland SignatureUbiquinol 200 mg200 mgper 1 Softgel(s)DSLD:239457
- KirkmanAdvanced Adult Multi-Vitamin/Mineral25 mgper 2 Capsule(s)DSLD:23871
- KirkmanChildren's Chewable Multi-Vitamin/Mineral Wafers10 mgper 2 Wafer(s)DSLD:23938
- KirkmanChildren's Multi-Vitamin/Mineral Capsules10 mgper 2 Capsule(s)DSLD:23991
- KirkmanCoenzyme Q10 100 mg Chewable Tablets w/Sucralose100 mgper 1 Tablet(s)DSLD:24004
- KirkmanCoenzyme Q10 Chewable Tablets 100 mg100 mgper 1 Tablet(s)DSLD:24001
- KirkmanCoenzyme Q10 Chewable Tablets-25 mg25 mgper 1 Tablet(s)DSLD:24044
- KirkmanCoenzyme Q10 Chewable Tablets-25 mg25 mgper 1 Tablet(s)DSLD:24049
- KirkmanMito-Cell Support60 mgper 4 Capsule(s)DSLD:25047
- KirkmanSpectrum Complete II Powder Flavored25 mgper 1 tspDSLD:25299
- Lee Haney's Nutritional Support SystemsAge Management Pack50 mgper 9 Capsule(s)DSLD:12985
- LegionTriumph Men's Sport MultivitaminUbidecarenone90 mgper 8 Veggie Capsule(s)DSLD:248756
- LegionTriumph Women'sUbiquinol · CoQ10 (Form: as Ubiquinol)90 mgper 8 Capsule(s)DSLD:248755
- Life ExtensionHighly-Absorbable CoQ10 (Ubiquinone) With D-Limonene 100 mg100 mgper 1 Softgel(s)DSLD:179252
- Life ExtensionSuper Ubiquinol CoQ10 Enhanced Mitochondrial SupportKaneka Ubiquinol · Ubiquinol (Form: as Kaneka Ubiquinol)100 mgper 1 Softgel(s)DSLD:211225
- Life ExtensionSuper Ubiquinol CoQ10 Enhanced Mitochondrial SupportKaneka Ubiquinol · Ubiquinol (Form: as Kaneka Ubiquinol)100 mgper 1 Softgel(s)DSLD:232782
- Life ExtensionSuper-Absorbable Co-Q10 (Ubiquinone) 50 mg with d-Limonene50 mgper 1 Softgel(s)DSLD:232605
- Life ExtensionSuper-Absorbable CoQ10 (Ubiquinone) 100 mg with D-Limonene100 mgper 1 Softgel(s)DSLD:232607
- LifeLinkCoQ10 Ubiquinone 3030 mgper 1 Capsule(s)DSLD:11828
- LifeLinkCoQ10 Ubiquinone 9090 mgper 1 Capsule(s)DSLD:11826
- Liquid HealthHydrosoluble CoQ10 Berry Flavor50 mgper 1 Tablespoon(s)DSLD:240223
- Lyfe FuelAll-In-One Daily Essentials Shake Chocolate10 mgper 32 Gram(s)DSLD:177010
- Lyfe FuelAll-In-One Daily Essentials Shake Chocolate10 mgper 33 Gram(s)DSLD:205239
- Lyfe FuelAll-In-One Daily Essentials Shake Chocolate10 mgper 33 Gram(s)DSLD:205351
- Lyfe FuelAll-In-One Daily Essentials Shake Vanilla Chai10 mgper 32 Gram(s)DSLD:177043
- Lyfe FuelAll-In-One Daily Essentials Shake Vanilla Chai10 mgper 32 Gram(s)DSLD:205359
- Lyfe FuelAll-In-One Daily Essentials Shake Vanilla Chai10 mgper 32 Gram(s)DSLD:205367
- MajorCo Q-10 50 mg50 mgper 1 Softgel(s)DSLD:201965
- MajorCoenzyme Q-10 100 mg100 mgper 1 Softgel(s)DSLD:202217
- MajorCoenzyme Q-10 200 mg200 mgper 1 Softgel(s)DSLD:202215
- MajorCoenzyme Q-10 30 mg30 mgper 1 Softgel(s)DSLD:201963
- Martin Avenue PharmacyCardio Health Support With Hawthorn And CoQ1060 mgper 3 Tablet(s)DSLD:18838
- Martin Avenue PharmacyChole Rx Depletion7 mgper 1 Capsule(s)DSLD:19070
- Martin Avenue PharmacyCoEnzyme Q10 100 mg100 mgper 1 Capsule(s)DSLD:18853
- Martin Avenue PharmacyCoEnzyme Q10 50 mg50 mgper 1 Capsule(s)DSLD:18857
- Martin Avenue PharmacyEnergizer Formula With Coenzyme Q10 & Lipoic Acidubiquinone50 mgper 2 Tablet(s)DSLD:19537
- Martin Avenue PharmacyHyper Rx Depletion5 mgper 1 Capsule(s)DSLD:19440
- Mason NaturalCo Q-10 200 mg200 mgper 1 Softgel(s)DSLD:207957
- Mason NaturalCoQ10 100 mg100 mgper 1 Softgel(s)DSLD:244733
- Mason NaturalCoQ10 30 mg200 mgper 1 Softgel(s)DSLD:244728
- Mason NaturalCoQ10 50 mg50 mgper 1 Softgel(s)DSLD:244734
- Mason NaturalCoQ10 plus Red Yeast Rice60 mgper 1 Softgel(s)DSLD:202081
- Mason NaturalCoQ10 with L-Carnitine30 mgper 1 Softgel(s)DSLD:244742
- Mason NaturalCoQ10 with Red Yeast Rice60 mgper 1 Softgel(s)DSLD:244740
- Mason NaturalCoQ10, Vitamin E, & Fish Oil50 mgper 2 Softgel(s)DSLD:216817
- MBi NutraceuticalsBio-Q1050 mgper 1 Tablet(s)DSLD:231539
- MBi NutraceuticalsOxyguard3.4 mgper 2 Capsule(s)DSLD:231758
- MediPlan Diet ServicesLipo Caps1 mgper 1 Capsule(s)DSLD:206844
- MelaleucaCoQ10+70 mgper 1 Softgel(s)DSLD:208886
- MelaleucaVitality 6 Essentials + Heart15 mgper 1 Packet(s)DSLD:13664
- MelaleucaVitality Total15 mgper 1 Packet(s)DSLD:13621
- Member's MarkCo Q-10 200 mg200 mgper 1 Softgel(s)DSLD:12259
- Mercola Advanced NutritionCoQ10100 mgper 1 Softgel(s)DSLD:14970
- Merry ClinicAnti-Aging Formula30 mgper 4 Caplet(s)DSLD:205030
- Merry ClinicAnti-Aging FormulaUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)15 mgper 2 Tablet(s)DSLD:215796
- Metabolic MaintenanceCoQ10Ubiquinone200 mgper 1 Capsule(s)DSLD:24801
- Metabolic MaintenanceCoQ10 100 mgUbiquinone100 mgper 1 Capsule(s)DSLD:24799
- Metabolic MaintenanceCoQ10 50 mgUbiquinone50 mgper 1 Capsule(s)DSLD:24796
- Metabolic MaintenanceDeluxe Scavengers With CoQ1030 mgper 3 Capsule(s)DSLD:24831
- Metabolic MaintenanceDeluxe Scavengers With CoQ1030 mgper 3 Capsule(s)DSLD:24832
- Metabolic MaintenanceRed Yeast Rice With CoQ10Ubiquinone200 mgper 2 Capsule(s)DSLD:25115
- MetagenicsCoQ BioVail Natural Apple FlavorUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 5 mLDSLD:216237
- MetagenicsNutraGems CoQ10 300Ubiquinone300 mgper 1 Chewable Gel(s)DSLD:210894
- MetagenicsNutraGems CoQ10 300Ubiquinone300 mgper 1 Chewable Gel(s)DSLD:216521
- MetagenicsWellness Essentials Brain HealthUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Packet(s)DSLD:211103
- Micro IngredientsCOQ-10400 mgper 2 Softgel(s)DSLD:231414
- Miller Pharmacal GroupCoEnzyme Q10 Liquid 3030 mgper 5 mLDSLD:252028
- Mimi's MiracleMulti50 mgper 3 Capsule(s)DSLD:230167
- MontiffSuper Antioxidant100 mcgper 1 Capsule(s)DSLD:237078
- Morphogen NutritionMorphoprimeCoenzyme Q10200 mgper 6 Capsule(s)DSLD:212817
- Moss NutritionCoQH Select100 mgper 1 Softgel(s)DSLD:247014
- Moss NutritionCV Select25 mgper 2 Capsule(s)DSLD:187437
- Moss NutritionCV Select25 mgper 2 Capsule(s)DSLD:187446
- Mountain Meadow HerbsCOQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:212569
- myDNAhealthCravings30 mgper 2 Capsule(s)DSLD:199642
- NanoNutraLiposomal CoQ10Ubiquinone100 mgper 6 mLDSLD:250705
- NatrolCo Q-10 200 mg200 mgper 1 Softgel(s)DSLD:203019
- NatrolCoQ-10 100 mg100 mgper 1 Softgel(s)DSLD:203122
- NatrolCoQ-10 100 mg Fast Dissolve Cherry Flavor100 mgper 2 Tablet(s)DSLD:202786
- Natural FactorsPQQ-10Coenzyme Q10 Note: microorganism200 mgper 1 Softgel(s)DSLD:220808
- Natural VitalityNutraRev!25 mgper 2 TbspDSLD:25393
- Nature MadeCoQ10 100 mgUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)100 mgper 1 Softgel(s)DSLD:179581
- Nature MadeCoQ10 100 mgUbidecarenone100 mgper 1 Softgel(s)DSLD:180233
- Nature MadeCoQ10 100 mgUbidecarenone100 mgper 1 Softgel(s)DSLD:180332
- Nature MadeCoQ10 100 mgUbidecarenone100 mgper 1 Softgel(s)DSLD:180420
- Nature MadeCoQ10 200 mgUbidecarenone200 mgper 1 Softgel(s)DSLD:179969
- Nature MadeCoQ10 200 mgUbidecarenone200 mgper 1 Softgel(s)DSLD:180379
- Nature MadeCoQ10 200 mgUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)200 mgper 1 Softgel(s)DSLD:179676
- Nature MadeCoQ10 200 mgUbidecarenone200 mgper 1 Softgel(s)DSLD:180125
- Nature MadeCoQ10 200 mgUbidecarenone200 mgper 1 Softgel(s)DSLD:180234
- Nature MadeCoQ10 200 mgUbidecarenone200 mgper 1 Softgel(s)DSLD:180262
- Nature MadeCoQ10 200 mgUbidecarenone200 mgper 1 Softgel(s)DSLD:255113
- Nature MadeCoQ10 30 mgUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)30 mgper 1 Softgel(s)DSLD:179510
- Nature MadeCoQ10 400 mgUbidecarenone400 mgper 1 Softgel(s)DSLD:179677
- Nature MadeCoQ10 400 mgUbidecarenone400 mgper 1 Softgel(s)DSLD:179710
- Nature MadeCoQ10 400 mgUbidecarenone400 mgper 1 Softgel(s)DSLD:180235
- Nature MadeCoQ10 Adult Gummies MangoUbidecarenone100 mgper 2 Gummie(s)DSLD:179908
- Nature MadeCoQ10 Adult Gummies Mango100 mgper 2 Gummy(ies)DSLD:209640
- Nature's AnswerCoQ-10 120 mg120 mgper 1 Softgel(s)DSLD:16539
- Nature's AnswerCoQ-10 30 mg30 mgper 1 Softgel(s)DSLD:12540
- Nature's AnswerCoQ-10 60 mg60 mgper 1 Capsule(s)DSLD:12553
- Nature's BountyCo Q-10 100 mg plus L-Carnitine100 mgper 1 Softgel(s)DSLD:239222
- Nature's BountyCo Q-10 200 mg Natural Orange Flavor200 mgper 1 Softgel(s)DSLD:253144
- Nature's BountyCo Q-10 400 mg400 mgper 1 Softgel(s)DSLD:253061
- Nature's BountyCoQ10 100 mg plus L-Carnitine100 mgper 1 Softgel(s)DSLD:242537
- Nature's BountyFish Oil 1000 mg Plus Co Q-1030 mgper 1 Softgel(s)DSLD:17473
- Nature's BountyUbiquinol 100 mg100 mgper 1 Softgel(s)DSLD:17550
- Nature's HarmonyCoenzyme Q10 50 mgUbiquinone50 mgper 1 Tablet(s)DSLD:21881
- Nature's HarmonyCoenzyme Q10 Ubiquinone 100 mgCoenzyme Q10100 mgper 1 Capsule(s)DSLD:21880
- Nature's HarmonyMulti-Mune10 mgper 1 Capsule(s)DSLD:21964
- Nature's LabCoQ10 + Alpha Lipoic Acid + Acetyl L-Carnitine HClUbiquinone · Coenzyme Q10 (Form: Ubiquinone) Note: naturally fermented200 mgper 2 Capsule(s)DSLD:205206
- Nature's LabCoQ10 + Alpha Lipoic Acid + Acetyl L-Carnitine HClCoQ10200 mgper 2 Capsule(s)DSLD:205217
- Nature's LabOne Daily MultivitaminUbiquinone100 mgper 1 Capsule(s)DSLD:205404
- Nature's LabOne Daily MultivitaminUbiquinone100 mgper 1 Capsule(s)DSLD:205516
- Nature's LabSix Daily Advanced Multivitamin100 mgper 6 Capsule(s)DSLD:207064
- Nature's SunshineCoQ10100 mgper 1 Softgel(s)DSLD:255227
- Nature's SunshineMega Chel3.3 mgper 4 Tablet(s)DSLD:255362
- Nature's TroveCoQ10 200 mg200 mgper 1 Capsule(s)DSLD:229415
- Nature's WayActivLife Q10 100 mgKaneka Ubiquinol · reduced form Coenzyme Q10 (Form: as Kaneka Ubiquinol)100 mgper 1 Softgel(s)DSLD:213971
- Nature's WayActivLife Q10 50 mgKaneka Ubiquinol · reduced form Coenzyme Q10 (Form: as Kaneka Ubiquinol)50 mgper 1 Softgel(s)DSLD:213975
- Nature's WayCell FormulaUbiquinone 104 mgper 2 Tablet(s)DSLD:213472
- Nature's WayFortify Digestive & Heart HealthUbiquinone 1030 mgper 1 Capsule(s)DSLD:213643
- Nature's WayHDL AssistUbiquinone 1025 mgper 2 Tablet(s)DSLD:212280
- Nature's WayHeartSure Red Yeast Rice with CoQ10Ubiquinone 1030 mgper 1 Capsule(s)DSLD:243202
- Nature's WaySmart Q10 100 mg Chocolate FlavoredUbiquinone 10100 mgper 1 Tablet(s)DSLD:228110
- Nature's WaySMART Q10 100 mg Maple Nut FlavoredUbiquinone 10100 mgper 1 Tablet(s)DSLD:212330
- Nature's WaySmart Q10 200 mg Maple Nut FlavorUbiquinone 10200 mgper 1 Tablet(s)DSLD:212363
- Natures PlusSource of Life Gold Tablets50 mgper 3 Tablet(s)DSLD:248867
- Natures Plus Keto LivingDaily Multi50 mgper 3 Capsule(s)DSLD:200801
- NaturesPlusHeartBeatUbiquinone10 mgper 3 Heart-Shaped Tablet(s)DSLD:249811
- NaturesPlus Herbal ActivesRed Yeast Rice & CoQ10 Extended ReleaseCoenzyme Q10 Note: 100% pure crystalline100 mgper 1 Extended-Release Tablet(s)DSLD:249780
- New HealthHeart SaviorUbidecarenone30 mgper 2 Capsule(s)DSLD:206160
- New Health Corp.Heart Savior30 mgper 2 Capsule(s)DSLD:25538
- New SunCo Q10 100 mg with Vitamin E100 mgper 1 Softgel(s)DSLD:202198
- New SunHer Vitamins30 mgper 3 Tablet(s)DSLD:247160
- New SunHi Energy Fat Burner +10 mgper 2 Capsule(s)DSLD:11614
- New SunHi Energy Thermogenic +10 mgper 2 Veg Capsule(s)DSLD:217950
- NewtonEverettCoQ10 200 mg200 mgper 1 Softgel(s)DSLD:213491
- NewtonEverettCoQ10 200 mg200 mgper 1 Vegetarian Capsule(s)DSLD:248922
- NewtonEverettCoQ10 400 mg400 mgper 1 Softgel(s)DSLD:213488
- NewtonEverettCoQ10 with Fish Oil30 mgper 1 Softgel(s)DSLD:248886
- Nootropics DepotCoenzyme Q10 Powder200 mgper 0.2 Gram(s)DSLD:232118
- Nootropics DepotCoenzyme Q10 Powder200 mgper 200 mgDSLD:251131
- Nootropics DepotCoQH-CF Softgels 100 mg100 mgper 1 Softgel(s)DSLD:232122
- Nordic NaturalsCoQ10 Gummies StrawberryUbiquinone100 mgper 1 Gummy(ies)DSLD:223350
- Nordic NaturalsOmega LDLUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 3 Softgel(s)DSLD:223429
- Nova NutritionsCoQ10 200 mgUbiquinone200 mgper 1 Capsule(s)DSLD:229291
- Nova NutritionsRed Yeast Rice COQ10Ubiquinone60 mgper 2 Capsule(s)DSLD:229223
- Novex BiotechOxydrene NAD+ Enhancer30 mgper 2 Vegetable Capsule(s)DSLD:228783
- Novex BiotechOxydrene NAD+ Enhancer30 mgper 2 Vegetable Capsule(s)DSLD:252223
- NOWCoQ10 100 mg100 mgper 1 Veg Capsule(s)DSLD:245784
- NOWCoQ10 100 mg100 mgper 1 Veg Capsule(s)DSLD:245785
- NOWCoQ10 100 mg100 mgper 1 Veg Capsule(s)DSLD:245789
- NOWCoQ10 100 mg With Rice Bran Oil And Vitamin E In An Enhanced Absorption Base100 mgper 1 Softgel(s)DSLD:13093
- NOWCoQ10 150 mg150 mgper 1 Vegetarian Capsule(s)DSLD:14650
- NOWCoQ10 30 mg30 mgper 1 Vegetarian Capsule(s)DSLD:13086
- NOWCoQ10 30 mg30 mgper 1 Veg Capsule(s)DSLD:245818
- NOWCoQ10 30 mg30 mgper 1 Veg Capsule(s)DSLD:245824
- NOWCoQ10 400 mg400 mgper 1 Softgel(s)DSLD:245786
- NOWCoQ10 400 mg400 mgper 1 Softgel(s)DSLD:245825
- NOWCoQ10 50 mg50 mgper 1 Softgel(s)DSLD:245832
- NOWCoQ10 60 mg With 200 mg Lecithin60 mgper 1 Capsule(s)DSLD:12799
- NOWCoQ10 60 mg With 200 mg Lecithin60 mgper 1 Capsule(s)DSLD:13088
- NOWCoQ10 60 mg with Omega-3 Fish Oil60 mgper 1 Softgel(s)DSLD:245777
- NOWCoQ10 60 mg with Omega-3 Fish Oil60 mgper 1 Softgel(s)DSLD:245788
- NOWCoQsol CF 100 mgCoQsol-CF(R) · Coenzyme Q10 (Form: from CoQsol-CF(R))100 mgper 1 Softgel(s)DSLD:14481
- NOWEffer-C Elderberry Effervescent Drink Mix5 mgper 5.5 Gram(s)DSLD:244592
- NOWHeart Support30 mgper 3 Tablet(s)DSLD:14886
- NOWMaximum Strength CoQ10 600 mg600 mgper 1 Softgel(s)DSLD:245815
- NOW SportsArginine Power Super Stack5 mgper 3 Capsule(s)DSLD:12854
- NOW SportsArginine Stack Tropical Punch5 mgper 20 Gram(s)DSLD:205158
- Nu-HealthHi-Absorption Co-Q10 100 mg100 mgper 1 Softgel(s)DSLD:206050
- NusaPureHigh Absorption Coenzyme Q10 with BioPerine400 mgper 2 Veg Capsule(s)DSLD:246378
- NusaPureHigh Absorption Coenzyme Q10 with BioPerine400 mgper 2 Veg Capsule(s)DSLD:246379
- Nutra SportBaseline CoQ10 100 mg100 mgper 1 Softgel(s)DSLD:249628
- NutraPro (Neutraceutical Corp.)Healthy Heart25 mgper 3 Capsule(s)DSLD:253174
- Nutri-RichCoQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:214105
- Nutri-RichCoQ10 50 mgUbiquinone50 mgper 1 Softgel(s)DSLD:176521
- NutriCologyCoenzyme Q10 30 mg with Vitamin C60 mgper 1 Capsule(s)DSLD:184248
- NutriCologyCoenzyme Q10 50 mg with Vitamin C100 mgper 1 Capsule(s)DSLD:235258
- NutriCologyCoenzyme Q10 with Tocotrienols300 mgper 1 Softgel(s)DSLD:193230
- NutriCologyCoenzyme Q10 with Tocotrienols300 mgper 1 Softgel(s)DSLD:235371
- NutriCologyCoenzyme Q10 with Tocotrienols300 mgper 1 Softgel(s)DSLD:235375
- NutriCologyCoQ-Gamma E with Tocotrienols & Carotenoids75 mgper 1 Softgel(s)DSLD:235479
- NutriCologyCoQH-CF UbiquinolCoQ10 · Ubiquinol (Form: reduced CoQ10)100 mgper 1 Softgel(s)DSLD:235495
- NutriCologyNTFactor CoQ10 Chocolate Chewables100 mgper 1 Tablet(s)DSLD:235542
- NutriCology Restore-BioticRestore-Biotic Heart100 mgper 2 Capsule(s)DSLD:234810
- NutricostCoQ10 100 mg100 mgper 1 Capsule(s)DSLD:223077
- Oceanblue ProfessionalOmega-3 2100 with CoQ10 Natural Orange Flavor150 mgper 3 Softgel(s)DSLD:248542
- OL Olympian LabsAgeless150 mgper 3 Softgel(s)DSLD:175962
- OL Olympian LabsCoQ10 300 mg300 mgper 1 Capsule(s)DSLD:175842
- OL Olympian LabsUltimate Krill Complex50 mgper 2 Softgel(s)DSLD:176045
- OnnitTotal MitochondriaCoQ-10 · MicroActive CoQ10 (Form: standardized to 26% CoQ-10)120 mgper 1 Capsule(s)DSLD:208906
- OptiChoiceCogniPro Sport 3.0Ubiquinone · CoQsource natural Coenzyme Q10 (Form: as Ubiquinone)50 mgper 4 Softgel(s)DSLD:216989
- OptiChoiceCoQ10 200 mg Maximum PotencyUbiquinone · natural Coenzyme Q10 (Form: as Ubiquinone)200 mgper 1 Softgel(s)DSLD:217058
- OptiChoiceCoQ10 Body Ready 100 mgUbiquinone · natural Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Softgel(s)DSLD:216993
- OptiChoiceCoQ10 plus Omega-3 1000 mgUbiquinone · natural Coenzyme Q10 (Form: as Ubiquinone)200 mgper 2 Softgel(s)DSLD:216997
- OptiChoiceCoQ10 QH-Ubiquinol 100 mgCoQ10 · Natural Coenzyme Q10 QH-Ubiquonal (Form: reduced form of CoQ10) (Alt. Name: Kaneka QH)100 mgper 1 Softgel(s)DSLD:216998
- OptiChoiceUltimate Red Yeast Rice + CoQ10 with Cholesstrinol HPUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Capsule(s)DSLD:217050
- OptimumCoenzyme Q-10 10 mgUbidecarenone · Coenzyme Q-10 (Form: as Ubidecarenone)10 mgper 1 Capsule(s)DSLD:239991
- Oregon HealthMulti-Guard30 mgper 2 Capsule(s)DSLD:180726
- Oregon HealthMulti-Guard30 mgper 2 Capsule(s)DSLD:180741
- Ortho Molecular ProductsCoQ-10100 mgper 1 Soft Gel Capsule(s)DSLD:173749
- Ortho Molecular ProductsCoQ-10100 mgper 1 Soft Gel Capsule(s)DSLD:173753
- Ortho Molecular ProductsCoQ-10100 mgper 1 Soft Gel Capsule(s)DSLD:173754
- Ortho Molecular ProductsCoQ-10 300 mg300 mgper 1 Softgel Capsule(s)DSLD:173802
- Ortho Molecular ProductsCoQ-10 300 mg300 mgper 1 Softgel Capsule(s)DSLD:173805
- Ortho Molecular ProductsUbiquinol100 mgper 1 Softgel Capsule(s)DSLD:173822
- P2LifeAnti-Oxidant20 mgper 1 Capsule(s)DSLD:19130
- Pathway To HealingBasic Nutrient Support Capsule12.5 mgper 1 Capsule(s)DSLD:15320
- Pathway To HealingBlood Sugar Support20 mgper 2 Capsule(s)DSLD:14981
- Patient One 1 MediNutritionalsCholest-PlexUbiquinone30 mgper 2 Capsule(s)DSLD:249211
- Patient One 1 MediNutritionalsCoQ10 100 mgUbiquinone100 mgper 1 Capsule(s)DSLD:249215
- Patient One 1 MediNutritionalsCoQ10 100 mgUbiquinone100 mgper 1 Capsule(s)DSLD:249220
- Patient One 1 MediNutritionalsOpticOneUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)30 mgper 3 Capsule(s)DSLD:249338
- Patient One 1 MediNutritionalsRed Yeast Rice with Ubiquinol QH50 mgper 2 Capsule(s)DSLD:205603
- Patient One MediNutritionalsCoQ10 300 mgUbiquinone300 mgper 1 Capsule(s)DSLD:181915
- Patient One MediNutritionalsCoQ10 300 mgUbiquinone300 mgper 1 Capsule(s)DSLD:181916
- Patient One MediNutritionalsRed Yeast Rice with CoQ10Ubiquinone50 mgper 1 Capsule(s)DSLD:249353
- Patient One MediNutritionalsRed Yeast Rice with CoQ10Ubiquinone50 mgper 1 Capsule(s)DSLD:249355
- PerqueLiva Guard CapsulesPure Coenzyme Q10 Note: water-soluble bioflavonoid5 mgper 2 Capsule(s)DSLD:18790
- PerqueLiva Guard CapsulesPure Coenzyme Q10 Note: water-soluble bioflavonoid5 mgper 2 Capsule(s)DSLD:18791
- PerqueLiva Guard ForteMicellized Ubiquinone100 mgper 1 Softgel(s)DSLD:240865
- PerqueLiva Guard ForteMicellized Ubiquinone100 mgper 1 Softgel(s)DSLD:240867
- PerqueLiva Guard Forte SoftgelsMicellized Ubiquinone200 mgper 2 Softgel(s)DSLD:18787
- PerqueLiva Guard Forte SoftgelsMicellized Ubiquinone200 mgper 2 Softgel(s)DSLD:18789
- PerqueMito Guard 100 PlusPure Coenzyme Q10 Note: soluble Ubiquinone100 mgper 1 Softgel Capsule(s)DSLD:240900
- PerqueMito Guard 60 Plussoluble ubiquinone60 mgper 1 Softgel(s)DSLD:18803
- Perricone MD NutriceuticalsPerricone Super Antioxidant6.25 mgper 2 Caplet(s)DSLD:209856
- Perricone MD NutriceuticalsRejuvenate5 mgper 1 Capsule(s)DSLD:209845
- PharmadenPerio Care10 mgper 1 Capsule(s)DSLD:203980
- PharmadenPerio Therapy25 mgper 1 Capsule(s)DSLD:203981
- PharmaxChewable CoQ10 60 mg Blackcurrant FlavorCoQ10 Note: from bacterial fermentation60 mgper 1 Tablet(s)DSLD:238896
- Physician DesignedBrain Support MicroPQQ + MicroActive CoQ10Ubiquinone220 mgper 2 Capsule(s)DSLD:249559
- Physician's SignatureTru-Sorb CoQ10 100 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Softgel(s)DSLD:229517
- plntWhole Food Men's Multivitamin425 mcgper 4 Vegetarian Capsule(s)DSLD:181329
- plntWhole Food Women's 50+ Multivitamin425 mcgper 4 Vegetarian Capsule(s)DSLD:180654
- plntWhole Food Women's Multivitamin425 mcgper 4 Vegetarian Capsule(s)DSLD:180754
- Premier Research LabsPQQ ComplexCoenzyme Q10 Note: fermented50 mgper 1 Capsule(s)DSLD:219444
- Premium CertifiedCoQ10 (with Ubiquinol)Ubiquinol250 mgper 2 Capsule(s)DSLD:248601
- Primal LabsCardioRelax AO100 mgper 2 Capsule(s)DSLD:206630
- Priority One Nutritional SupplementsOmega Daily Essentials50 mgper 2 Softgel(s)DSLD:236825
- ProCaps LaboratoriesAndrew's Five FavoritesUbiquinone · Coenzyme Q-10 (Form: natural Ubiquinone)200 mgper 2 Capsule(s)DSLD:248401
- ProCaps LaboratoriesCoenzyme Q-10 200 mgUbiquinone · Coenzyme Q-10 (Form: natural Ubiquinone)200 mgper 1 Capsule(s)DSLD:220816
- ProCaps LaboratoriesCoenzyme Q-10 200 mg with Vitamin D3 2000Ubiquinone · Coenzyme Q-10 (Form: natural Ubiquinone)200 mgper 1 Capsule(s)DSLD:240057
- ProCaps LaboratoriesTruQ10-QH Ubiquinol 100Activated CoQ10100 mgper 1 Softgel(s)DSLD:178922
- ProJoba InternationalProJoba Super Daily10 mgper 3 Tablet(s)DSLD:12909
- Protocol for Life BalanceLiquid CoQ10100 mgper 0.5 tspDSLD:11424
- Protocol For Life BalanceCoQ10 60 mg with Omega-3 Fish Oil60 mgper 1 Softgel(s)DSLD:10899
- Protocol For Life BalanceLiquid CoQ10 100 mg100 mgper 0.5 tspDSLD:11419
- Protocol For Life BalanceOrtho Multi For MenUbiquinone5 mgper 2 Tablet(s)DSLD:11777
- Protocol For Life BalanceProtoClear Berry12.5 mgper 25 Gram(s)DSLD:201335
- Protocol For Life BalanceProtoClear Chocolate12.5 mgper 27 Gram(s)DSLD:200420
- Protocol For Life BalanceProtoClear Detoxification Formula25 mgper 27.5 Gram(s)DSLD:11708
- Protocol For Life BalanceProtoClear Natural Orange Flavor25 mgper 55 Gram(s)DSLD:11725
- Protocol For Life BalanceProtoClear Natural Vanilla Flavor25 mgper 50 Gram(s)DSLD:23850
- Protocol For Life BalanceProtoClear Vanilla12.5 mgper 25 Gram(s)DSLD:201340
- Protocol For Life BalanceProtoMeal Natural Berry Flavor30 mgper 50 Gram(s)DSLD:15429
- Pure AdvantageMRP Chocolate8 mgper 69 Gram(s)DSLD:180795
- Pure AdvantageMRP Vanilla8 mgper 69 Gram(s)DSLD:180822
- Pure EncapsulationsAthletic Pure Pack145 mgper 9 Capsule(s)DSLD:182730
- Pure EncapsulationsCoQ10 30 mg30 mgper 1 Capsule(s)DSLD:184016
- Pure EncapsulationsCoQ10 60 mg60 mgper 1 Capsule(s)DSLD:182820
- Pure EncapsulationsCoQ10 60 mg60 mgper 1 Capsule(s)DSLD:184683
- Pure EncapsulationsCoQ10 L-Carnitine Fumarate120 mgper 2 Capsule(s)DSLD:184046
- Pure EncapsulationsDetox Pure Pack25 mgper 1 Packet(s)DSLD:246080
- Pure EncapsulationsEmulsiSorb CoQ10100 mgper 1 tspDSLD:184279
- Pure EncapsulationsEnergize Plus Pure Pack30 mgper 7 Capsule(s)DSLD:184817
- Pure EncapsulationsEPA/DHA CoQ10 Natural Orange Flavor100 mgper 1 tspDSLD:201487
- Pure EncapsulationsMen's Pure Pack60 mgper 8 Capsule(s)DSLD:183007
- Pure EncapsulationsMitochondria-ATPCoenzyme Q10 · Kaneka Ubiquinol (Form: active antioxidant form of Coenzyme Q10)25 mgper 2 Capsule(s)DSLD:185118
- Pure EncapsulationsMitochondria-ATPCoenzyme Q10 · Kaneka Ubiquinol (Form: active antioxidant form of Coenzyme Q10)25 mgper 2 Capsule(s)DSLD:219690
- Pure EncapsulationsNeuroMood Pure PackMicroActive Q10-Cyclodextrin Complex · Coenzyme Q10 (Form: 18% from sustained-release MicroActive Q10-Cyclodextrin Complex) (Alt. Name: CoQ10)50 mgper 5 Capsule(s)DSLD:246351
- Pure EncapsulationsQ-Gel 100100 mgper 1 Softgel Capsule(s)DSLD:187535
- Pure EncapsulationsRevitalAge NerveMicroActive Q10-Cyclodextrin Complex · Coenzyme Q10 (Form: from MicroActive Q10-Cyclodextrin Complex)15 mgper 2 Capsule(s)DSLD:187580
- Pure EncapsulationsRevitalAge UltraMicroActive Q10-Cyclodextrin Complex · CoQ10 (Form: from MicroActive Q10-Cyclodextrin Complex) Note: sustained release30 mgper 3 Capsule(s)DSLD:247312
- Pure EncapsulationsRibo Carnitine-Q1050 mgper 3 Capsule(s)DSLD:187545
- Pure EncapsulationsUbiquinol VESIsorbCoenzyme Q10 · Kaneka Ubiquinol (Form: active antioxidant form of Coenzyme Q10)100 mgper 1 Softgel(s)DSLD:233419
- Pure EncapsulationsUltra Pure Pack85 mgper 7 Capsule(s)DSLD:247017
- Pure EncapsulationsUltraDetox 10-Day Pure PackCoQ10 · Coenzyme Q10 complex (Form: as CoQ10, and as from sustained-release 18% Microactive Q10-Cyclodextrin)50 mgper 9 Capsule(s)DSLD:247322
- Pure EncapsulationsWomen's Pure Pack60 mgper 9 Capsule(s)DSLD:183301
- Pure PrescriptionsCoenzyme Q10 100 mg100 mgper 1 Softgel(s)DSLD:228150
- Pure PrescriptionsRed Yeast Rice+Ubiquinone · Coenzyme Q10 (Form: as Ubiquinone)50 mgper 2 Capsule(s)DSLD:228212
- Pure VeganAntioxidant Formula30 mgper 3 Capsule(s)DSLD:231543
- Pure VeganVegan Complete Vanilla15 mgper 43 Gram(s)DSLD:180409
- PureBulk.comCoenzyme Q10 (COQ10)Ubiquinone200 mgper 50 mgDSLD:23059
- PureBulk.comCoenzyme Q10 (COQ10) JapanUbiquinone200 mgper 50 mgDSLD:23061
- PureBulk.comCoenzyme Q10 (COQ10) USAUbiquinone200 mgper 50 mgDSLD:23060
- PureFormulasRed Yeast Rice 1200 mg with CoQ10Ubidicarenone · Coenzyme Q10 (Form: as Ubidicarenone)30 mgper 2 Capsule(s)DSLD:205977
- PureFormulasUbiquinol-QHCoQ10 · Ubiquinol (Form: reduced form of CoQ10) (Alt. Name: Kaneka QH)100 mgper 1 Softgel Capsule(s)DSLD:205997
- Puritan's PrideCO Q-10 & Cinnamon120 mgper 1 Softgel(s)DSLD:239282
- Puritan's PrideCO Q-10 & L-Carnitine30 mgper 1 Softgel(s)DSLD:12291
- Puritan's PrideCo Q-10 200 mg200 mgper 1 Softgel(s)DSLD:250768
- Puritan's PrideCO Q-10 200 mg200 mgper 1 Softgel(s)DSLD:250763
- Puritan's PrideQ-SORB Co Q-10 200 mg200 mgper 1 Softgel(s)DSLD:250777
- Puritan's PrideQ-Sorb Co Q-10 400 mg400 mgper 1 Softgel(s)DSLD:250844
- Puritan's PrideQ-Sorb Co Q-10 400 mg400 mgper 1 Softgel(s)DSLD:250847
- Puritan's PrideQ-Sorb Co-Q10 200 mg200 mgper 1 Softgel(s)DSLD:250783
- Puritan's Pride PremiumQ-Sorb Co Q-10 100 mg100 mgper 1 Softgel(s)DSLD:250836
- Puritan's Pride PremiumQ-Sorb Co Q-10 100 mg100 mgper 1 Softgel(s)DSLD:250840
- Puritan's Pride PremiumQ-Sorb Co Q-10 100 mg100 mgper 1 Softgel(s)DSLD:250842
- Puritan's Pride PremiumQ-SORB Co Q-10 100 mg100 mgper 1 Softgel(s)DSLD:250838
- Puritan's Pride PremiumQ-Sorb Co Q-10 30 mg30 mgper 1 Softgel(s)DSLD:12240
- Puritan's Pride PremiumQ-SORB Co Q-10 400 mg400 mgper 1 Softgel(s)DSLD:250845
- Purity ProductsCO-Q-Omega50 mgper 2 Softgel(s)DSLD:243505
- Purity ProductsCoQ10 Daily Melt with Resveratrol100 mgper 2 Fast Dissolving Tablet(s)DSLD:243507
- Purity ProductsCoQ10 Daily Super BoostUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: KanekaQ10)100 mgper 2 Vegetarian Capsule(s)DSLD:243672
- Purity ProductsCoQ10 Daily with Hawthorn Extract100 mgper 2 Vegetarian Capsule(s)DSLD:243675
- Purity ProductsCoQ10 Daily with Lutein100 mgper 2 Vegetarian Capsule(s)DSLD:243682
- Purity ProductsElite Multivitamin2 mgper 4 Vegetarian Capsule(s)DSLD:244328
- Purity ProductsKrill Omega 10X with CoQ10100 mgper 2 Softgel(s)DSLD:243789
- Purity ProductsKrill Omega 50+ with CoQ10100 mgper 2 Softgel(s)DSLD:243791
- Purity ProductsLiquid Triple Action Omega Delicious Tropical Mango Flavor25 mgper 2.5 mLDSLD:244209
- Purity ProductsPerfect Multi Super Greens2 mgper 4 Vegetarian Capsule(s)DSLD:244038
- Purity ProductsPycnogenol + CoQ10Kaneka Q10 Ubiquinone · Coenzyme Q10 (Form: as Kaneka Q10 Ubiquinone)50 mgper 2 Capsule(s)DSLD:244105
- Purity ProductsSasquatch Pre-Workout25 mgper 16.9 Gram(s)DSLD:244118
- Purity ProductsThe Purity Super Pill100 mgper 3 Softgel(s)DSLD:244204
- Purity ProductsTriple Action Omega-325 mgper 1 Softgel(s)DSLD:244213
- Purity ProductsUbiquinol CoQ10 Daily200 mgper 2 Capsule(s)DSLD:244253
- Purity ProductsUbiquinol Daily100 mgper 2 Capsule(s)DSLD:244255
- Purity ProductsUltimate Performance EverStrong Elite25 mgper 16.9 Gram(s)DSLD:243712
- Purity ProductsUltra-Pure Fish Oil + CoQ10 Packet50 mgper 2 Softgel(s)DSLD:244329
- QualiaQualia LifeUbiquinone65 mgper 8 Vegetarian Capsule(s)DSLD:239649
- Quality Of LifeCoQ10-SR100 mgper 1 Vegetarian Capsule(s)DSLD:175585
- Quicksilver ScientificDr. Shade's The OneUbiquinone · CoQ10 (Form: as Ubiquinone)30 mgper 1 Teaspoon(s)DSLD:248523
- Quicksilver ScientificNanoemulsified CoQ1030 mgper 1 mLDSLD:220200
- QunolLiquid CoQ10 100 mg Orange Pineapple FlavorUbiquinone100 mgper 10 mLDSLD:205465
- QunolUltra CoQ10 100 mg100 mgper 1 Softgel(s)DSLD:241623
- Redcon1Aftermath100 mgper 2 Capsule(s)DSLD:172173
- Rejuvenation ScienceMaximum Vitality20 mgper 2 Tablet(s)DSLD:206219
- Reliable-1 LaboratoriesCoQ10 100 mg with Vitamin EUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone Note: USP)100 mgper 1 Softgel(s)DSLD:180294
- Reliable-1 LaboratoriesCoQ10 200 mg with Vitamin EUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone Note: USP)200 mgper 1 Softgel(s)DSLD:180298
- RelivCardio Sentials50 mgper 11 Gram(s)DSLD:218628
- RelivCardioSentials50 mgper 11 Gram(s)DSLD:201243
- RoexNutra- 2Ubidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)2 mgper 2 Capsule(s)DSLD:211518
- RugbyNatural Coenzyme Q10 100 mg100 mgper 1 Softgel(s)DSLD:201223
- RugbyNatural Coenzyme Q10 200 mgUbidecarenone200 mgper 1 Softgel(s)DSLD:201189
- Ryno PowerEndurance50 mgper 5 Capsule(s)DSLD:231284
- Ryno PowerEndurance50 mgper 5 Capsule(s)DSLD:231328
- SANCoQ10 100 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Capsule(s)DSLD:175262
- Schiff MegaRedAdvanced CoQ10 200 mg200 mgper 1 Capsule(s)DSLD:241066
- Seeking HealthOptimal Liposomal CoQ10 200 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)200 mgper 6 mLDSLD:210963
- Seeking HealthOptimal PrenatalUbidecarenone75 mgper 8 Capsule(s)DSLD:211037
- Seeking HealthOptimal Prenatal Chewable50 mgper 2 Chewable Tablet(s)DSLD:211039
- Seeking HealthOptimal Prenatal ChocolateUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)75 mgper 43.2 Gram(s)DSLD:174745
- Seeking HealthOptimal Prenatal ChocolateUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)75 mgper 43.4 Gram(s)DSLD:211047
- Seeking HealthOptimal Prenatal VanillaUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)75 mgper 36.4 Gram(s)DSLD:174748
- Seeking HealthOptimal Prenatal VanillaUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)75 mgper 1 Gram(s)DSLD:211052
- Seeking HealthOptimal StartUbidecarenone · Coenzyme Q10 (Form: as Ubidecarenone)50 mgper 2 Capsule(s)DSLD:211058
- ShakleeCoQHeart with Q-Trol100 mgper 1 Softgel(s)DSLD:210137
- ShakleeTriple Strength CoQHeart With Q-Trol100 mgper 1 Softgel(s)DSLD:17531
- SimplyBestHeartAce Plus50 mgper 2 Tablet(s)DSLD:22519
- SimplySupplementsCo Enzyme Q10 100 mg100 mgper 1 Capsule(s)DSLD:22376
- SimplySupplementsCo Enzyme Q10 300 mg300 mgper 1 Capsule(s)DSLD:22370
- SmartyPantsMaster's Formula Women 50+Ubiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 4 Gummy(ies)DSLD:233352
- SmartyPantsMen's FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 6 Gummy(ies)DSLD:227991
- SmartyPantsMen's FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 6 Gummy(ies)DSLD:228035
- SmartyPantsWomen's FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 6 Gummy(ies)DSLD:228057
- SmartyPantsWomen's FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 6 Gummy(ies)DSLD:228064
- SmartyPantsWomen's FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 6 Gummy(ies)DSLD:233275
- SmartyPants PhDMen's 50+ FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 2 Capsule(s)DSLD:227881
- SmartyPants PhDMen's FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)50 mgper 2 Capsule(s)DSLD:243128
- SmartyPants PhDPrenatal FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 2 Capsule(s)DSLD:227896
- SmartyPants PhDWomen's 50+ FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)60 mgper 2 Capsule(s)DSLD:227886
- SmartyPants PhDWomen's FormulaUbiquinone · Coenzyme Q10 (Form: as Ubiquinone Note: USP)50 mgper 2 Capsule(s)DSLD:242378
- Smoky Mountain NutritionEstro-AidUbidicarenone · Coenzyme Q10 (Form: as Ubidicarenone)15 mgper 1 Vegetarian Capsule(s)DSLD:219532
- SolarayPure CoQ-10 60 mg60 mgper 1 Capsule(s)DSLD:13316
- SolgarCoQ-10 100 mgUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)100 mgper 1 Vegetable Capsule(s)DSLD:213965
- SolgarCoQ-10 100 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)100 mgper 1 Vegetable Capsule(s)DSLD:213972
- SolgarCoQ-10 100 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)100 mgper 1 Vegetable Capsule(s)DSLD:213974
- SolgarMegasorb CoQ-10 100 mgUbiquinone · Megasorb Coenzyme Q-10 (Form: as Ubiquinone) (Alt. Name: KanekaQ10)100 mgper 1 Softgel(s)DSLD:201089
- SolgarMegasorb CoQ-10 100 mgUbiquinone · Megasorb Coenzyme Q-10 (Form: as Ubiquinone) (Alt. Name: KanekaQ10)100 mgper 1 Softgel(s)DSLD:201096
- SolgarMegasorb CoQ-10 100 mgUbiquinone · Megasorb Coenzyme Q-10 (Form: as Ubiquinone) (Alt. Name: KanekaQ10)100 mgper 1 Softgel(s)DSLD:201097
- SolgarMegasorb CoQ-10 30 mgUbiquinone · Megasorb Coenzyme Q-10 (Form: as Ubiquinone) (Alt. Name: KanekaQ10)30 mgper 1 Softgel(s)DSLD:217627
- SolgarMegasorb CoQ-10 L-Carnitine 50 mg/250 mgUbiquinone · Megasorb Coenzyme Q-10 (Form: as Ubiquinone)50 mgper 1 Softgel(s)DSLD:213976
- SolgarOmega-3 "700" Coenzyme Q-10 Policosanol30 mgper 1 Softgel(s)DSLD:214685
- SolgarOmega-3 "700" Coenzyme Q-10 Policosanol30 mgper 1 Softgel(s)DSLD:214702
- SolgarOmnium10 mgper 2 Tablet(s)DSLD:220806
- SolgarOmnium10 mgper 2 Tablet(s)DSLD:241158
- SolgarOmnium10 mgper 2 Tablet(s)DSLD:241161
- SolgarOmnium Iron-Free10 mgper 2 Tablet(s)DSLD:201577
- SolgarPeak ATP with CoQ-10Ubiquinone · Coenzyme Q-10 (Form: as Ubiquinone)30 mgper 1 Tablet(s)DSLD:213858
- SolgarUbiquinol 100 mgCoQ10 · Ubiquinol (Form: reduced CoQ10) (Alt. Name: Kaneka QH, Q+)100 mgper 1 Softgel(s)DSLD:218709
- SolgarUbiquinol 100 mg (Reduced CoQ-10)CoQ10 · Ubiquinol (Form: reduced CoQ10) (Alt. Name: Kaneka QH)100 mgper 1 Softgel(s)DSLD:220783
- SolgarVegan CoQ-10 200 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)200 mgper 1 Vegetable Capsule(s)DSLD:217634
- SolgarVegan CoQ-10 200 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)200 mgper 1 Vegetable Capsule(s)DSLD:217637
- SolgarVegetarian CoQ-10 100 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)100 mgper 1 Vegetable Capsule(s)DSLD:213968
- SolgarVegetarian CoQ-10 30 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)30 mgper 1 Vegetable Capsule(s)DSLD:217615
- SolgarVegetarian CoQ-10 30 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)30 mgper 1 Vegetable Capsule(s)DSLD:217619
- Source NaturalsAdvanced One Multiple15 mgper 1 Tablet(s)DSLD:181591
- Source NaturalsAdvanced One Multiple15 mgper 1 Tablet(s)DSLD:181628
- Source NaturalsAdvanced One Multiple15 mgper 1 Tablet(s)DSLD:181630
- Source NaturalsAdvanced One Multiple15 mgper 1 Tablet(s)DSLD:181633
- Source NaturalsAdvanced One Multiple15 mgper 1 Tablet(s)DSLD:181634
- Source NaturalsAdvanced One Multiple15 mgper 1 Tablet(s)DSLD:181635
- Source NaturalsBlood Pressure Response18 mgper 3 Tablet(s)DSLD:214394
- Source NaturalsBlood Pressure Response18 mgper 3 Tablet(s)DSLD:214396
- Source NaturalsBlood Pressure Response18 mgper 3 Tablet(s)DSLD:214397
- Source NaturalsBlood Pressure Response18 mgper 5 Tablet(s)DSLD:214719
- Source NaturalsCoenzyme Q10 100 mgUbiquinone100 mgper 1 Capsule(s)DSLD:185180
- Source NaturalsCoenzyme Q10 100 mgUbiquinone100 mgper 1 Capsule(s)DSLD:185215
- Source NaturalsCoenzyme Q10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:185249
- Source NaturalsCoenzyme Q10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:185251
- Source NaturalsCoenzyme Q10 125 mgUbiquinone125 mgper 1 Capsule(s)DSLD:185182
- Source NaturalsCoenzyme Q10 125 mgUbiquinone125 mgper 1 Capsule(s)DSLD:185184
- Source NaturalsCoenzyme Q10 200 mgUbiquinone200 mgper 1 Softgel(s)DSLD:185301
- Source NaturalsCoenzyme Q10 30 mg Lipoic Acid 30 mgUbiquinone120 mgper 1 Capsule(s)DSLD:211648
- Source NaturalsCoenzyme Q10 Lipoic Acid 30 mg / 30 mgUbiquinone120 mgper 1 Capsule(s)DSLD:211646
- Source NaturalsCoenzyme Q10 with BioperineUbiquinone100 mgper 1 Softgel(s)DSLD:185231
- Source NaturalsCoenzyme Q10 with BioperineUbiquinone100 mgper 1 Softgel(s)DSLD:185232
- Source NaturalsCoenzyme Q10 with BioperineUbiquinone100 mgper 1 Softgel(s)DSLD:185233
- Source NaturalsCoQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:185314
- Source NaturalsCoQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:185317
- Source NaturalsCoQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:185319
- Source NaturalsCoQ10 100 mgUbiquinone100 mgper 1 Softgel(s)DSLD:185323
- Source NaturalsElan Vital Multiple33 mgper 3 Tablet(s)DSLD:211578
- Source NaturalsElan Vital Multiple33 mgper 3 Tablet(s)DSLD:211581
- Source NaturalsElan Vital Multiple33 mgper 3 Tablet(s)DSLD:211576
- Source NaturalsEnergevity150 mgper 3 Tablet(s)DSLD:217302
- Source NaturalsEnergevity150 mgper 3 Tablet(s)DSLD:217318
- Source NaturalsEnergevity150 mgper 3 Tablet(s)DSLD:217321
- Source NaturalsEnerVital100 mgper 1 Tablet(s)DSLD:217085
- Source NaturalsEnerVital100 mgper 1 Tablet(s)DSLD:217180
- Source NaturalsEnerVital100 mgper 1 Tablet(s)DSLD:217242
- Source NaturalsFibro-ResponseUbiquinone15 mgper 3 Tablet(s)DSLD:214073
- Source NaturalsGluco-Science3 mgper 1 Tablet(s)DSLD:214217
- Source NaturalsMenopause Multiple7.5 mgper 2 Tablet(s)DSLD:213574
- Source NaturalsMenopause Multiple7.5 mgper 2 Tablet(s)DSLD:213578
- Spray For LifeCoQ10 Complex Orange & Tropical FlavorUbiquinone · CoQ10 (Form: as Ubiquinone)25 mgper 0.042 mLDSLD:176279
- Spring ValleyAdult Gummy CoQ10 Natural Flavors200 mgper 2 Gummie(s)DSLD:178606
- Spring ValleyCoQ-10100 mgper 1 Softgel(s)DSLD:178318
- Spring ValleyCoQ-10100 mgper 1 Softgel(s)DSLD:178363
- Spring ValleyCoQ-10Coenzyme Q-10 Note: natural100 mgper 1 Softgel(s)DSLD:178793
- Spring ValleyCoQ10 100 mg Plus L-Carnitine200 mgper 2 Softgel(s)DSLD:178599
- Spring ValleyCoQ10 50 mg50 mgper 1 Softgel(s)DSLD:210337
- Spring ValleyRapid Release CoQ10 100 mg100 mgper 1 Softgel(s)DSLD:210343
- Spring ValleyRapid-Release CoQ10 100 mg100 mgper 1 Softgel(s)DSLD:178577
- Spring ValleyRapid-Release CoQ10 200 mg200 mgper 1 Softgel(s)DSLD:178601
- Stop Aging NowCur-Q10 UltraUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)200 mgper 2 Veggie Capsule(s)DSLD:240333
- Stop Aging NowMax-Q10 UltraUbiquinone · Coenzyme Q10 (Form: as Ubiquinone)200 mgper 1 Softgel(s)DSLD:206818
- SundownCo Q-10 100 mg100 mgper 1 Softgel(s)DSLD:212375
- SundownCO Q-10 100 mg100 mgper 1 Softgel(s)DSLD:212093
- SundownCo Q-10 200 mg200 mgper 1 Softgel(s)DSLD:212382
- SundownCo Q-10 400 mg400 mgper 1 Softgel(s)DSLD:212327
- SundownCo Q-10 Gummies 200 mg Peach Mango Flavored200 mgper 2 Gummy(ies)DSLD:240854
- Sundown NaturalsCO Q-10 200 mg200 mgper 1 Softgel(s)DSLD:175265
- Sunfood SuperfoodsLiposomal Immune Boost89 mgper 1 Ounce(s)DSLD:218589
- SuperiorLabsCoQ10100 mgper 1 Vegetarian Capsule(s)DSLD:224756
- SuperSmartCoenzyme Q10 + Tocotrienols 300 mg300 mgper 2 Softgel(s)DSLD:250258
- SwansonCoQ10 100 mg100 mgper 1 Softgel(s)DSLD:188921
- SwansonCoQ10 120 mg120 mgper 1 Capsule(s)DSLD:203755
- SwansonCoQ10 200 mg200 mgper 1 Capsule(s)DSLD:250246
- SwansonCoQ10 400 mg400 mgper 1 Softgel(s)DSLD:187492
- SwansonCoQ10 60 mg60 mgper 1 Softgel(s)DSLD:203763
- SwansonMulti Women's Prime2 mgper 1 Tablet(s)DSLD:202791
- SwansonQ-Gel Mega 200 200 mgProprietary base · Q-Gel Coenzyme Q10 (Form: in a Proprietary base Note: specially formulated to enhance absorption) (Alt. Name: Hydrosoluble)200 mgper 1 Softgel(s)DSLD:204206
- SynergyCoQ10 50 mg50 mgper 1 Capsule(s)DSLD:217185
- Systemic FormulaseNRG LQ Quantum Cellular ATP Energyamount not statedper 0.5 Dropper(s)DSLD:22506
- Systemic Formulas Bio NutrimentMLTI LQ Mulit-Vitamin & Mineral2 mgper 2 mLDSLD:22117
- The Professional SeriesCholostat Support7 mgper 1 Capsule(s)DSLD:10736
- The Professional SeriesCoQ10 + E Licaps30 mgper 1 Capsule(s)DSLD:10719
- The Professional SeriesCoQ10 + E Licaps30 mgper 1 Capsule(s)DSLD:10720
- The Professional SeriesHyper Ten Support5 mgper 1 Capsule(s)DSLD:10737
- The Vitamin ShoppeCoQ-10Ubiquinone · Coenzyme Q-10 (Form: as Ubiquinone)100 mgper 1 Capsule(s)DSLD:204752
- The Vitamin ShoppeCoQ-10 100 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)100 mgper 1 Capsule(s)DSLD:183501
- The Vitamin ShoppeCoQ-10 100 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)100 mgper 1 Capsule(s)DSLD:183508
- The Vitamin ShoppeCoQ-10 100 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)100 mgper 1 Capsule(s)DSLD:183514
- The Vitamin ShoppeCoQ-10 100 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)100 mgper 1 Capsule(s)DSLD:183528
- The Vitamin ShoppeCoQ-10 100 mg Plus Vitamin E100 mgper 1 Softgel(s)DSLD:217607
- The Vitamin ShoppeCoQ-10 100 mg Plus Vitamin E100 mgper 1 Softgel(s)DSLD:217616
- The Vitamin ShoppeCoQ-10 200 mg200 mgper 1 Capsule(s)DSLD:208748
- The Vitamin ShoppeCoQ-10 200 mg200 mgper 1 Capsule(s)DSLD:208763
- The Vitamin ShoppeCoQ-10 200 mg200 mgper 1 Capsule(s)DSLD:208819
- The Vitamin ShoppeCoQ-10 30 mg30 mgper 1 Capsule(s)DSLD:13049
- The Vitamin ShoppeCoQ-10 30 mgUbidecarenone · Coenzyme Q-10 (Form: as Ubidecarenone)30 mgper 1 Capsule(s)DSLD:213626
- The Vitamin ShoppeCoQ-10 400 mg400 mgper 1 Softgel(s)DSLD:217977
- The Vitamin ShoppeCoQ-10 400 mg400 mgper 1 Softgel(s)DSLD:218262
- The Vitamin ShoppeCoQ-10 60 mg60 mgper 1 Capsule(s)DSLD:188905
- The Vitamin ShoppeEnergy Formula100 mcgper 1 Tablet(s)DSLD:213786
- The Vitamin ShoppeSuper Antioxidant10 mgper 2 Capsule(s)DSLD:12989
- The Vitamin ShoppeSuper Antioxidant10 mgper 2 Capsule(s)DSLD:184561
- The Vitamin ShoppeSuper Antioxidant10 mgper 2 Capsule(s)DSLD:184549
- The Vitamin ShoppeTriple Strength Ubiquinol 300 mg300 mgper 1 Softgel(s)DSLD:204828
- The Vitamin ShoppeUltimate Man 50+20 mgper 3 Tablet(s)DSLD:204798
- The Vitamin ShoppeUltimate Man 50+20 mgper 3 Tablet(s)DSLD:204812
- The Vitamin ShoppeUltimate Woman 50+50 mgper 3 Tablet(s)DSLD:203515
- The Vitamin ShoppeUltimate Woman 50+50 mgper 3 Tablet(s)DSLD:217711
- The Vitamin ShoppeUltimate Woman GoldUbidecarenone50 mgper 3 Tablet(s)DSLD:204324
- The Vitamin ShoppeUltimate Woman GoldUbidecarenone50 mgper 3 Tablet(s)DSLD:204329
- Theramedix BioSETSerratio10 mgper 2 Capsule(s)DSLD:247624
- ThrivousVitality GeroprotectorUbiquinone100 mgper 4 Capsule(s)DSLD:206256
- Thymely SolutionsCoQ10 100 mgUbiquinone100 mgper 1 Veggie Cap(s)DSLD:211763
- Thymely SolutionsRed Yeast RiceUbiquinone30 mgper 1 Veggie Cap(s)DSLD:212105
- Tishcon Corp.Active-Q Maximum Strength Ubiquinol 300 mgCoenzyme Q10 · Ubiquinol (Form: active form of Coenzyme Q10) (Alt. Name: Kaneka Ubiquinol)300 mgper 1 Softgel(s)DSLD:243372
- Tishcon Corp.Active-Q Ubiquinol 100 mgCoenzyme Q10 · Ubiquinol (Form: active form of Coenzyme Q10) (Alt. Name: Kaneka Ubiquinol)100 mgper 1 Softgel(s)DSLD:243367
- Tishcon Corp.Active-Q Ubiquinol 100 mgCoenzyme Q10 · Ubiquinol (Form: active form of Coenzyme Q10) (Alt. Name: Kaneka Ubiquinol)100 mgper 1 Softgel(s)DSLD:243427
- Tishcon Corp.Active-Q Ubiquinol 200 mgCoenzyme Q10 · Ubiquinol (Form: active form of Coenzyme Q10) (Alt. Name: Kaneka Ubiquinol)200 mgper 1 Softgel(s)DSLD:243380
- Tishcon Corp.Active-Q Ubiquinol 200 mgCoenzyme Q10 · Ubiquinol (Form: active form of Coenzyme Q10) (Alt. Name: Kaneka Ubiquinol)200 mgper 1 Softgel(s)DSLD:243429
- Tishcon Corp.Active-Q Ubiquinol 200 mgCoenzyme Q10 · Ubiquinol (Form: active form of Coenzyme Q10) (Alt. Name: Kaneka Ubiquinol)200 mgper 1 Softgel(s)DSLD:243431
- Tishcon Corp.ChewQ 100 mgUbidecarenone100 mgper 1 Chewtab(s)DSLD:243371
- Tishcon Corp.Driver's Friend Energy Chews Mocha FlavorCoenzyme Q1025 mgper 1 Chewable Tablet(s)DSLD:243426
- Tishcon Corp.Q-Gel ETS Mega 100 Coenzyme Q10 100 mg100 mgper 1 Softgel(s)DSLD:243468
- Tishcon Corp.Q-Gel ETS Mega 200 Coenzyme Q10 200 mgUbidecarenone200 mgper 1 Softgel(s)DSLD:243423
- Tishcon Corp.Q-Gel Forte Coenzyme Q10 30 mgUbidecarenone30 mgper 1 Softgel(s)DSLD:243461
- Tishcon Corp.Q-Gel Forte Coenzyme Q10 30 mgUbidecarenone30 mgper 1 Softgel(s)DSLD:243375
- Tishcon Corp.Q-Gel Forte Coenzyme Q10 30 mgUbidecarenone30 mgper 1 Softgel(s)DSLD:243434
- Tishcon Corp.Q-Gel Forte Coenzyme Q10 30 mgUbidecarenone30 mgper 1 Softgel(s)DSLD:243458
- Tishcon Corp.Q-Gel Forte Coenzyme Q10 30 mgUbidecarenone30 mgper 1 Softgel(s)DSLD:243464
- Tishcon Corp.Q-Gel Mega 100 Coenzyme Q10 100 mgUbidecarenone100 mgper 1 Softgel(s)DSLD:243417
- Tishcon Corp.Q-Gel Mega 100 Coenzyme Q10 100 mgUbidecarenone100 mgper 1 Softgel(s)DSLD:243472
- Tishcon Corp.Q-Gel Ultra Coenzyme Q10 60 mgUbidecarenone60 mgper 1 Softgel(s)DSLD:243421
- Tishcon Corp.Q-Gel Ultra Coenzyme Q10 60 mg + 100 mg Vitamin EUbidecarenone60 mgper 1 Softgel(s)DSLD:243469
- Tishcon Corp.Q-Gel Ultra Coenzyme Q10 60 mg + 100 mg Vitamin EUbidecarenone60 mgper 1 Softgel(s)DSLD:243471
- tnvitaminsCoQ10 50 mgUbiquinone 1050 mgper 1 Capsule(s)DSLD:217916
- tnvitaminsRadical Raiders2,000 mcgper 2 Tablet(s)DSLD:217859
- tnvitaminsSuper Energy UpUbidicarenone · Coenzyme Q10 (Form: as Ubidicarenone)250 mcgper 2 Tablet(s)DSLD:217612
- Trader Joe'sCo Enzyme Q 10Ubiquinone100 mgper 1 Softgel(s)DSLD:207386
- TriVitaCoEnzyme Q-1050 mgper 1 Softgel(s)DSLD:11702
- Tropical OasisMega Multiple Vitamin Mineral Tropical Plus5 mgper 1 fl. Oz.DSLD:219315
- Tropical OasisMen's Mega Multi-Vitamin5 mgper 1 fl. Oz.DSLD:219322
- True HealthDr. Cutler's Ultimate CoQ10 FormulaCoQsol-CF(R) · Coenzyme Q10 (Form: as CoQsol-CF(R))100 mgper 1 Softgel(s)DSLD:16768
- True HealthDr. Cutler's Ultimate Krill-QUbiquinol100 mgper 2 Capsule(s)DSLD:16773
- Ultra PlanUltimate-Plus20 mcgper 3 Tablet(s)DSLD:12951
- up&upCoenzyme Q10 100 mg100 mgper 1 Softgel(s)DSLD:20028
- up&upCoenzyme Q10 200 mg200 mgper 1 Softgel(s)DSLD:20033
- USANA CellSentialsMega Antioxidant4 mgper 1 Tablet(s)DSLD:211631
- VerVitaCir-Q TonicUbiquinone25 mgper 1 Capsule(s)DSLD:213618
- VerVitaReGenerZyme Heart10 mgper 3 Tablet(s)DSLD:207060
- VerVitaReGenerZyme Heart15 mgper 3 Not PresentDSLD:213640
- Village VitalityCoQ10 100 mgUbiquinone100 mgper 1 Veggie Cap(s)DSLD:215521
- Village VitalityRed Yeast Rice with CoQ10Ubiquinone · CoQ10 (Form: as Ubiquinone)30 mgper 1 Veggie Cap(s)DSLD:216705
- Vimerson HealthCoQ10Ubiquinone200 mgper 1 Capsule(s)DSLD:252045
- ViMultiLean Complex5 mgper 4 Capsule(s)DSLD:230970
- ViMultiSweatFX3 mgper 2 Capsule(s)DSLD:231029
- ViMulti Beautiful MeExtreme Lean Burn5 mgper 4 Capsule(s)DSLD:230874
- VincoCoQ-Complete 100100 mgper 1 Softgel(s)DSLD:206434
- VincoCoQ-Complete 400400 mgper 1 Softgel(s)DSLD:206436
- VincoEnergy Ignitor with Cordyceps30 mgper 4 Capsule(s)DSLD:206437
- VincoMultiMen's5 mgper 1 Tablet(s)DSLD:206495
- VincoMultiWomen's5 mgper 1 Tablet(s)DSLD:206503
- VitacostCoQ10 100 mgUbiquinone100 mgper 1 Capsule(s)DSLD:247631
- VitacostCoQ10 30 mgUbiquinone30 mgper 1 Capsule(s)DSLD:207610
- Vitacost SynergyOnce Daily Multi-VitaminUbiquinone · Coenzyme Q10 (Form: Ubiquinone) Note: naturally fermented100 mgper 1 Capsule(s)DSLD:207788
- vitafusionEveryday Energy Natural Peach Tea Flavored BlendUbiquinone · CoQ10 (Form: as Ubiquinone)100 mgper 4 Gummie(s)DSLD:176800
- Vital NutrientsUltra Pure Fish Oil 2600 with CoQ10 Lemon Flavor100 mgper 5 mLDSLD:223265
- Vitamer LaboratoriesVegetarian CoQ10 300 mg300 mgper 1 Capsule(s)DSLD:23259
- Vitamin WorldCo Q-10 50 mgUbidecarenone1,050 mgper 1 Rapid Release Softgel(s)DSLD:240029
- Vitamin WorldMaximum Antioxidant1,000 mcgper 2 Caplet(s)DSLD:21130
- Vitamin WorldMaximum Strength Q-Sorb Co Q-10 600 mg600 mgper 1 Softgel(s)DSLD:1507
- Vitamin WorldMega Vita Gel Iron Free100 mcgper 2 Softgel(s)DSLD:20756
- Vitamin WorldMega Vita Min For Seniors500 mcgper 2 Caplet(s)DSLD:20751
- Vitamin WorldMega Vita-Gel100 mcgper 2 Softgel(s)DSLD:2458
- Vitamin WorldOmega-3 Fish Oil 1000 mg Plus Q-Sorb Co-Q1030 mgper 1 Softgel(s)DSLD:20270
- Vitamin WorldQ-Sorb Co Q-10 & Cinnamon120 mgper 1 Softgel(s)DSLD:20816
- Vitamin WorldQ-Sorb Co Q-10 & Grapeseed50 mgper 1 Softgel(s)DSLD:20338
- Vitamin WorldQ-Sorb Co Q-10 & L-Carnitine30 mgper 1 Softgel(s)DSLD:1323
- Vitamin WorldQ-Sorb Co Q-10 100 mg100 mgper 1 Softgel(s)DSLD:21159
- Vitamin WorldQ-Sorb Co Q-10 100 mg100 mgper 1 Softgel(s)DSLD:21156
- Vitamin WorldQ-Sorb Co Q-10 200 mg200 mgper 1 Softgel(s)DSLD:20714
- Vitamin WorldQ-Sorb Co Q-10 200 mg200 mgper 1 Softgel(s)DSLD:20611
- Vitamin WorldQ-Sorb Co Q-10 30 mg30 mgper 1 Softgel(s)DSLD:21265
- Vitamin WorldQ-Sorb Co Q-10 Plus Red Yeast Rice120 mgper 2 Softgel(s)DSLD:1469
- Vitamin WorldQ-Sorb Ultra Co Q-10 & Cinnamon200 mgper 1 Softgel(s)DSLD:20339
- Vitamin WorldUbiquinol 100 mgCO Q-10 · Ubiquinol (Form: enhanced bioactivity CO Q-10) (Alt. Name: Kaneka QH)100 mgper 1 Softgel(s)DSLD:20653
- Vitamins BecauseCo-Q10 10 mg10 mgper 1 Capsule(s)DSLD:206458
- VitaMonkMitoTrax30 mgper 2 Capsule(s)DSLD:242160
- Viva NaturalsCoQ10 100 mg100 mgper 1 Softgel(s)DSLD:240174
- Viva NaturalsCoQ10 200 mg200 mgper 1 Softgel(s)DSLD:248073
- Viva NaturalsCoQ10 400 mg400 mgper 1 Softgel(s)DSLD:248081
- Viva VitaminsCSA Complete Spectrum Antioxidant50 mgper 2 Tablet(s)DSLD:1791
- VivioptalVivioptal Women30 mgper 1 Softgel(s)DSLD:206045
- Vthrive The Vitamin ShoppeOmega-3 with CoQ-10200 mgper 1 Softgel(s)DSLD:209261
- We Like VitaminsCoQ-10 200 mgUbiquinone200 mgper 1 Capsule(s)DSLD:244186
- We Like VitaminsCoQ-10 400 mgUbiquinone · Coenzyme Q-10 (Form: as Ubiquinone)400 mgper 2 Capsule(s)DSLD:244188
- Whitaker NutritionBioActive Q Ubiquinol 100 mgUbiquinol · Coenzyme Q10 (Form: as Ubiquinol)100 mgper 1 Softgel(s)DSLD:239010
- WholeHealthCoEnzyme Q10 100 mg100 mgper 1 Capsule(s)DSLD:248471
- WholeHealthCoEnzyme Q10 150 mg150 mgper 1 Capsule(s)DSLD:248464
- WholeHealthCoEnzyme Q10 200 mgCoQsol200 mgper 1 Soft Gel(s)DSLD:248459
- WholeHealthCoEnzyme Q10 300 mg300 mgper 1 Capsule(s)DSLD:248467
- WindmillCo-Q10 400 mg400 mgper 1 Capsule(s)DSLD:181040
- WindmillOpti-Sorb Co Q-10 200 mg200 mgper 1 Softgel(s)DSLD:215687
- Wonder LaboratoriesCo Q10 100 with Hawthorn100 mgper 1 Capsule(s)DSLD:215208
- Wonder LaboratoriesQ10 Supreme 10 mg10 mgper 1 Capsule(s)DSLD:215587
- Wonder LaboratoriesQ10 Supreme 10 mg10 mgper 1 Capsule(s)DSLD:215592
- Wonder LaboratoriesQ10 Ultra 30 mg30 mgper 1 Capsule(s)DSLD:215594
- Wonder LaboratoriesQ10 Ultra 30 mg30 mgper 1 Capsule(s)DSLD:215596
- Wonder LabsCoQ10 High Absorption with BioPerine200 mgper 1 Capsule(s)DSLD:215233
- World NutritionNattovita50 mgper 1 Capsule(s)DSLD:176379
- XtendlifeCardio-Klenz39 mgper 6 Tablet(s)DSLD:17014
- XYMOGENBrainSustain Creamy ChocolateUbiquinone · Kaneka Q10 (Form: as Ubiquinone) (Alt. Name: Coenzyme Q10)200 mgper 51 Gram(s)DSLD:240120
- XYMOGENBrainSustain Vanilla DelightUbiquinone · Kaneka Q10 (Form: as Ubiquinone) (Alt. Name: Coenzyme Q10)200 mgper 48 Gram(s)DSLD:218511
- XYMOGENCoQmax-100 MEUbiquinone · Coenzyme Q10 (Form: as Ubiquinone) (Alt. Name: KanekaQ10)100 mgper 1 Softgel(s)DSLD:240147
- XyngularAxion12.5 mgper 2 Tablet(s)DSLD:206023
- Yes You Can!Shake Booster Memory and Focus Unflavored25 mgper 5 Gram(s)DSLD:215757
- YoungevityBeyond Tangy Tangerine3 mgper 13.9 Gram(s)DSLD:209087
- YoungevityBeyond Tangy Tangerine 2.03 mgper 4 Tablet(s)DSLD:209214
- YoungevityBeyond Tangy Tangerine 2.0 Citrus Peach Fusion3 mgper 16 Gram(s)DSLD:209347
- ZemveloCoQ10Ubiquinone100 mgper 6 mLDSLD:249778
Label record: NIH Office of Dietary Supplements · CC0
Registered, and not reported
- Source
- ClinicalTrials.gov
- Intervention
- coenzyme Q10
- Status
- Completed, terminated or suspended
- Results posted
- No
Trials without posted results
130 trials
130 registered trials without posted results · Overdue (FDAAA 801): 112 · Showing 120 of 130
112 past the window8 within it, or no actual date
- NCT07530250completed2026-07-01a university or hospital
- NCT07771153completed2026-06-30a university or hospital
- NCT07255079completed2026-06-29industry
- NCT07703215completed2026-04-30industry
- NCT06911905completed2026-03-21a university or hospital
- NCT06040905completed2026-02-12a university or hospital
- NCT07307911completed2026-02-10a university or hospital
- NCT07455890completed2026-01-01a university or hospital
- NCT06640465completed2025-09-17a research networkpast the reporting window
- NCT06429059completed2025-05-22a university or hospitalpast the reporting window
- NCT06570811completed2025-03-10a university or hospitalpast the reporting window
- NCT05384431completed2024-12-20industrypast the reporting window
Show the remaining 118
- NCT06736366completed2024-12-16a university or hospitalpast the reporting window
- NCT07303088completed2024-11-30a university or hospitalpast the reporting window
- NCT07096557completed2024-11-10a university or hospitalpast the reporting window
- NCT06661018completed2024-04-30a university or hospitalpast the reporting window
- NCT04286178completed2024-03-05a university or hospitalpast the reporting window
- NCT06576245completed2024-02-28a university or hospitalpast the reporting window
- NCT05653895completed2023-12-30a university or hospitalpast the reporting window
- NCT07537283completed2023-09-28a university or hospitalpast the reporting window
- NCT05680857completed2023-07-11industrypast the reporting window
- NCT05293132completed2023-06-01a university or hospitalpast the reporting window
- NCT02804828completed2023-04-03a university or hospitalpast the reporting window
- NCT05711810completed2023-01-10an individualpast the reporting window
- NCT03113994terminated— COVID-19 Pandemic2022-12-31a university or hospitalpast the reporting window
- NCT05616000completed2022-11-28a university or hospitalpast the reporting window
- NCT06151171completed2022-10-31industrypast the reporting window
- NCT05847257completed2022-10-30a university or hospitalpast the reporting window
- NCT04784234terminated— company was bought and discontinued producing supplement2022-10-27a university or hospitalpast the reporting window
- NCT04487652completed2022-08-31a university or hospitalpast the reporting window
- NCT05170893completed2022-07-14a university or hospitalpast the reporting window
- NCT06045377completed2022-06-25a university or hospitalpast the reporting window
- NCT05527106completed2022-05-25a university or hospitalpast the reporting window
- NCT05272228completed2022-05-15a university or hospitalpast the reporting window
- NCT03611530terminated— low accrual2022-04-29a university or hospitalpast the reporting window
- NCT04960215completed2022-02-10a university or hospitalpast the reporting window
- NCT04574505completed2021-11-19a university or hospitalpast the reporting window
- NCT06042738completed2021-11-01a university or hospitalpast the reporting window
- NCT05178225completed2021-06-30a university or hospitalpast the reporting window
- NCT04780074completed2021-05-21a university or hospitalpast the reporting window
- NCT04302532completed2020-09-30a university or hospitalpast the reporting window
- NCT04870502completed2020-07-31a university or hospitalpast the reporting window
- NCT03186027completed2020-05-28a university or hospitalpast the reporting window
- NCT03898752completed2020-05-01a university or hospitalpast the reporting window
- NCT04463875completed2020-04-30a university or hospitalpast the reporting window
- NCT03321110completed2019-07-31a university or hospitalpast the reporting window
- NCT05266794completed2019-04-23a university or hospitalpast the reporting window
- NCT03020602completed2019-04-04a university or hospitalpast the reporting window
- NCT06391606completed2019-03-01a university or hospitalpast the reporting window
- NCT03850561completed2018-11-20a university or hospitalpast the reporting window
- NCT03834831completed2018-10-31a university or hospitalpast the reporting window
- NCT05128292completed2018-09-01a university or hospitalpast the reporting window
- NCT05011643completed2018-07-20a university or hospitalpast the reporting window
- NCT03306745completed2018-06-25a university or hospitalpast the reporting window
- NCT03893864completed2018-05-30a university or hospitalpast the reporting window
- NCT02119117completed2018-05a university or hospitalpast the reporting window
- NCT03429231completed2018-03-31a university or hospitalpast the reporting window
- NCT03111433completed2018-01-20a university or hospitalpast the reporting window
- NCT03020680completed2017-12-31a university or hospitalpast the reporting window
- NCT01126697completed2017-12a research networkpast the reporting window
- NCT04433429completed2017-12a university or hospitalpast the reporting window
- NCT03470376completed2017-11-15a university or hospitalpast the reporting window
- NCT03216811completed2017-10-31a university or hospitalpast the reporting window
- NCT03284814completed2017-10-20a university or hospitalpast the reporting window
- NCT03003442completed2017-10-16a university or hospitalpast the reporting window
- NCT02333305completed2017-09a university or hospitalpast the reporting window
- NCT03295760completed2017-07-31a university or hospitalpast the reporting window
- NCT02407548completed2017-04a university or hospitalpast the reporting window
- NCT03002935completed2017-03industrypast the reporting window
- NCT02984813terminated— Investigator left the institution2017-01-15a university or hospitalpast the reporting window
- NCT03621683completed2017-01-10industrypast the reporting window
- NCT02255682completed2016-12a university or hospitalpast the reporting window
- NCT02622672completed2016-10-25a university or hospitalpast the reporting window
- NCT03074344completed2016-07a university or hospitalpast the reporting window
- NCT01964001completed2016-05a university or hospitalpast the reporting window
- NCT02382679terminated— Study was halted prematurely due to enrollment issues2016-05a university or hospitalpast the reporting window
- NCT01381354completed2016-02a university or hospitalpast the reporting window
- NCT02088307completed2016-01a university or hospitalpast the reporting window
- NCT02486055completed2016-01industrypast the reporting window
- NCT02901756completed2015-12industrypast the reporting window
- NCT04177667completed2015-06-30a university or hospitalpast the reporting window
- NCT02415114completed2015-06industrypast the reporting window
- NCT02604641completed2015-05a university or hospitalpast the reporting window
- NCT02422927completed2015-01a university or hospitalpast the reporting window
- NCT01293162completed2014-10a university or hospitalpast the reporting window
- NCT00997269completed2014-07a university or hospitalpast the reporting window
- NCT01819701completed2014-02a university or hospitalpast the reporting window
- NCT02062034completed2013-11a university or hospitalpast the reporting window
- NCT01408680completed2013-10a university or hospitalpast the reporting window
- NCT01940627completed2013-07a university or hospitalpast the reporting window
- NCT01424761completed2013-03a university or hospitalpast the reporting window
- NCT01965990completed2013-02a university or hospitalpast the reporting window
- NCT02381964completed2013-02a university or hospitalpast the reporting window
- NCT00541164completed2013-01a university or hospitalpast the reporting window
- NCT01910766completed2013-01a university or hospitalpast the reporting window
- NCT02063126completed2013-01a university or hospitalpast the reporting window
- NCT01048385terminated— A new study had shown that polar body biopsies might negatively effect the implantation potential of the embryo.2012-12a university or hospitalpast the reporting window
- NCT01892176completed2012-12a university or hospitalpast the reporting window
- NCT00976131completed2012-09-30a university or hospitalpast the reporting window
- NCT00716612completed2012-09a university or hospitalpast the reporting window
- NCT00980694completed2012-07a university or hospitalpast the reporting window
- NCT01562080completed2012-06industrypast the reporting window
- NCT01488656completed2012-03a university or hospitalpast the reporting window
- NCT01011348completed2011-07a university or hospitalpast the reporting window
- NCT01650883completed2011-04a university or hospitalpast the reporting window
- NCT01026311completed2011-03a university or hospitalpast the reporting window
- NCT00908297completed2010-10a university or hospitalpast the reporting window
- NCT01152073completed2010-09a university or hospitalpast the reporting window
- NCT01087632completed2010-07industrypast the reporting window
- NCT01443780completed2010-02a university or hospitalpast the reporting window
- NCT00718796completed2009-10a university or hospitalpast the reporting window
- NCT00957216completed2009-08a university or hospitalpast the reporting window
- NCT02012322completed2009-07a university or hospitalpast the reporting window
- NCT01163500completed2009-03a university or hospitalpast the reporting window
- NCT00590408terminated— Lack of recruitment2008-08a university or hospitalpast the reporting window
- NCT00229632completed2007-12-17NIHpast the reporting window
- NCT00113477completed2007-12a university or hospitalpast the reporting window
- NCT00117403completed2007-09NIHpast the reporting window
- NCT00906646completed2006-06a government bodypast the reporting window
- NCT00076492completed2005-09a university or hospitalpast the reporting window
Where it reaches
10 systems, 27 regions, 193 tissues, 193 transporter routes — routes, not measurements: transporters known to carry coenzyme Q10 are expressed there, and no source reports it arriving.
Loading the model…
Papers screened
2,537 papers
- Compound
- coenzyme Q10
- Screened
- 2,537
- Admitted
- 30
- Discarded
- 1,742
- Not read
- 765
- Showing
- 200 of 2,537
Read and discarded1,742 papers
- PMID:10193737cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:10801754cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:12645638cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:15082700cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:15084551cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:19177190cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:2000375cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:22359071cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:2247468cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:3773199cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:7487097cited by PMID:24192015; not about the subject it would be filed under2026-10-16
- PMID:7599208cited by PMID:24192015; not about the subject it would be filed under2026-10-16
and 1,730 more.
Not read yet765 papers
- PMID:29836132026-10-13
- PMID:152566112026-10-12
- PMID:216746402026-10-10
- PMID:257286342026-10-10
- PMID:187043392026-10-10
- PMID:260563912026-10-10
- PMID:238944572026-10-10
- PMID:238951652026-10-09
- PMID:249966142026-10-09
- PMID:252721632026-10-09
and 755 more.
Measured, not recorded
- Compound
- coenzyme Q10
- Endpoints measured
- 1,792 endpoints
- Recorded as a finding
- No
Show what was measured
coenzyme Q10 concentration in muscle biopsies
decreases, markedly decreased levels of CoQ10 in 13 of 135 patients with childhood-onset ataxia and cerebellar atrophy, n = 13
Not recorded as a finding: the compound is what was measured, not what was given
Thirteen patients with childhood-onset ataxia and cerebellar atrophy had markedly decreased levels of CoQ10.
PMID:12682339 · both readings recorded this
all-cause mortality
non-significant trend towards reduced mortality across nine trials
In nine randomised trials of CoQ10 in heart failure published up to 2003 there were non-significant trends towards increased ejection fraction and reduced mortality.
PMID:14695924 · one of two readings recorded this
all-cause mortality, meta-analysis of nine randomised trials of CoQ10 in heart failure
non-significant trend towards reduced mortality
Not recorded as a finding: direction_stated_but_not_significant: sentence carries a direction word (reduced) but states the trend was non-significant, and no two-sided absence-in-words statement is given
In nine randomised trials of CoQ10 in heart failure published up to 2003 there were non-significant trends towards increased ejection fraction and reduced mortality.
PMID:14695924 · one of two readings recorded this
all-cause mortality (pooled heart failure trials)
non-significant trend towards reduced mortality across nine randomised trials
In nine randomised trials of CoQ10 in heart failure published up to 2003 there were non-significant trends towards increased ejection fraction and reduced mortality.
PMID:14695924 · one of two readings recorded this
diastolic blood pressure
decreases, mean decrease in diastolic blood pressure was 10 mm Hg across the eight studies
Altogether in the eight studies the mean decrease in systolic blood pressure was 16 mm Hg and in diastolic blood pressure, 10 mm Hg.
PMID:14695924 · one of two readings recorded this
effect of CoQ10 supplementation on exercise capacity across eleven identified studies
Not recorded as a finding: a review that discusses its trials without pooling them
We identified eleven studies in which CoQ10 was tested for an effect on exercise capacity, six showed a modest improvement in exercise capacity with CoQ10 supplementation but five showed no effect.
PMID:14695924 · one of two readings recorded this
exercise capacity, pooled narratively across eleven studies (instrument not stated)
six of eleven studies showed a modest improvement in exercise capacity with CoQ10 supplementation, five showed no effect
Not recorded as a finding: narrated_not_pooled: discordant results across studies (6 improved, 5 no effect), no pooled numeric estimate given for exercise capacity
We identified eleven studies in which CoQ10 was tested for an effect on exercise capacity, six showed a modest improvement in exercise capacity with CoQ10 supplementation but five showed no effect.
PMID:14695924 · one of two readings recorded this
exercise capacity (pooled narratively across eleven studies)
six of eleven studies showed a modest improvement in exercise capacity with CoQ10 supplementation, five showed no effect
We identified eleven studies in which CoQ10 was tested for an effect on exercise capacity, six showed a modest improvement in exercise capacity with CoQ10 supplementation but five showed no effect.
PMID:14695924 · one of two readings recorded this
exercise capacity
We identified eleven studies in which CoQ10 was tested for an effect on exercise capacity, six showed a modest improvement in exercise capacity with CoQ10 supplementation but five showed no effect.
PMID:14695924 · one of two readings recorded this
exercise time (heart failure pilot trial)
a trend towards improvements in exercise time in the CoQ10 group, not stated as significant, n = 35
Over 3 months, in the CoQ10 patients but not in the placebo patients there were significant improvements in symptom class and a trend towards improvements in exercise time.
PMID:14695924 · one of two readings recorded this
exercise time, randomised placebo-controlled pilot trial of CoQ10 in heart failure (n=35)
a trend towards improvements in exercise time in CoQ10 patients, n = 35
Not recorded as a finding: within_arm_only / non-significant: reported only as a trend within the CoQ10 arm, not a between-arm test, and not significant
Over 3 months, in the CoQ10 patients but not in the placebo patients there were significant improvements in symptom class and a trend towards improvements in exercise time.
PMID:14695924 · one of two readings recorded this
exercise time
a trend towards improvements in exercise time in CoQ10 patients, n = 35
Over 3 months, in the CoQ10 patients but not in the placebo patients there were significant improvements in symptom class and a trend towards improvements in exercise time.
PMID:14695924 · one of two readings recorded this
heart failure symptom class (NYHA)
increases, significant improvements in symptom class in the CoQ10 group but not the placebo group, n = 35
Over 3 months, in the CoQ10 patients but not in the placebo patients there were significant improvements in symptom class and a trend towards improvements in exercise time.
PMID:14695924 · one of two readings recorded this
left ventricular ejection fraction, meta-analysis of nine randomised trials of CoQ10 in heart failure
non-significant trend towards increased ejection fraction
Not recorded as a finding: direction_stated_but_not_significant: sentence carries a direction word (increased) but states the trend was non-significant, and no two-sided absence-in-words statement is given
In nine randomised trials of CoQ10 in heart failure published up to 2003 there were non-significant trends towards increased ejection fraction and reduced mortality.
PMID:14695924 · one of two readings recorded this
left ventricular ejection fraction (pooled heart failure trials)
non-significant trend towards increased ejection fraction across nine randomised trials
In nine randomised trials of CoQ10 in heart failure published up to 2003 there were non-significant trends towards increased ejection fraction and reduced mortality.
PMID:14695924 · one of two readings recorded this
left ventricular ejection fraction
non-significant trend towards increased ejection fraction across nine trials
In nine randomised trials of CoQ10 in heart failure published up to 2003 there were non-significant trends towards increased ejection fraction and reduced mortality.
PMID:14695924 · one of two readings recorded this
NYHA symptom class, randomised placebo-controlled pilot trial of CoQ10 in heart failure (n=35)
increases, significant improvements in symptom class in CoQ10 patients but not in placebo patients over 3 months, n = 35
Not recorded as a finding: no_outcome_node: NYHA/symptom-class staging has no entry in the outcome list; reported as a within-arm change (improved in CoQ10 patients, not in placebo patients) rather than a stated between-arm contrast
Over 3 months, in the CoQ10 patients but not in the placebo patients there were significant improvements in symptom class and a trend towards improvements in exercise time.
PMID:14695924 · one of two readings recorded this
NYHA symptom class
increases, significant improvements in symptom class in CoQ10 patients but not in placebo patients over 3 months, n = 35
Over 3 months, in the CoQ10 patients but not in the placebo patients there were significant improvements in symptom class and a trend towards improvements in exercise time.
PMID:14695924 · one of two readings recorded this
systolic blood pressure
decreases, mean decrease in systolic blood pressure was 16 mm Hg across the eight studies
Altogether in the eight studies the mean decrease in systolic blood pressure was 16 mm Hg and in diastolic blood pressure, 10 mm Hg.
PMID:14695924 · one of two readings recorded this
6-min walk test, dyspnea, NYHA class, nocturia, fatigue; ANF and TNF blood levels; echocardiography, after 3 months of Ultrasome-CoQ10 60 mg/day vs placebo
increases, significant improvement in the 6-min walk test in the study group
Not recorded as a finding: the result compares a group with itself, not with a control
The study group showed significant improvement in the 6-min walk test and a decrease in dyspnea, New York Heart Association (NYHA) classification, nocturia, and fatigue.
PMID:15188947 · one of two readings recorded this
6-min walk test, dyspnea, NYHA class, nocturia, fatigue, echocardiography, ANF and TNF blood levels over 3 months
increases
Not recorded as a finding: the supporting sentence never names the compound
The study group showed significant improvement in the 6-min walk test and a decrease in dyspnea, New York Heart Association (NYHA) classification, nocturia, and fatigue.
PMID:15188947 · one of two readings recorded this
6-min walk test
increases
The study group showed significant improvement in the 6-min walk test and a decrease in dyspnea, New York Heart Association (NYHA) classification, nocturia, and fatigue
PMID:15188947 · one of two readings recorded this
Atrial natriuretic factor (ANF) blood level
no effect
No significant changes were noted after 3 months of treatment in echocardiography parameters (dimensions and contractility of cardiac chambers) or ANF and TNF blood levels
PMID:15188947 · one of two readings recorded this
Dyspnea
decreases
The study group showed significant improvement in the 6-min walk test and a decrease in dyspnea, New York Heart Association (NYHA) classification, nocturia, and fatigue
PMID:15188947 · one of two readings recorded this
Echocardiography parameters (dimensions and contractility of cardiac chambers)
no effect
No significant changes were noted after 3 months of treatment in echocardiography parameters (dimensions and contractility of cardiac chambers) or ANF and TNF blood levels
PMID:15188947 · one of two readings recorded this
Fatigue
decreases
The study group showed significant improvement in the 6-min walk test and a decrease in dyspnea, New York Heart Association (NYHA) classification, nocturia, and fatigue
PMID:15188947 · one of two readings recorded this
Nocturia
decreases
The study group showed significant improvement in the 6-min walk test and a decrease in dyspnea, New York Heart Association (NYHA) classification, nocturia, and fatigue
PMID:15188947 · one of two readings recorded this
NYHA classification
decreases
The study group showed significant improvement in the 6-min walk test and a decrease in dyspnea, New York Heart Association (NYHA) classification, nocturia, and fatigue
PMID:15188947 · one of two readings recorded this
Tumor necrosis factor (TNF) blood level
no effect
No significant changes were noted after 3 months of treatment in echocardiography parameters (dimensions and contractility of cardiac chambers) or ANF and TNF blood levels
PMID:15188947 · one of two readings recorded this
cardiotoxicity and liver toxicity during cancer treatment (predominantly anthracycline-based), oral CoQ10 monopreparation
decreases, some protection against cardiotoxicity or liver toxicity during cancer treatment, though not conclusive due to inadequate reporting and analysis
Not recorded as a finding: a review that discusses its trials without pooling them
The results suggested that CoQ10 provides some protection against cardiotoxicity or liver toxicity during cancer treatment.
PMID:15514384 · one of two readings recorded this
cardiotoxicity and liver toxicity during cancer treatment
decreases, some protection against cardiotoxicity or liver toxicity, though not conclusive
The results suggested that CoQ10 provides some protection against cardiotoxicity or liver toxicity during cancer treatment.
PMID:15514384 · one of two readings recorded this
cardiotoxicity or liver toxicity during cancer treatment
The results suggested that CoQ10 provides some protection against cardiotoxicity or liver toxicity during cancer treatment.
PMID:15514384 · one of two readings recorded this
diastolic blood pressure
decreases, p = 0.001
Diastolic blood pressure in the treatment group was 103 (101-105) mm Hg before, and 94.8 (92.8-96.8) mm Hg after treatment, a decrease of 8.2 (6.2-10.2, P<0.001) mm Hg
PMID:17287847 · one of two readings recorded this
diastolic blood pressure
decreases, p = 0.001, n = 18
In the crossover study (n=18), systolic blood pressure decreased by 11 mm Hg and diastolic blood pressure by 8 mm Hg (P<0.001)
PMID:17287847 · one of two readings recorded this
diastolic blood pressure
decreases, p = 0.001
Mean diastolic blood pressure was 97.1 (95.2-99.1) mm Hg before, and 86.8 (84.9-88.8) mm Hg after treatment, a decrease of 10.3 (8.4-12.3, P<0.001) mm Hg
PMID:17287847 · one of two readings recorded this
diastolic blood pressure
no effect
with no significant change in the placebo group
PMID:17287847 · one of two readings recorded this
systolic blood pressure
decreases, p = 0.001, n = 120
In the randomized controlled trials (n=120), systolic blood pressure in the treatment group was 167.7 (95% confidence interval, CI: 163.7-171.1) mm Hg before, and 151.1 (147.1-155.1) mm Hg after treatment, a decrease of 16.6 (12.6-20.6, P<0.001) mm Hg
PMID:17287847 · one of two readings recorded this
systolic blood pressure
decreases, p = 0.001, n = 18
In the crossover study (n=18), systolic blood pressure decreased by 11 mm Hg and diastolic blood pressure by 8 mm Hg (P<0.001)
PMID:17287847 · one of two readings recorded this
systolic blood pressure
decreases, p = 0.001, n = 214
In the open label studies (n=214), mean systolic blood pressure was 162 (158.4-165.7) mm Hg before, and 148.6 (145-152.2) mm Hg after treatment, a decrease of 13.5 (9.8-17.1, P<0.001) mm Hg
PMID:17287847 · one of two readings recorded this
systolic blood pressure
no effect
with no significant change in the placebo group
PMID:17287847 · one of two readings recorded this
circulating and intramuscular CoQ10 levels as affected by statin treatment; myopathic symptoms in statin-treated patients as affected by CoQ10 supplementation
decreases
Not recorded as a finding: the compound is what was measured, not what was given
Statin treatment reduces circulating levels of CoQ10.
PMID:17560286 · one of two readings recorded this
circulating coenzyme Q10 levels with statin treatment
decreases
Statin treatment reduces circulating levels of CoQ10.
PMID:17560286 · one of two readings recorded this
circulating CoQ10 levels (statin effect)
decreases
Statin treatment reduces circulating levels of CoQ10.
PMID:17560286 · one of two readings recorded this
intramuscular CoQ10 levels (statin effect)
The effect of statin therapy on intramuscular levels of CoQ10 is not clear, and data on intramuscular CoQ10 levels in symptomatic patients with statin-associated myopathy are scarce.
PMID:17560286 · one of two readings recorded this
myopathic symptoms in statin-associated myopathy
Supplementation can raise the circulating levels of CoQ10, but data on the effect of CoQ10 supplementation on myopathic symptoms are scarce and contradictory.
PMID:17560286 · one of two readings recorded this
24-h ambulatory diastolic blood pressure, Spacelabs Ultralite monitor
decreases, CoQ -2.2 ± 0.5 mmHg vs placebo
Not recorded as a finding: no 24-hour ambulatory diastolic node; unspecified-setting DBP node excludes recoverable acquisition conditions
Fenofibrate (−1.3 ± 0.5 mmHg, P = 0.013) and CoQ (−2.2 ± 0.5 mmHg, P < 0.001) had independent effects in lowering 24-h diastolic BP (DBP): fenofibrate lowered asleep DBP (−2.6 ± 0.9, P = 0.005), whereas CoQ lowered awake DBP (−2.7 ± 0.6, P < 0.001).
PMID:18487480 · one of two readings recorded this
24-h ambulatory diastolic blood pressure
decreases, CoQ -2.2 ± 0.5 mmHg
Not recorded as a finding: Ambulatory diastolic node absent (only 24-h systolic exists); office and unspecified diastolic nodes do not match 24-h ABP acquisition.
Fenofibrate (−1.3 ± 0.5 mmHg, P = 0.013) and CoQ (−2.2 ± 0.5 mmHg, P < 0.001) had independent effects in lowering 24-h diastolic BP (DBP): fenofibrate lowered asleep DBP (−2.6 ± 0.9, P = 0.005), whereas CoQ lowered awake DBP (−2.7 ± 0.6, P < 0.001).
PMID:18487480 · one of two readings recorded this
24-h diastolic BP
decreases, p = 0.001
CoQ (−2.2 ± 0.5 mmHg, P < 0.001)
PMID:18487480 · one of two readings recorded this
24-h diastolic BP
decreases, p = 0.013
Fenofibrate (−1.3 ± 0.5 mmHg, P = 0.013)
PMID:18487480 · one of two readings recorded this
24-h heart rate
no effect
CoQ supplementation did not alter HR
PMID:18487480 · one of two readings recorded this
24-h heart rate
decreases, p = 0.001
Fenofibrate also decreased 24-h HR (−3.3 ± 0.5 beats/min, P < 0.001)
PMID:18487480 · one of two readings recorded this
24-h systolic BP, fenofibrate x CoQ interaction
decreases, p = 0.001
Fenofibrate and CoQ synergistically (P = 0.001) lowered 24-h systolic BP (SBP)
PMID:18487480 · one of two readings recorded this
24-h systolic BP
no effect, p = 0.992
CoQ: −0.3 ± 1.1 mmHg, P = 0.992
PMID:18487480 · one of two readings recorded this
24-h systolic BP
no effect, p = 0.341
fenofibrate: 1.8 ± 1.0 mmHg, P = 0.341
PMID:18487480 · one of two readings recorded this
24-h systolic BP
decreases, p = 0.01
fenofibrate + CoQ: −3.4 ± 0.9 mmHg, P = 0.010
PMID:18487480 · one of two readings recorded this
Asleep diastolic BP
decreases, p = 0.005
fenofibrate lowered asleep DBP (−2.6 ± 0.9, P = 0.005)
PMID:18487480 · one of two readings recorded this
Asleep systolic BP
no effect, p = 0.647
CoQ: 2.2 ± 1.7 mmHg, P = 0.647
PMID:18487480 · one of two readings recorded this
Asleep systolic BP
no effect, p = 0.999
fenofibrate: −0.2 ± 1.5 mmHg, P = 0.999
PMID:18487480 · one of two readings recorded this
Asleep systolic BP
decreases, p = 0.006
fenofibrate + CoQ: −5.7 ± 1.5 mmHg, P = 0.006
PMID:18487480 · one of two readings recorded this
Atrial systolic pulmonary venous reversal flow velocity (PV 'a' rev)
increases, p = 0.009
PV ‘a’ rev (0.02 ± 0.01m/s, P = 0.009)
PMID:18487480 · one of two readings recorded this
Awake diastolic BP
decreases, p = 0.001
CoQ lowered awake DBP (−2.7 ± 0.6, P < 0.001)
PMID:18487480 · one of two readings recorded this
E/Vp
increases, p = 0.007
CoQ increased E/Vp (0.12 ± 0.05, P = 0.007)
PMID:18487480 · one of two readings recorded this
Early diastolic mitral annular relaxation velocity (E') and other diastolic indexes (E/A, DT, IVRT, PV S/D, E/E')
no effect
Compared with placebo, none of the treatments significantly altered the primary end point (E′) or any of the following diastolic function indexes: E/A, DT, IVRT, PV S/D, or E/E′ (Table 3)
PMID:18487480 · one of two readings recorded this
early diastolic mitral annular relaxation velocity E', tissue Doppler echocardiography (primary endpoint)
no effect
Not recorded as a finding: No outcome node for E' or other diastolic function indexes.
Compared with placebo, none of the treatments significantly altered the primary end point (E′) or any of the following diastolic function indexes: E/A, DT, IVRT, PV S/D, or E/E′ (Table 3).
PMID:18487480 · one of two readings recorded this
Flow propagation velocity (Vp)
increases, p = 0.02
fenofibrate increased Vp (2.4 ± 1.0 cm/s, P = 0.020)
PMID:18487480 · one of two readings recorded this
LVDD classification unchanged by treatment
no effect
In most subjects (82.6%), LVDD classification was unchanged by treatment
PMID:18487480 · one of two readings recorded this
Plasma and cellular CoQ levels
increases, p = 0.01
CoQ supplementation increased both plasma and cellular CoQ levels (P < 0.01)
PMID:18487480 · one of two readings recorded this
Systolic function (S', LVEF) and cardiac structure (LAV, LVM)
no effect
None of the treatments significantly altered systolic function (systolic myocardial contraction velocity [S′ and LVEF) or cardiac structure (LAV and LVM)
PMID:18487480 · one of two readings recorded this
Triglycerides, apoB-100, apoC-III, apoA-I, apoA-II
modulates, p = 0.05
fenofibrate lowered triglycerides, apoB-100, and apoC-III and increased apoA-I and apoA-II (P < 0.05)
PMID:18487480 · one of two readings recorded this
Baseline brachial artery diameter change
no effect, p = 0.69
Change | −0.1 ± 0.0 | 0.0 ± 0.0 | 0.69
PMID:19228872 · one of two readings recorded this
Brachial artery FMD, between-arm difference CoQ10 vs placebo
increases, p = 0.04
CoQ10 increased brachial artery FMD by mean ± SEM 1.0 ± 0.5% (P = 0.04) compared with placebo
PMID:19228872 · one of two readings recorded this
Brachial artery FMD change per arm
increases, p = 0.04
Change | 0.0 ± 0.5 | 1.0 ± 0.6 | 0.04
PMID:19228872 · one of two readings recorded this
Brachial artery FMD, treatment end
Treatment end | 2.1 ± 0.7 | 3.2 ± 0.5
PMID:19228872 · one of two readings recorded this
Diastolic blood pressure change
no effect, p = 0.09
Change | −2 ± 1 | 1 ± 1 | 0.09
PMID:19228872 · one of two readings recorded this
GHb change
no effect, p = 0.58
Change | −0.1 ± 0.1 | −0.1 ± 0.1 | 0.58
PMID:19228872 · one of two readings recorded this
LDL cholesterol change
no effect, p = 0.41
Change | 0.1 ± 0.1 | 0.2 ± 0.1 | 0.41
PMID:19228872 · one of two readings recorded this
nitrate-mediated dilatation (endothelium-independent), brachial ultrasound after glyceryl trinitrate
p = 0.66
Not recorded as a finding: no outcome node for nitrate-mediated dilatation
CoQ10 increased brachial artery FMD by mean ± SEM 1.0 ± 0.5% (P = 0.04) compared with placebo but did not alter nitrate-mediated dilatation (P = 0.66).
PMID:19228872 · one of two readings recorded this
Nitrate-mediated dilatation (NMD), between-arm
no effect, p = 0.66
Change | 0.9 ± 0.9 | 0.2 ± 0.8 | 0.66
PMID:19228872 · one of two readings recorded this
nitrate-mediated dilatation of the brachial artery (glyceryl trinitrate, ultrasound)
no effect, p = 0.66
Not recorded as a finding: No outcome node for endothelium-independent nitrate-mediated dilatation.
CoQ10 increased brachial artery FMD by mean ± SEM 1.0 ± 0.5% (P = 0.04) compared with placebo but did not alter nitrate-mediated dilatation (P = 0.66).
PMID:19228872 · one of two readings recorded this
Plasma CoQ10 change
increases, p = 0.001
Change | 0.0 (0.1) | 1.2 (1.5) | <0.001
PMID:19228872 · one of two readings recorded this
Plasma CoQ10 fold increase
increases, p = 0.001
Despite increasing plasma CoQ10 levels 2.7-fold (P < 0.001)
PMID:19228872 · one of two readings recorded this
plasma F2-isoprostane, gas chromatography-mass spectrometry
p = 0.58
Not recorded as a finding: no outcome node for F2-isoprostane
Despite increasing plasma CoQ10 levels 2.7-fold (P < 0.001), CoQ10 supplementation did not alter plasma F2-isoprostane (P = 0.58) or urinary 20-hydroxyeicosatetraenoic acid levels (P = 0.28) or influence glycemia, blood pressure, or lipids (P > 0.05).
PMID:19228872 · one of two readings recorded this
Plasma F2-isoprostanes change
no effect, p = 0.58
Change | −27 ± 55 | 14 ± 42 | 0.58
PMID:19228872 · one of two readings recorded this
Systolic blood pressure change
no effect, p = 0.38
Change | −4 ± 3 | −1 ± 2 | 0.38
PMID:19228872 · one of two readings recorded this
Urinary 20-HETE change
no effect, p = 0.28
Change | −53 ± 80 | 57 ± 117 | 0.28
PMID:19228872 · one of two readings recorded this
Postprandial catalase (CAT) activity
decreases
and lower SOD, CAT, and GPx activities than the SFA diet
PMID:21170684 · one of two readings recorded this
Postprandial decrease in protein carbonyl (PC)
decreases
Moreover, the Med+CoQ diet produced a lower postprandial decrease in total nitrite and a greater decrease in PC levels compared to the other two diets
PMID:21170684 · one of two readings recorded this
Postprandial decrease in total nitrite
decreases
Moreover, the Med+CoQ diet produced a lower postprandial decrease in total nitrite and a greater decrease in PC levels compared to the other two diets
PMID:21170684 · one of two readings recorded this
Postprandial decrease in total nitrite
decreases
Med diet produced a lower postprandial GPx activity and a lower decrease in total nitrite level compared to the SFA diet
PMID:21170684 · one of two readings recorded this
Postprandial glutathione peroxidase (GPx) activity
decreases
and lower SOD, CAT, and GPx activities than the SFA diet
PMID:21170684 · one of two readings recorded this
Postprandial glutathione peroxidase (GPx) activity
decreases
Med diet produced a lower postprandial GPx activity and a lower decrease in total nitrite level compared to the SFA diet
PMID:21170684 · one of two readings recorded this
Postprandial ischemic reactive hyperaemia (IRH) increase
increases
Med and Med+CoQ diets induced a higher postprandial increase in IRH and a lower postprandial LPO, oxLDL, and nitrotyrosine plasma levels than the SFA diet
PMID:21170684 · one of two readings recorded this
Postprandial plasma lipid peroxides (LPO)
decreases
Med and Med+CoQ diets induced a higher postprandial increase in IRH and a lower postprandial LPO, oxLDL, and nitrotyrosine plasma levels than the SFA diet
PMID:21170684 · one of two readings recorded this
Postprandial plasma nitrotyrosine
decreases
Med and Med+CoQ diets induced a higher postprandial increase in IRH and a lower postprandial LPO, oxLDL, and nitrotyrosine plasma levels than the SFA diet
PMID:21170684 · one of two readings recorded this
Postprandial plasma oxidized LDL (oxLDL)
decreases
Med and Med+CoQ diets induced a higher postprandial increase in IRH and a lower postprandial LPO, oxLDL, and nitrotyrosine plasma levels than the SFA diet
PMID:21170684 · one of two readings recorded this
Postprandial superoxide dismutase (SOD) activity
decreases
and lower SOD, CAT, and GPx activities than the SFA diet
PMID:21170684 · one of two readings recorded this
postprandial total nitrite, protein carbonyl, lipid peroxides, oxLDL, nitrotyrosine, SOD/catalase/GPx activities and ischemic reactive hyperaemia after Med+CoQ, Med and SFA diets
Not recorded as a finding: the comparison was against another active treatment
Moreover, the Med+CoQ diet produced a lower postprandial decrease in total nitrite and a greater decrease in PC levels compared to the other two diets and lower SOD, CAT, and GPx activities than the SFA diet.
PMID:21170684 · one of two readings recorded this
Postprandial cytoplasmic p53 protein
decreases, p = 0.05, n = 20
Moreover, Med+CoQ diet induced a postprandial decrease of cytoplasmatic p53, nuclear p-p53 (Ser20), and nuclear and cytoplasmatic monoubiquitinated p53 protein (p < 0.05)
PMID:21404051 · one of two readings recorded this
Postprandial Mdm2 mRNA
decreases, p = 0.05, n = 20
SFA diet displayed higher postprandial 8-OHdG concentrations, p53 mRNA and monoubiquitinated p53, and lower postprandial Mdm2 mRNA levels compared with Med and Med+CoQ diets (p < 0.05)
PMID:21404051 · one of two readings recorded this
Postprandial monoubiquitinated p53
increases, p = 0.05, n = 20
SFA diet displayed higher postprandial 8-OHdG concentrations, p53 mRNA and monoubiquitinated p53, and lower postprandial Mdm2 mRNA levels compared with Med and Med+CoQ diets (p < 0.05)
PMID:21404051 · one of two readings recorded this
Postprandial nuclear and cytoplasmic monoubiquitinated p53 protein
decreases, p = 0.05, n = 20
Moreover, Med+CoQ diet induced a postprandial decrease of cytoplasmatic p53, nuclear p-p53 (Ser20), and nuclear and cytoplasmatic monoubiquitinated p53 protein (p < 0.05)
PMID:21404051 · one of two readings recorded this
Postprandial nuclear phosphorylated p53 (Ser20)
decreases, p = 0.05, n = 20
Moreover, Med+CoQ diet induced a postprandial decrease of cytoplasmatic p53, nuclear p-p53 (Ser20), and nuclear and cytoplasmatic monoubiquitinated p53 protein (p < 0.05)
PMID:21404051 · one of two readings recorded this
Postprandial p53 mRNA
increases, p = 0.05, n = 20
SFA diet displayed higher postprandial 8-OHdG concentrations, p53 mRNA and monoubiquitinated p53, and lower postprandial Mdm2 mRNA levels compared with Med and Med+CoQ diets (p < 0.05)
PMID:21404051 · one of two readings recorded this
postprandial p53 pathway mRNA and protein (p53, phospho-p53 Ser20, monoubiquitinated p53, Mdm2) and plasma 8-OHdG as oxidative DNA damage
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Moreover, Med+CoQ diet induced a postprandial decrease of cytoplasmatic p53, nuclear p-p53 (Ser20), and nuclear and cytoplasmatic monoubiquitinated p53 protein (p < 0.05).
PMID:21404051 · one of two readings recorded this
Postprandial plasma 8-OHdG
increases, p = 0.05, n = 20
SFA diet displayed higher postprandial 8-OHdG concentrations, p53 mRNA and monoubiquitinated p53, and lower postprandial Mdm2 mRNA levels compared with Med and Med+CoQ diets (p < 0.05)
PMID:21404051 · one of two readings recorded this
Peak oxygen consumption (peak VO2), adjusted difference active vs placebo
increases, p = 0.05, n = 67
At multivariate analysis, 8-week peak VO(2) was significantly higher in the active treatment group than in the placebo group (+1.8 ± 0.9 mL/min/kg, 95% CI: 0.1-3.6, P < 0.05)
PMID:21462215 · one of two readings recorded this
peak oxygen consumption (peak VO2, mL/min/kg) from a cardiopulmonary exercise test at 8 weeks
increases, +1.8 ± 0.9 mL/min/kg, 95% CI 0.1-3.6
Not recorded as a finding: the intervention held more than the compound
At multivariate analysis, 8-week peak VO(2) was significantly higher in the active treatment group than in the placebo group (+1.8 ± 0.9 mL/min/kg, 95% CI: 0.1-3.6, P < 0.05).
PMID:21462215 · one of two readings recorded this
peak oxygen consumption (VO2, mL/min/kg) from cardiopulmonary exercise test at 8 weeks
increases, +1.8 ± 0.9 mL/min/kg, 95% CI 0.1-3.6, n = 67
Not recorded as a finding: the intervention held more than the compound
At multivariate analysis, 8-week peak VO(2) was significantly higher in the active treatment group than in the placebo group (+1.8 ± 0.9 mL/min/kg, 95% CI: 0.1-3.6, P < 0.05).
PMID:21462215 · one of two readings recorded this
Association of plasma CoQ10 with E-selectin
unclear, p = 0.03
E-selectin (r2 = 0.17; P = -0.03)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with IL-10
decreases, p = 0.02
IL-10 (r2 = 0.24; P = 0.02)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with IL-10
unclear, p = 0.025
IL-10 (r2 = 0.18; P = 0.025)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with IL-1ra
unclear, p = 0.014
IL-1ra (r2 = 0.21; P = 0.014)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with IL-2
unclear, p = 0.009
IL-2 (r2 = 0.23; P = 0.009)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with IL-6
unclear, p = 0.029
IL-6 (r2 = 0.17; P = 0.029)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with IL-8
unclear, p = 0.015
IL-8 (r2 = 0.21; P = 0.015)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with TNF-α
unclear, p = 0.004
TNF-α (r2 = 0.28; P = 0.004)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with VCAM
decreases, p = 0.01
inverse relationship between plasma CoQ10 levels and levels of VCAM (r2 = 0.24; P = 0.01)
PMID:21827677 · one of two readings recorded this
Association of plasma CoQ10 with VCAM
unclear, p = 0.008
vascular cell adhesion molecule (VCAM) (r2 = 0.2; P = 0.008)
PMID:21827677 · one of two readings recorded this
plasma CoQ10 level in septic shock patients versus healthy controls, and its correlation with inflammatory and endothelial biomarkers
decreases, median 0.49 (IQR 0.26 to 0.62) versus 0.95 ± 0.29 μmol/L in healthy controls
Not recorded as a finding: the compound is what was measured, not what was given
CoQ10 levels were low, with a median of 0.49 (interquartile range 0.26 to 0.62) compared to levels in healthy control patients (CoQ10 = 0.95 μmol/L ± 0.29; P < 0.0001).
PMID:21827677 · one of two readings recorded this
Plasma CoQ10 level over time, effect of simvastatin
no effect, p = 0.13
Statin therapy had no effect on plasma CoQ10 levels over time (P = 0.13)
PMID:21827677 · one of two readings recorded this
Plasma CoQ10 level, septic shock vs healthy controls
decreases, p = 0.0001
CoQ10 levels were low, with a median of 0.49 (interquartile range 0.26 to 0.62) compared to levels in healthy control patients (CoQ10 = 0.95 μmol/L ± 0.29; P < 0.0001)
PMID:21827677 · one of two readings recorded this
endothelial function by flow-mediated dilatation
increases, p = 0.0001
flow-mediated dilatation (SMD 1.70, 95% CI: 1.00-2.4, p<0.0001)
PMID:22088605 · one of two readings recorded this
endothelial function by nitrate-mediated arterial dilatation
no effect, p = 0.81
nitrate-mediated arterial dilatation was not significantly improved by using fix-effects model (SMD -0.19, 95% CI: -1.75 to 1.38, p = 0.81)
PMID:22088605 · one of two readings recorded this
CSF Abeta42 change
no effect
Changes in CSF Aβ42, tau, and P-tau(181) levels did not differ between the 3 groups
PMID:22431837 · one of two readings recorded this
CSF Abeta42, tau, P-tau181 and F2-isoprostane levels; MMSE; ADCS-ADL after 16 weeks of 400 mg coenzyme Q three times daily vs placebo
no effect, Changes in CSF Abeta42, tau and P-tau181 did not differ between the 3 groups
Not recorded as a finding: this platform holds no node for the endpoint
Changes in CSF Aβ42, tau, and P-tau(181) levels did not differ between the 3 groups.
PMID:22431837 · one of two readings recorded this
CSF F2-isoprostane change from baseline
no effect
Cerebrospinal fluid F2-isoprostane levels, an oxidative stress biomarker, decreased on average by 19% from baseline to week 16 in the E/C/ALA group but were unchanged in the other groups
PMID:22431837 · one of two readings recorded this
CSF F2-isoprostane change from baseline
decreases
Cerebrospinal fluid F2-isoprostane levels, an oxidative stress biomarker, decreased on average by 19% from baseline to week 16 in the E/C/ALA group but were unchanged in the other groups
PMID:22431837 · one of two readings recorded this
CSF P-tau181 change
no effect
Changes in CSF Aβ42, tau, and P-tau(181) levels did not differ between the 3 groups
PMID:22431837 · one of two readings recorded this
CSF tau change
no effect
Changes in CSF Aβ42, tau, and P-tau(181) levels did not differ between the 3 groups
PMID:22431837 · one of two readings recorded this
Mini-Mental State Examination decline
decreases
accelerated decline in Mini-Mental State Examination scores occurred in the E/C/ALA group, a potential safety concern
PMID:22431837 · one of two readings recorded this
functional intracellular deficiency of coenzyme Q10 status, Functional Intracellular Assay (SpectraCell), PD cases versus matched controls
increases, OR 4.7-5.4 for CoQ10 deficiency in PD cases (95% CI 1.5-17.7)
Not recorded as a finding: the compound is what was measured, not what was given
Compared to cases, PD patients had a significantly greater odds of deficiency in coenzyme Q10 status (OR: 4.7-5.4; 95% CI: 1.5-17.7; P=0.003-0.009) based on FIA results, but not of vitamin E, selenium, lipoic acid, or glutathione (all P>0.05).
PMID:22542608 · one of two readings recorded this
Odds of functional coenzyme Q10 deficiency (FIA), PD vs controls
increases, n = 22
Compared to cases, PD patients had a significantly greater odds of deficiency in coenzyme Q10 status (OR: 4.7-5.4; 95% CI: 1.5-17.7; P=0.003-0.009) based on FIA results
PMID:22542608 · one of two readings recorded this
Odds of functional deficiency in vitamin E, selenium, lipoic acid, glutathione, PD vs controls
no effect, p = 0.05, n = 22
but not of vitamin E, selenium, lipoic acid, or glutathione (all P>0.05)
PMID:22542608 · one of two readings recorded this
Proportion with coenzyme Q10 deficiency, cases vs controls
increases
The proportion of cases with coenzyme Q10 deficiency was also significantly greater in cases than in controls (32-36% vs. 8-9%; P=0.0012-0.006)
PMID:22542608 · one of two readings recorded this
Activities of daily living UPDRS
decreases
there were improvements in activities of daily living (ADL) UPDRS (WMD -3.12, 95% CI -5.88 to -0.36)
PMID:22592726 · one of two readings recorded this
Diarrhea
no effect
diarrhea (RR 1.39, 95% CI 0.62 to 3.16)
PMID:22592726 · one of two readings recorded this
Pharyngitis
no effect
the risk ratios (RR) of pharyngitis (RR 1.04, 95% CI 0.18 to 5.89)
PMID:22592726 · one of two readings recorded this
Schwab and England scale
increases
Schwab and England (WMD 4.43, 95% CI 0.05 to 8.81) for coenzyme Q10 at 1200 mg/d for 16 months versus placebo
PMID:22592726 · one of two readings recorded this
Withdrawals due to adverse effects
no effect
there were no differences in the number of withdrawals due to adverse effects (RR 0.61, 95% CI 0.23 to 1.62)
PMID:22592726 · one of two readings recorded this
Depression, CES-D
no effect, p = 0.632
or the Center for Epidemiologic Studies-Depression scale (11.6 vs 12.3, P = .632)
PMID:22682875 · one of two readings recorded this
Fatigue, FACIT-Fatigue
no effect, p = 0.965
the Functional Assessment of Chronic Illness Therapy-Fatigue tool (37.6 vs 37.6, P = .965)
PMID:22682875 · one of two readings recorded this
Fatigue, Profile of Mood States-Fatigue
no effect, p = 0.257
There were no significant differences between the CoQ10 and placebo arms at 24 weeks for scores on the Profile of Mood States-Fatigue questionnaire (least squares means, 7.08 vs 8.24, P = .257)
PMID:22682875 · one of two readings recorded this
Plasma CoQ10 level
increases
Baseline CoQ10 levels in the CoQ10 and placebo arms were 0.70 and 0.73 microg/mL, respectively; the 24-week CoQ10 levels were 1.83 and 0.79 microg/mL, respectively
PMID:22682875 · one of two readings recorded this
Quality of life, FACT-B
no effect, p = 0.577
the Functional Assessment of Cancer Therapy-Breast Cancer instrument (111.9 vs 110.4, P = .577)
PMID:22682875 · one of two readings recorded this
baseline area under the temperature curve (TMP-AUC)
no effect, p = 0.3
Similarly, there was no difference between the AGE/CoQ10 and placebo groups in baseline TMP-AUC (61.4 ± 8.3 versus 47.3 ± 7.3, P = 0.3)
PMID:22858191 · one of two readings recorded this
baseline pulse-wave velocity (PWV)
no effect, p = 0.6
The baseline PWV was no different in the AGE/CoQ10 group than in the placebo group (8.11 ± 0.91 versus 8.26 ± 1.15 m/s, P = 0.6)
PMID:22858191 · one of two readings recorded this
C-reactive protein decrease in firefighters with PWV decrease greater than 0.18
decreases
firefighters in the AGE/CoQ10 group who had a PWV decrease greater than 0.18 showed the greatest CRP decrease
PMID:22858191 · one of two readings recorded this
pulse-wave velocity (PWV) decrease, adjusted
decreases, p = 0.005
After 1 y of the study, the mean decrease in PWV was 1.21 m/s in the AGE/CoQ10 group compared with the placebo group (P = 0.005)
PMID:22858191 · one of two readings recorded this
PWV decrease, regression estimate reported as relative risk
decreases, p = 0.005
the relative risk of the AGE/CoQ10 treatment in decreasing the PWV was 1.21 (95% confidence limit −2.1 to −0.32, P = 0.005)
PMID:22858191 · one of two readings recorded this
TMP-AUC increase, adjusted
increases, p = 0.01
the mean increase in TMP-AUC was 31.28 in the AGE/CoQ10 group compared with the placebo group (P = 0.01) after an adjustment for all risk factors
PMID:22858191 · one of two readings recorded this
TMP-AUC increase, regression estimate reported as relative risk
increases, p = 0.01
a relative risk of 31.3 (95% confidence limit 1.67–60.91, P = 0.01)
PMID:22858191 · one of two readings recorded this
Blood oxidative stress (lactate, malondialdehyde, hydrogen peroxide)
no effect
but did not improve exercise performance (with the exception of selected individuals) or impact oxidative stress
PMID:22966414 · one of two readings recorded this
Correlation of percentage change in total blood CoQ10 with cycle sprint total work
unclear
The relationship between the percentage change in total blood CoQ10 and the cycle sprint total work (R(2) = 0.6009) was noted to be moderate to strong
PMID:22966414 · one of two readings recorded this
Exercise performance (graded treadmill test and repeated cycle sprint test)
no effect
but did not improve exercise performance (with the exception of selected individuals) or impact oxidative stress
PMID:22966414 · one of two readings recorded this
Reduced blood CoQ10 (ubiquinol)
increases, p = 0.02
Treatment with CoQ10 resulted in a significant increase in total blood CoQ10 (138%; P = 0.02) and reduced blood CoQ10 (168%; P = 0.02)
PMID:22966414 · one of two readings recorded this
Total blood CoQ10
increases, p = 0.02
Treatment with CoQ10 resulted in a significant increase in total blood CoQ10 (138%; P = 0.02) and reduced blood CoQ10 (168%; P = 0.02)
PMID:22966414 · one of two readings recorded this
ejection fraction (EF) in congestive heart failure, pooled mean net change; NYHA functional class
pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF
Not recorded as a finding: the direction is carried only as a signed number
Supplementation with CoQ₁₀ resulted in a pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF and -0.30 (95% CI: -0.66, 0.06) in the NYHA functional class.
PMID:23221577 · one of two readings recorded this
ejection fraction (EF) in congestive heart failure, pooled mean net change
pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF
Not recorded as a finding: the direction is carried only as a signed number
Supplementation with CoQ₁₀ resulted in a pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF and -0.30 (95% CI: -0.66, 0.06) in the NYHA functional class.
PMID:23221577 · one of two readings recorded this
Ejection fraction (pooled mean net change)
increases
Supplementation with CoQ₁₀ resulted in a pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF and -0.30 (95% CI: -0.66, 0.06) in the NYHA functional class
PMID:23221577 · one of two readings recorded this
Ejection fraction
increases
Subgroup analyses showed significant improvement in EF for crossover trials, trials with treatment duration ≤12 wk in length, studies published before 1994, and studies with a dose ≤100 mg CoQ₁₀/d and in patients with less severe CHF
PMID:23221577 · one of two readings recorded this
Ejection fraction
increases
Subgroup analyses showed significant improvement in EF for crossover trials, trials with treatment duration ≤12 wk in length, studies published before 1994, and studies with a dose ≤100 mg CoQ₁₀/d and in patients with less severe CHF
PMID:23221577 · one of two readings recorded this
Ejection fraction
increases
Subgroup analyses showed significant improvement in EF for crossover trials, trials with treatment duration ≤12 wk in length, studies published before 1994, and studies with a dose ≤100 mg CoQ₁₀/d and in patients with less severe CHF
PMID:23221577 · one of two readings recorded this
Ejection fraction
increases
Subgroup analyses showed significant improvement in EF for crossover trials, trials with treatment duration ≤12 wk in length, studies published before 1994, and studies with a dose ≤100 mg CoQ₁₀/d and in patients with less severe CHF
PMID:23221577 · one of two readings recorded this
Ejection fraction
increases
Subgroup analyses showed significant improvement in EF for crossover trials, trials with treatment duration ≤12 wk in length, studies published before 1994, and studies with a dose ≤100 mg CoQ₁₀/d and in patients with less severe CHF
PMID:23221577 · one of two readings recorded this
Left heart ejection fraction (EF), pooled mean net percentage change; NYHA functional classification, pooled mean net change
increases, pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in EF
Not recorded as a finding: this platform holds no node for the endpoint
Supplementation with CoQ₁₀ resulted in a pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF and -0.30 (95% CI: -0.66, 0.06) in the NYHA functional class.
PMID:23221577 · one of two readings recorded this
Left ventricular ejection fraction (EF)
increases, pooled mean net change 3.67% (95% CI 1.60%, 5.74%)
Supplementation with CoQ₁₀ resulted in a pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF and -0.30 (95% CI: -0.66, 0.06) in the NYHA functional class.
PMID:23221577 · one of two readings recorded this
NYHA functional class (pooled mean net change)
no effect
Supplementation with CoQ₁₀ resulted in a pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF and -0.30 (95% CI: -0.66, 0.06) in the NYHA functional class
PMID:23221577 · one of two readings recorded this
NYHA functional class
no effect, pooled mean net change -0.30 (95% CI -0.66, 0.06)
Supplementation with CoQ₁₀ resulted in a pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF and -0.30 (95% CI: -0.66, 0.06) in the NYHA functional class.
PMID:23221577 · one of two readings recorded this
chronic fatigue score
decreases
Ubiquinol-10 supplementation also improved chronic fatigue scores as measured by the Chalder Fatigue Scale
PMID:23394493 · one of two readings recorded this
%CoQ10 after supplementation
decreases
This resulted in an increase in coenzyme Q10 levels and a decrease in %CoQ10
PMID:23394493 · one of two readings recorded this
FFA levels and composition after supplementation
no effect
No changes were observed in FFA levels or their composition
PMID:23394493 · one of two readings recorded this
monoenoic acids (oleic and palmitoleic acids) content
increases
the content of monoenoic acids, such as oleic and palmitoleic acids, was significantly increased in FM relative to controls
PMID:23394493 · one of two readings recorded this
plasma cholesterol esters (CE)
increases
Levels of FC and CE were significantly increased in juvenile FM as compared with controls
PMID:23394493 · one of two readings recorded this
plasma coenzyme Q10 levels after supplementation
increases
This resulted in an increase in coenzyme Q10 levels and a decrease in %CoQ10
PMID:23394493 · one of two readings recorded this
plasma FC and CE after supplementation
decreases
plasma levels of FC and CE significantly decreased and the ratio of FC to CE also significantly decreased
PMID:23394493 · one of two readings recorded this
plasma free cholesterol, cholesterol esters and free fatty acids; plasma CoQ10 and %CoQ10; fatigue on the Chalder Fatigue Scale, before and after supplementation in juvenile fibromyalgia patients
decreases, improved chronic fatigue scores on the Chalder Fatigue Scale after ubiquinol-10
Not recorded as a finding: the trial gave a chemically different species
Ubiquinol-10 supplementation also improved chronic fatigue scores as measured by the Chalder Fatigue Scale.
PMID:23394493 · one of two readings recorded this
plasma free cholesterol (FC)
increases
Levels of FC and CE were significantly increased in juvenile FM as compared with controls
PMID:23394493 · one of two readings recorded this
plasma free fatty acids (FFA)
increases
plasma level of FFA was significantly higher and the content of polyunsaturated fatty acids (PUFA) in total FFA was significantly lower in FM than in controls
PMID:23394493 · one of two readings recorded this
plasma ubiquinol-10
decreases
plasma level of ubiquinol-10 was significantly decreased and the ratio of ubiquinone-10 to total coenzyme Q10 (%CoQ10) was significantly increased in juvenile FM relative to healthy controls
PMID:23394493 · one of two readings recorded this
polyunsaturated fatty acid (PUFA) content of total FFA
decreases
plasma level of FFA was significantly higher and the content of polyunsaturated fatty acids (PUFA) in total FFA was significantly lower in FM than in controls
PMID:23394493 · one of two readings recorded this
ratio of FC to CE after supplementation
decreases
plasma levels of FC and CE significantly decreased and the ratio of FC to CE also significantly decreased
PMID:23394493 · one of two readings recorded this
ratio of ubiquinone-10 to total coenzyme Q10 (%CoQ10)
increases
plasma level of ubiquinol-10 was significantly decreased and the ratio of ubiquinone-10 to total coenzyme Q10 (%CoQ10) was significantly increased in juvenile FM relative to healthy controls
PMID:23394493 · one of two readings recorded this
IL-1β, NLRP3 protein expression and caspase-1 activation
increases
Mitochondrial dysfunction was accompanied by increased protein expression of interleukin (IL)-1β, NLRP3 (NOD-like receptor family, pyrin domain containing 3) and caspase-1 activation
PMID:23886272 · one of two readings recorded this
NLRP3 inflammasome activation and algesia
increases
CoQ10 deficiency induced by p-aminobenzoate treatment in blood mononuclear cells and mice showed NLRP3 inflammasome activation with marked algesia
PMID:23886272 · one of two readings recorded this
NLRP3 inflammasome activation
decreases
A placebo-controlled trial of CoQ10 in FM patients has shown a reduced NLRP3 inflammasome activation and IL-1β and IL-18 serum levels
PMID:23886272 · one of two readings recorded this
serum IL-1β and IL-18
decreases
A placebo-controlled trial of CoQ10 in FM patients has shown a reduced NLRP3 inflammasome activation and IL-1β and IL-18 serum levels
PMID:23886272 · one of two readings recorded this
serum IL-1beta and IL-18 in fibromyalgia patients, placebo-controlled CoQ10 trial
decreases
Not recorded as a finding: no outcome node for IL-1beta or IL-18; abstract only, no estimate or p value stated
A placebo-controlled trial of CoQ10 in FM patients has shown a reduced NLRP3 inflammasome activation and IL-1β and IL-18 serum levels.
PMID:23886272 · one of two readings recorded this
serum interleukin-1 beta and interleukin-18 levels in fibromyalgia patients, placebo-controlled CoQ10 trial (abstract only)
decreases
Not recorded as a finding: no outcome node for IL-1 beta or IL-18; the abstract gives no estimate and no between-group figure
A placebo-controlled trial of CoQ10 in FM patients has shown a reduced NLRP3 inflammasome activation and IL-1β and IL-18 serum levels.
PMID:23886272 · one of two readings recorded this
serum proinflammatory cytokines IL-1β and IL-18
increases
an increase of serum levels of proinflammatory cytokines (IL-1β and IL-18)
PMID:23886272 · one of two readings recorded this
sperm concentration
increases
sperm concentration (RR 5.33, 95 % CI 4.18 to 6.47, I(2) = 58 %)
PMID:23912751 · one of two readings recorded this
CoQ10 seminal concentration
increases
CoQ10 seminal concentration (RR 49.55, 95 % CI 46.44 to 52.66, I(2) = 17 %)
PMID:23912751 · one of two readings recorded this
Live birth rate
Not recorded as a finding: No trial in the meta-analysis reported any data on live births.
None of the included trials provided any data regarding live births.
PMID:23912751 · both readings recorded this
live birth rate
None of the included trials provided any data regarding live births.
PMID:23912751 · one of two readings recorded this
pregnancy rate
Not recorded as a finding: clinical-pregnancy-rate node requires an ultrasound-confirmed intrauterine gestational sac; the abstract states only 'pregnancy rates' with no instrument named (instrument_not_stated), and the finding is a one-sided negation ('does not increase') so no_effect cannot be recorded either
The results of this meta-analysis show that supplementing infertile men with CoQ10 does not increase pregnancy rates.
PMID:23912751 · both readings recorded this
Pregnancy rate
n = 296
The results of this meta-analysis show that supplementing infertile men with CoQ10 does not increase pregnancy rates.
PMID:23912751 · one of two readings recorded this
pregnancy rate
no effect
The results of this meta-analysis show that supplementing infertile men with CoQ10 does not increase pregnancy rates.
PMID:23912751 · one of two readings recorded this
sperm motility
increases
sperm motility (RR 4.50, 95 % CI 3.92 to 5.08, I(2) = 0 %)
PMID:23912751 · one of two readings recorded this
New York Heart Association (NYHA) classification of clinical status
not poolable due to heterogeneity
Five trials reported on the New York Heart Association (NYHA) classification of clinical status, but it was impossible to pool data due to heterogeneity.
PMID:24049047 · one of two readings recorded this
New York Heart Association (NYHA) functional classification
Not recorded as a finding: no outcome node exists for NYHA class; also unpoolable due to heterogeneity across five trials
Five trials reported on the New York Heart Association (NYHA) classification of clinical status, but it was impossible to pool data due to heterogeneity.
PMID:24049047 · one of two readings recorded this
total mortality, major cardiovascular events and hospitalisation
Not recorded as a finding: outcome nodes exist (all-cause-mortality) but no quantitative result was reported; only one study contributed data
Only one study reported on total mortality, major cardiovascular events and hospitalisation.
PMID:24049047 · one of two readings recorded this
Sources cited
34 papers
- Subject
- coenzyme Q10
- Findings
- 67
- Papers
- 34
Coenzyme Q10 Impact on Ovarian Reserve Measures and the Intra-Cytoplasmic Sperm Injection (ICSI) Outcomes in Women with Poor Ovarian Response: A Randomized Controlled Study.record2026PMID:418002951 finding
Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta-Analyses of Randomised Controlled Trials.record2026PMID:418597721 finding
The effects of coenzyme Q10 supplementation on glycemic control in diabetic and non-diabetic individuals: a systematic review and meta-analysis.record2026PMID:416305011 finding
Clinical efficacy of adjunctive use of coenzyme Q10 in non-surgical periodontal treatment: A systematic review.record2025PMID:399208832 findings
Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.record2025PMID:412942511 finding
Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment.record2025PMID:412615121 finding
The effect of coenzyme Q10 supplementation on depressive symptoms and anxiety: a systematic review and meta-analysis of randomized controlled trials.record2025PMID:408334701 finding
Coenzyme Q10 prevents RANKL-induced osteoclastogenesis by promoting autophagy via inactivation of the PI3K/AKT/mTOR and MAPK pathways.record2024PMID:387169851 finding
Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.record2024PMID:3843160010 findings
The effects of coenzyme Q10 supplementation on biomarkers of exercise-induced muscle damage, physical performance, and oxidative stress: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.record2024PMID:384799001 finding
Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease.record2023PMID:371592641 finding
TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis.record2023PMID:374643571 finding
A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.record2022PMID:337828205 findings
The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.record2022PMID:346645271 finding
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.record2021PMID:325440113 findings
The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network Meta-analysis.record2021PMID:339884781 finding
Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.record2020PMID:325833564 findings
Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.record2020PMID:323753401 finding
No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.record2020PMID:333470241 finding
Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.record2019PMID:308353271 finding
Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.record2018PMID:301513732 findings
The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.record2018PMID:293307041 finding
The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.record2018PMID:304177827 findings
Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.record2017PMID:281792053 findings
Effect of Coenzyme Q10 Supplementation on Diabetes Biomarkers: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials.record2016PMID:275443691 finding
Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis.record2016PMID:268368881 finding
Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.record2015PMID:259137562 findings
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.record2014PMID:254744844 findings
Coenzyme Q10 for heart failure.record2014PMID:240490471 finding
Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial.record2013PMID:241920151 finding
Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials.record2012PMID:220886051 finding
Coenzyme Q10 for Parkinson's disease.recordRetracted2011PMID:221614201 finding
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.record2009PMID:198214182 findings
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.record2009PMID:192288721 finding
Other names
15 names
Resolves to: coenzyme Q10
- Also called
- 2-((all-E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone2-(3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2E,6E,10E,14E,18E,22E,26E,30E,34E,38-decaenyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinoneAdelirall-trans-ubiquinoneCoQCoQ10Q 199Q10Ubidecarenoneubiquinoneubiquinone 10ubiquinone 50Ubiquinone-10
- Systematic name
- 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione